A colleague has been talking about a company called AST SpaceMobile for months.

Space-based cellular broadband. Direct-to-device. Governments involved. Verizon. 50+ mobile network operators. Nearly 3 billion potential subscribers. A monopolistic position in the making. 20-30x by 2030.

He speaks about it with the fluency of someone who has done serious work.

I recognize that fluency. I have had it myself, on other ideas, at other times.

The confidence that comes from absorbing a compelling thesis is almost indistinguishable from the confidence that comes from actually doing the work.

So I asked him four questions.

What is the current dilution tempo? What does the cash burn look like relative to the cash position? What is SBC as a percentage of revenue? And — specifically — why do the short sellers have it wrong?

Silence.

Not approximately. Not directionally. Not at all.

He had the destination. He did not have any of the map.

So I went and found the answers myself.

Subscribe now

Around $37 billion market cap. $71 million in revenue. $342 million net loss in 2025. $363 million in operating cash burn in a single quarter. Multiple senior executives — President, CFO, COO, CTO — selling hundreds of thousands of shares in the months prior, with no meaningful insider buying on the other side.

And a race against SpaceX, which has more capital, more launches, and more satellites already in orbit.

The short thesis is not a bombshell. There is no fraud allegation, no regulatory smoking gun. It is simply: the valuation is enormous, the losses are real, the execution risk is significant, and the entire thesis requires a sequence of engineering milestones all going right simultaneously against a better-capitalised competitor.

I presented this to my colleague.

His response:

And I have been thinking about that response since.

Not as a judgment on him, but as a mirror.

Because… where do I show the same kind of behavior?

When contradicting evidence arrives and we respond by doubling down, something specific is happening. We are not evaluating information. Instead we are more likely to defend the story. The short sellers become confirmation of a squeeze opportunity, the losses become the price of a revolution, the insider selling becomes noise.

Every piece of contrary evidence gets reprocessed as support.

This is the backfire effect. Contradicting evidence does not update the model. It reinforces it.

And the reason it happens is not stupidity. It happens because we outsourced the work somewhere along the way, and absorbed a conclusion from someone we trust, without acquiring the reasoning that produced it. When that conclusion is challenged, we have nothing to defend it with except the conclusion itself.

We have all done this. The question is whether we notice it when we do.

Share

I know my own version.

For a period, my portfolio looked different every week. I would spend days building conviction in a company. Reading the annual reports, running the numbers, convincing myself I understood the moat, and then sell it two weeks later because the price moved against me, or because I read something unsettling, or simply because doubt crept in overnight.

I bought companies I loved on a Tuesday and questioned on a Thursday. I called it being responsive. It was something else.

It was the same problem in a different costume. My colleague holds a narrative too tightly to update it. I held my own conclusions too loosely to trust them. Both of us, for the same underlying reason: we had not done enough of the real work to know, with genuine conviction, what we owned and why.

One person doubles down, the other keeps rotating. But they share a common origin: borrowed confidence. My colleague borrowed his from a few voices on X. I borrowed mine from the last thing I read that was more compelling than my own reasoning.

Real conviction is the kind that survives a bad week, a negative article, and a price drop. It does not come from a thesis you absorbed. It comes from work you cannot hand to someone else.

Subscribe now

Which brings me back to the question I started with.

What my colleague has is not an investment thesis. It is a story with a price target attached.

And I do think the story is genuinely compelling.

Space connectivity is real. The technology works. The contracts are real. It may even be that the 20-30x call proves correct. I cannot rule that out, and I want to be honest about that.

But here is what I do know: he cannot tell you why the short sellers are wrong. He cannot tell you what happens to the thesis if the next launch fails. He cannot tell you at what cash burn rate the dilution becomes thesis-breaking rather than manageable.

So when the story hits turbulence (and all stories do) there will be no framework for evaluating whether the thesis is broken or merely delayed. The result will be a decision made on feeling, at exactly the moment when feeling is least reliable.

Not from volatility. Not from short sellers. Not from macro.

From not knowing.

The most dangerous form of not knowing is not knowing that you do not know. And the “that’s it?!” response is its signature, because someone who genuinely understood the risk would not dismiss the short thesis in four words. They would engage with it. Even if they ultimately disagreed.

Share

I am not in ASTS. Not because I am certain it fails, but because I cannot get inside the circle of competence fast enough to evaluate whether the execution risk is adequately priced at this valuation. The framework I use says: when you cannot answer that question, the correct response is to pass.

There are businesses I can evaluate. There are businesses whose earnings in ten years I can describe with something approaching confidence. A pre-profit satellite constellation racing SpaceX to commercial scale is not one of them.

My colleague may make a lot of money. That outcome is genuinely possible. But a good outcome does not validate the process that produced it. The nut does not prove the squirrel could see.

The question I try to ask now, before committing capital to anything, including the ideas I am most excited about:

If I cannot do that, I am not really holding a position. I am holding someone else’s research and conviction.

That distinction is worth sitting with.

Especially on the ideas that feel most certain.

If you read the Thesis Brief, you know the business. You know the flywheel, you know the Estonian tax shock, you know that a 78% EBITDA margin on a classifieds portfolio is genuinely extraordinary. You know the thesis.

This piece goes underneath it.

I want to be upfront about something before we start. I bought a position in BCG after writing the Thesis Brief. But by the time I finished this Deep Dive, I had sold it.

Not because the business disappointed me. The business is everything the Brief said it was, and more. But going through every corner of a company sometimes teaches you something the headline numbers cannot.

It’s about what you are actually paying, and about what you are taking on that does not show up in any financial model.

That lesson is in here, in this deep dive. It comes near the end. I think it is worth the walk to get there.

In this deep dive we are going to:

• look at each of BCG’s four segments individually, not just the revenue number but what is actually driving it and whether it sustains.

• look at the two people running this business and whether they have earned the trust their shareholders are placing in them.

• examine the one acquisition BCG has made and what it says about their capital discipline.

• build the valuation from scratch, assumption by assumption, rather than just quoting a range.

(Put this on listen. It is built for the walk, the commute, and the gym.)

Let’s get into it.

Subscribe now

The four segments, one at a time

BCG reports four business lines:

1. Auto

2. Real Estate

3. Jobs and Services

4. Generalist

Together they produced €44.8m in revenue in the first half of BCG’s 2026 financial year — the six months to the end of October 2025.

But the aggregate number hides something interesting.

Three of the four segments are telling a story of genuine momentum. The fourth is telling a very different story, and understanding the difference is the key to understanding whether this thesis holds.

Real Estate

Let’s start with Real Estate, because Real Estate is where BCG is doing something that deserves more attention than it has received.

In the six months to October 2025, Real Estate revenue was €13.2m. That is up 20% from the year before. Twenty percent revenue growth from a business that already dominates its market. The interesting part is where that growth came from. It was not just price increases, though there were price increases.

The number of real estate brokers paying BCG a monthly subscription grew 4%. The monthly fee each broker pays (the ARPU) grew 16%. And on the consumer side, private sellers paying per listing saw their per-listing yield increase 27%.

Three levers pulling in the same direction at the same time. That does not happen by accident.

Share

What is driving it is a combination of two things. The first is the Baltic real estate market itself, which is genuinely hot right now. Real estate transactions across Lithuania, Estonia, and Latvia grew 7% in the period. Average apartment prices in the three capital cities are up 4%.

When the underlying market is active, brokers are busier, developers are more willing to pay for visibility, and private sellers are more motivated to list at a premium tier because faster sales justify the cost. BCG benefits from a healthy market.

But the second driver is more interesting and more durable. BCG has been deepening the Real Estate product in ways that are changing the relationship between the platform and its professional users. Property Price Compass, the tool that integrates national land registry transaction data with listing history to produce a professional pricing report, was introduced at Aruodas.lt in Lithuania over the last two years.

It is now something broker clients expect. At Untu.lt, the recently acquired platform, agents are handling leads through an AI-assisted call tracking service that logs conversations, suggests follow-up actions, and gives brokers visibility into what happens after a lead is acquired.

These are not cosmetic features. They are workflow tools. And workflow tools create a completely different switching cost profile than listing services. A broker who uses Property Price Compass at every vendor meeting cannot easily switch to a competitor platform without losing the tool her clients have come to expect. BCG is not just the place where listings happen. It is becoming the software layer through which Baltic real estate professionals run their business.

The honest question to ask about Real Estate is whether this growth is repeatable.

The market tailwind (active transactions, rising prices) could cool. Interest rates in the Baltics have been falling, which has supported the market, but that tailwind is not permanent. And the ARPU expansion of 16% reflects pricing changes implemented in September and October 2024.

Those changes have now fully annualised. The next set of pricing changes was implemented in September and October 2025, and they have not yet fully fed through. So the near-term revenue picture for Real Estate looks strong. The medium-term picture depends on whether the Baltic real estate market stays active and whether BCG can continue deepening the product quickly enough to justify continued pricing power.

My read is that Real Estate is the segment carrying the thesis right now. It is growing at a rate that suggests the moat is widening rather than just holding.

Auto

Now Auto, which is the segment everyone has been focused on for the wrong reasons.

Auto produced €16.0m in revenue in the half. Exactly flat with the year before.

Not collapsing, not growing. Just flat.

The Brief explained why; the Estonian vehicle tax halved car transactions, listing volumes fell 29%, but dealer subscriptions held and per-listing prices rose enough to compensate.

What the Brief did not go into is what Auto actually looks like at the unit level, and the unit level picture is more interesting than the flat headline suggests.

On the B2C side (the professional dealer subscriptions) the number of dealers paying BCG fell by just 1% despite the Estonian market collapsing. One percent. In a country where car transactions were down between 45% and 66% every single month. Dealers stayed on the platform because where else were they going to advertise? And the monthly fee each dealer pays grew 13%. In Auto, in a terrible market, BCG still managed to raise prices and keep almost every dealer on the subscription.

On the C2C side (private sellers) the volume picture is ugly. Listed ads down 29%, active ads down 26%. That is the Estonian tax at work. But the per-listing yield grew 29%. The sellers who did list paid more. Again, because there is nowhere else to go.

Subscribe now

Now here is the thing about Auto that makes me genuinely optimistic about H2. The terrible Estonian comparison base rolls off in January 2026. The tax was introduced in December 2024, so from January 2026 onwards you are comparing current Auto performance against already-collapsed prior-year numbers. The year-on-year percentage will flip from negative to positive almost mechanically. Management has confirmed this explicitly.

Lithuania, which is the larger Auto market for BCG, grew car transactions 8% in the same period. BCG’s Autoplusas platform in Lithuania leads the nearest competitor by 6 times on time spent on site. That market is healthy and BCG’s position in it is strong. Auto is not broken. One country implemented a severe tax that hurt one year’s results. The business underneath is intact.

Jobs and Services

Jobs and Services grew 7%, driven by a combination of more customers and better yields. The Jobs side, primarily CVbankas in Lithuania, grew both customer numbers and the monthly fee per customer. The unemployment rate in Lithuania ticked up slightly to 7.1%, which sounds like a headwind but actually reflects a growing labour force rather than a shrinking economy. Lithuanian wages grew 8.5% in the year. Companies are still hiring and still willing to pay for CVbankas’s recruitment tools, including the salary estimator that gives them a data advantage in setting competitive offers.

Services — the C2C classifieds for tradespeople and service providers — grew active ads 11%. More plumbers, cleaners, and builders are listing on BCG’s services portals. This is a steadily growing vertical that does not get much attention because it is modest in size but the trend is consistent.

Generalist

Generalist grew 4%, which looks unimpressive until you understand what it is.

Skelbiu.lt, BCG’s main generalist portal in Lithuania, is the sixth most visited website in the entire country. It competes partly with BCG’s own vertical platforms through cross-listing.

A private seller who lists a car on Skelbiu.lt may also get redirected to Autoplusas. The generalist portal is as much a traffic acquisition tool for the verticals as it is a standalone business. Growth of 4% driven by yield improvement, with active inventory holding steady, is the right outcome for this segment.

The synthesis is straightforward. Real Estate is carrying the thesis, growing at 20% with unit economics that suggest the moat is deepening. Auto is temporarily impaired by policy, structurally intact, and set to show positive year-on-year growth from January 2026 onwards. Jobs and Services is growing steadily with no signs of stress. Generalist is modest, useful, and not the point.

Share

The people running this business

BCG listed on the London Stock Exchange in July 2021. Justinas Šimkus has been CEO since before the IPO. Lina Mačienė is CFO.

They have been running this business together through the IPO, through the post-COVID normalisation, through the Estonian tax shock, and through a sustained period of annual price increases that have pushed ARPU and yields consistently higher across every segment.

The way to evaluate management is not to read their investor presentations. It is to compare what they said with what happened.

At the IPO, BCG’s stated capital allocation policy was to return one third of adjusted net income annually through dividends, with the preference for returning excess cash through share buybacks. Three and a half years later, that is exactly what they have done.

The dividend policy has been adhered to with mechanical consistency. Buybacks have continued through good periods and bad ones.

In the half-year to October 2025, with the Estonian situation creating uncertainty, they still bought back €6.4m of shares and paid a €12.5m dividend. They also voluntarily repaid €10m of debt, which was not required but was the right use of surplus cash.

The Estonian Auto situation is itself a management test. When the vehicle tax was introduced and it became clear that Estonian car transactions were going to collapse, there was a decision to be made about whether to adjust B2C pricing for Estonian car dealers.

BCG’s annual B2C pricing actions were implemented in September and October 2024 for most of its markets. For Estonian Auto dealers specifically, the pricing adjustments were postponed.

They made the right call.

Hitting Estonian dealers with a price increase at the same moment the tax was destroying their market would have been extractive and short-sighted. Instead they held pricing for that one market, kept almost all their dealer base, and positioned themselves for recovery when the comparisons normalise.

That is the Bloopers Test in action. A management team making obvious, decent decisions rather than clever ones.

Share

The one area where I would want more information is on organic growth strategy beyond price increases.

BCG’s revenue growth has been driven primarily by yield expansion (charging existing users more) rather than by growing the user base materially. The number of real estate brokers grew 4% in the half. Auto dealers actually fell 1%. Jobs companies grew 1%. These are not large customer base expansions. The strategy is to extract more value from an already-dominant position rather than to expand the addressable market.

That is a legitimate and often excellent strategy. It is the strategy of a business that knows it has already won its market. But it does mean that the long-term growth trajectory is bounded by how far you can push yields before the customer pushes back. Management has not yet found that wall. Three consecutive years of pricing increases and no material customer loss suggests the wall is further away than bears assume. But it exists, and an honest assessment of management has to acknowledge it.

Overall: yes, I trust these people.

They have done what they said they would do, they have made sensible operational decisions under pressure, and they have not done anything that suggests they are optimising for personal benefit at the expense of shareholders.

The one acquisition

BCG has made one acquisition since listing: Untu.lt, a Lithuanian real estate technology platform, acquired in FY2025 for €1.0m.

One million euros. For context, BCG generates approximately €60m in operating cash annually. This was not a transformative deal. It was a targeted technology acquisition.

What Untu.lt brought was a set of AI-assisted real estate tools;

• The property valuation technology that became Property Price Compass

• The call tracking and lead management system now used by agents on the platform.

BCG acquired a technology capability that deepened their Real Estate moat rather than a revenue stream or a new market.

The price discipline is the notable thing.

€1.0m for a technology acquisition that is now embedded in the workflow of thousands of real estate brokers across the Baltics. That is not a trophy acquisition. That is a specific capability bought at a sensible price and integrated into the core product.

What it signals about BCG’s M&A appetite: they are not empire builders. They are not using their cash generation to buy adjacencies or to pay premium multiples for growth. The one acquisition they made was small, targeted, and directly additive to the moat they already have. That is the right behaviour for a dominant franchise in a small market.

Where the numbers came from; the history since listing

BCG listed in July 2021. Here is what has happened to the business since then:

When BCG listed, revenue for the financial year ending April 2021 was approximately €42m. This financial year, ending April 2026, the annualized run rate puts revenue somewhere around €87m. That is a doubling in five years, which implies a compound annual growth rate of roughly 16%.

The margin history tells an equally interesting story. In financial year 2021, the EBITDA margin was 76%. In 2022 it was closer to 47% , which was a significant step down driven by post-IPO operating cost increases and heavy amortization of acquired intangibles.

But that was a one-off. From 2023 onwards the margin has moved consistently upward: 75.6% in 2023, 76.9% in 2024, 78% in 2025. The business did not find efficiency after a period of inefficiency. It went through a brief post-IPO cost absorption period and then returned to its structural margin level, which has been improving gently ever since.

The capital return history is consistent with the stated policy. Dividends have been paid every year. Buybacks have been ongoing. The share count has been declining. A company that listed with approximately 489 million shares now has approximately 483 million in issue, and that number will continue to fall as buybacks continue.

The key question to ask about the historical picture is whether yield expansion is accelerating or slowing.

The data from H1 2026 suggests it is actually accelerating in some segments. Real Estate C2C per-listed-ad yield grew 27% in the half. Auto C2C per-listed-ad yield grew 29%. These are larger percentage increases than in prior periods.

That tells you one of two things:

1. either BCG has more pricing power than the market appreciates

2. or the base effects from low prior-year prices are temporarily flattering the percentages.

The truth is probably some of both. But the direction is right and the magnitude is not trivial.

Given everything that has happened since the IPO, is BCG better or worse than the prospectus implied? Better. Revenue has grown faster than the prospectus suggested. Margins have recovered to above the listing-period levels.

Capital returns have been disciplined and consistent. The Estonian shock is the first genuine operational headwind since listing, and the business absorbed it without a revenue decline. That is a better track record than most businesses produce in the same period.

Subscribe now

Valuation

Start with what BCG actually earns for its owners, because reported profit and owner earnings are not the same thing for this business.

Net income for H1 2026 was €26.4m. That is the GAAP number. Three adjustments are needed to get to owner earnings.

First, add back the non-cash amortization of acquired intangibles — €3.7m in the half — because this is an accounting artefact of the 2020 acquisition of business client relationships, not a real economic cost. Those intangibles are now fully amortized, so this adjustment disappears going forward.

Second, subtract stock-based compensation of €0.5m. This is real dilution and must be treated as a cost regardless of how it is classified in the income statement.

Third, the maintenance capex is €0.4m against depreciation of €0.4m on non-acquired assets. These roughly cancel out.

The result: owner earnings of approximately €25.9m for the half, or €52m annualised.

Now the assumptions;

Revenue growth: Management has guided for H2 revenue growth above H1’s 7%, and double-digit growth for the full 2027 financial year. The B2C price increases implemented in September and October 2025 will fully annualise into H2 2026 revenue.

Estonian Auto comparables flip positive from January 2026. Real Estate is growing at 20% with a strong market backdrop. A 10% to 12% annualised revenue growth rate for the next three years is conservative relative to management guidance and recent trends.

Margin assumption: BCG has guided that EBITDA margins will remain in the mid-seventies even with investment in data and AI. The structural reason for this is simple: the cost base does not need to grow proportionally with revenue. More listings, higher yields, more broker customers — none of these require meaningful additional headcount or infrastructure. A 75% to 77% EBITDA margin assumption is conservative.

At 10% revenue growth and 76% margins, owner earnings grow from approximately €52m today to approximately €70m by year three. At 12% growth and 77% margins, the number is closer to €78m.

What multiple is warranted?

BCG operates in a market so small that it has essentially pre-empted competition. The moat is deepening through product development. The capital requirements are negligible.

The management team has a clean track record. For a business with these characteristics and this growth profile, a multiple of 22 to 25 times owner earnings is defensible.

At the lower end of the growth assumption and the lower end of the multiple range, the implied value is approximately €1.28bn. At the upper end of both, the implied value reaches €1.95bn.

The base case: €1.28bn, or approximately 220p per share.

The bear case: growth disappoints at 5%, margins compress to 74%, and the multiple contracts to 18 times. Implied value approximately €846m, or around 145p. The current price of 190p sits about 30% above the bear floor.

The bull case: growth runs at 14%, margins hold at 78%, and the multiple expands to 25 times as the debt-free capital return story gets priced in. Implied value approximately €1.95bn, or around 330p.

This is not a business trading at a severe discount to obvious value. It is a good business at a fair price, temporarily de-rated by a policy shock, with a specific catalyst — the Estonian comparison base — that is already reversing.

So, the case for owning it is not that it is obviously cheap. The case is that the de-rating was an overreaction to a temporary problem in a business that has now demonstrated it can absorb that problem without a revenue decline.

The distinction between what BCG earns on its own capital and what an investor earns at today’s price is worth dwelling on. BCG’s return on tangible capital is essentially infinite — the platform requires almost no tangible capital to operate.

But the investor buying at 190p and an enterprise value of approximately €1.05bn is paying for that extraordinary capital efficiency at a 4.9% owner earnings yield. The business earns extraordinary returns. The investor earns fair returns. These are different numbers, and conflating them is one of the most common errors in quality growth investing.

BCG is a wonderful business at a fair price. Not a fair business at a wonderful price.

Share

The balance sheet

BCG ended October 2025 with net cash of €5.1m. Six months earlier it had net debt of €3.6m. The transition happened because BCG generated €30.6m in operating cash in the half, used €12.5m to pay the final dividend, bought back €6.4m of shares, and voluntarily repaid €10m of the bank loan.

The remaining loan balance is €15m, maturing in July 2026. This is trivial against the cash generation rate.

BCG generates the equivalent of the entire loan balance in operating cash every six months. Watch the refinancing terms when the facility matures, not because there is a solvency concern but because the interest rate will likely improve if they choose to maintain any debt capacity.

Management has said the company could be debt-free by the end of the current financial year; April 2026. When that happens, the full approximately €60m of annual operating cash flow becomes available for buybacks and dividends.

At the current market capitalisation of £880m, that is a total cash return yield of around 7%, growing at double digits. That is what the capital return conversation will look like in a few months.

The item on the balance sheet that looks alarming until you understand it is the goodwill. BCG’s balance sheet shows €330m of goodwill out of €386m of total assets. That is 85% of total assets in a single line item. For most businesses that would be a serious red flag.

For BCG it reflects the structure of how the business was assembled. Before the IPO, private equity assembled the portfolio of Baltic classifieds portals through a series of acquisitions. The goodwill represents the premium paid for those businesses above their book value. The assets underlying the goodwill are not tangible — they are the brand relationships, the audience, the network effects, the professional workflows. These are real assets.

They generate €60m of operating cash per year. They have never required impairment. BCG has not paid too much for businesses that subsequently disappointed. The goodwill is the price of buying dominant market positions and those positions have produced exactly what was paid for.

The risks

Let’s go through the risks, because there are things we need to be aware of with Baltic Classifieds.

The first is the free-listing attack.

If a platform with existing Baltic user trust (Facebook Marketplace for example) decided to offer free listings at scale across all three Baltic states, the consumer C2C side of BCG’s business would come under genuine pressure.

Private sellers deciding whether to pay €42 to list their car or €0 to list it on Facebook will choose free. The question is what percentage of BCG’s economics depends on private seller behaviour versus professional subscriber behaviour.

On the Auto segment, B2C dealer subscriptions represent the majority of revenue. Dealers will not stop paying for Autoplusas because Facebook offers free listings — they need the professional tools and they need the inventory depth that comes from a dominant platform.

On Real Estate, professional broker subscriptions and the workflow tools like Property Price Compass represent the core economics. A free-listing generalist platform does not threaten that. The vulnerable segment is generalist C2C, which is 15% of group revenue and where the competitive moat is weakest.

The early warning signal for this risk is BCG’s Auto and Real Estate C2C active ad volumes. If those numbers start declining for multiple consecutive quarters without a named policy explanation, it is the signal that inventory depth — the foundation of the flywheel — is eroding. Track those numbers every half-year.

The second mechanism is regulatory.

BCG raises prices every year on customers who have no practical alternative. That is the definition of a business that attracts antitrust scrutiny.

The Estonian Competition Authority has active enquiries open. BCG’s directors have assessed the likelihood of a material outflow from those enquiries as remote. I give that assessment weight because BCG’s market, while dominant, is also small. The harm from BCG raising annual prices on Lithuanian real estate brokers is genuinely minimal in the context of the national economy. The antitrust case is harder to make when the affected market is modest in size.

But the risk is real and observable. Any formal announcement from the Lithuanian or Estonian competition authorities opening an investigation specifically into BCG’s B2C pricing practices would change the valuation materially. The primary driver of BCG’s revenue growth is yield expansion. A cap on that expansion is a cap on the growth thesis.

And we can’t leave out macro/geopolitical risk.

I rarely include macro in my analysis, but in this case, we must address the elephant in the room.

Lithuania, Latvia, and Estonia sit at the eastern edge of NATO, sharing borders with Russia and Belarus. Estonia and Latvia border Russia directly.

Lithuania borders the Kaliningrad exclave and Belarus. These are not abstract geographic observations. The three Baltic states have lived under Soviet occupation within living memory, they understand the threat more clearly than most of their NATO allies, and they have responded to it seriously. All three now exceed NATO’s 2% of GDP defence spending commitment, with Estonia leading European allies at roughly 3.4%. NATO has substantially increased its forward presence in the region since 2022, with multinational battle groups deployed in each country.

None of this eliminates the risk. A significant escalation in the wider conflict or a direct threat to Baltic territory would affect consumer confidence, transaction volumes, and the attractiveness of Baltic equities to foreign investors in ways that BCG’s moat cannot insulate against. Small open economies with active property and labour markets are sensitive to geopolitical uncertainty in a way that larger, more diversified economies are not.

The Baltics have been pricing in proximity to Russia for thirty years. Their institutions are strong, their NATO integration is deep, and their populations have not needed recent events to remind them what is at stake. BCG’s business has compounded through every period of elevated tension since 1999. That does not make the risk theoretical. It means the risk is understood and priced locally in a way that external investors sometimes overreact to.

Of the risks in this piece, geopolitics is the one I think about least in terms of the day-to-day thesis and most in terms of position sizing. It is not a reason to avoid BCG. It is a reason not to make it the only thing you own.

The verdict

After going through all of this, here is where I land.

Going through the segment data, the management track record, the acquisition history, and the full financial picture has not weakened the case to me since writing the thesis brief. Real Estate is the strongest it has ever been. Auto is temporarily impaired in a way that is already reversing.

Management has done exactly what it said it would do since listing. The balance sheet is about to become debt-free. The capital return story is getting more interesting by the half-year.

If I had to name one thing that would most change my view, it would be evidence that the professional workflow integration is not as sticky as the product narrative suggests.

If broker churn on Aruodas.lt were rising, or if dealer retention on Autoplusas were declining, or if the ARPU growth started requiring unusual commercial concessions to maintain, any of those would suggest the moat is less embedded than it appears. None of those signals are present in the current data.

The verdict

After going through all of this, here is where I land, and it is not where I expected to when I started:

First, the business is excellent. The moat is real and deepening. Management has earned trust. The Estonian shock is temporary and the comparables will flip. None of that has changed in my mind after going through every corner of this company.

What has changed is my view on the price and what I am being paid to own it.

At 4.9% owner earnings yield, BCG is fairly priced for what it is.

Not cheap. The base case gets you to around 220p, which is roughly 15% from current levels.

That is a reasonable return for a dominant franchise in a small market. But reasonable is doing a lot of work in that sentence. Fifteen percent upside, with a 4.9% starting yield, is not the kind of asymmetry that makes me want to concentrate capital.

The bull case requires things to go better than guided. The bear case, where regulation caps pricing or a free-listing platform gets traction, does not look remote enough to dismiss.

And then there is the… map.

I laid out the geopolitical picture honestly in the section above. The Baltics have strong institutions, deep NATO integration, and thirty years of experience pricing in proximity to Russia. I believe all of that.

But when I combine a valuation that requires things to go right with a geography that carries tail risk I cannot model, I find myself looking for a better combination elsewhere.

And not because BCG is a bad investment. Because my opportunity cost is real and the risk-adjusted return here does not clear my bar.

I bought a small starter position in BCG earlier. I have since sold it. Not because the thesis broke (it did not) but because the price never gave me enough margin of safety to sit comfortably with the geography.

A wonderful business at a fair price is still a fair price. I want wonderful businesses at prices that make the geopolitical risk feel adequately compensated.

If BCG trades down toward 145p to 155p, the conversation changes entirely. At that level the owner earnings yield moves above 7%, the bear case is closer to priced in, and the same geopolitical risk starts to feel adequately compensated. That is the price where I would consider to own this properly rather than tentatively.

Until then: thesis intact, position closed, watching carefully.

Sources and references

• Baltic Classifieds Group PLC — Half Year Results for the Six Months Ended 31 October 2025. Published 4 December 2025. Available at balticclassifieds.com.

• Baltic Classifieds Group PLC — Half Year Results Presentation, Six Months Ended 31 October 2025. Published 4 December 2025.

• Baltic Classifieds Group PLC — Annual Report and Accounts 2025. Financial year ended 30 April 2025.

• Maanteeamet (Estonian Road Administration) — Monthly vehicle registration and transaction data, calendar year 2025.

• Similarweb — Time on site data, leadership position vs nearest competitor. Referenced via BCG H1 2026 results presentation.

• Google Analytics — Baltic site visit data, averaged based on Baltic population statistics. Referenced via BCG H1 2026 results presentation.

• Skandinaviska Enskilda Banken (SEB) — Nordic Outlook Update, November 2025. GDP, inflation, unemployment, and wage growth forecasts for Baltic states.

• Eurostat — Real GDP per capita CAGR, 2000–2024.

• Swedbank — Average apartment prices in Vilnius, Riga, and Tallinn, calendar H1 2025.

• State Enterprise Centre of Registers Lithuania, Land Register Latvia, Land Board Estonia — Real estate transaction volumes.

• Euromonitor — E-commerce market growth, Lithuania and Estonia, 2019–2028.

• Börsdata — Financial data export, Baltic Classifieds Group PLC, historical annual and quarterly figures.

Disclaimer
This Deep Dive is an educational breakdown of a public company based on information available in the materials provided (e.g., annual/quarterly reports, investor presentations, earnings transcripts) and my interpretation of that information. It is designed to be a “bolt-on” intelligence layer to your own due diligence — not a replacement for it.

Independence: I do not accept compensation of any kind from the companies discussed. My research is driven solely by my personal search for high-quality compounders.

Skin in the Game: Unless otherwise stated, assume the author may hold a long position in securities mentioned. Any position creates bias — treat this as commentary, not gospel.

Not Financial Advice: Nothing here is investment advice, a recommendation, or a solicitation. I am not a financial advisor. You are responsible for your own decisions. The stars rating is not a buy recommendation, but meant as a guide to understand the quality of the financial statement of the respective companies.

Error & Update Risk: Financial statements change, companies restate, guidance evolves, and I can be wrong. Verify key figures in the primary filings and consider reading the footnotes before deploying capital.

Most people who know Charlie Munger know the ending.

The wit. The aphorisms. The Berkshire annual meetings. The billionaire who sat next to Warren Buffett for six decades and made the whole thing sharper, deeper, and more permanent than it would have been without him.

But the ending is not the interesting part. Not for you. Not if you are in your 30s, building something real, trying to figure out how someone goes from a standing start — broken, broke, starting over — to the kind of wealth and freedom that makes everything else possible.

The interesting part is the middle. The decade most biographies rush through. The years between the disaster and the breakthrough.

That decade is what this piece is about.

And I want to be direct about why: because if you are where Munger was at 30, the path he took is one of the most instructive case studies in modern financial history. Not because you should copy it (you can’t, the world has changed) but because the logic of what he did is completely transferable. The mindset. The sequencing. The willingness to run two things simultaneously before committing fully to either.

Let’s go back to the beginning of the hard part.

Subscribe now

Pasadena, 1953. Everything Gone.

Charlie Munger was 29 years old.

He had a Harvard Law degree, a small practice in California, and almost nothing else. His marriage to Nancy Huggins — a rushed, youthful marriage that his own daughter Molly later described as two people who had “utterly no idea what they were doing” — had ended. The family home went to Nancy. His savings, already modest on a lawyer’s salary, were largely gone. He had three children he was supporting: Teddy, Molly, and Wendy.

He was living in a single room.

This is not a detail you often see in the Munger mythology, which tends to begin at Berkshire and work backwards. But it matters enormously, because the man who emerged from that period remarried by 32 to Nancy Barry, with whom he would go on to have four more children, rebuilt not just his finances but his entire operating philosophy during the years that followed.

He later said, with characteristic bluntness:

“Like Warren, I had a considerable passion to get rich. Not because I wanted Ferraris — I wanted the independence.”

Independence. Not lifestyle. Not status. The freedom to think without financial constraint, to act without begging permission, to say no to work you don’t respect. That was the goal. And it is a materially different goal from simply wanting to be wealthy, because it focuses your attention on the structure of your financial life rather than the level.

Munger wanted to own things that generated returns while he slept. He wanted out of the time-for-money trap as fast as possible. And he was willing to run two careers simultaneously — law and investing — to get there.

Share

The First Business Lesson: Transformer Engineers

Before the real estate, before the investment partnership, before any of the things that actually worked, Munger made a mistake.

In 1950, aged 26, he was doing legal work for a man named Ed Hoskins, an engineer and entrepreneur who ran a small company called Transformer Engineers Ltd. Munger liked Hoskins. He found the business interesting. He had the instinct, even then, that sitting around waiting for clients he liked was too passive.

One morning, driving past the Transformer Engineers office on his way to work, Munger made a decision. He did a U-turn in the middle of the street, walked in, and told Hoskins he wanted more work and more involvement in the business.

Hoskins had a problem with his venture capital backers, who, in typical fashion, wanted to replace the founder. Munger helped Hoskins structure a buyout, using debt.

Munger himself borrowed money to buy into the business as a part-owner.

He later described the deal this way: “It was an early leveraged buyout. It was a nonlegal solution to what looked like a legal problem.”

The only problem was that Transformer Engineers was a bad business.

Munger didn’t know it when he got in. But the Korean War ended, defence contracts dried up, and the company slowly lost momentum. It was Munger’s first experience of the painful gap between a business that looks interesting and a business that actually works.

He lost money. He learned something more valuable.

The lesson he took from Transformer Engineers was one he would repeat for the rest of his life: the quality of the business is not a soft consideration. It is the central one.

A mediocre business bought at a cheap price gives you a one-time gain. A bad business bought at any price eventually destroys capital. The structure of the economics;

• what happens to margins as the business scales

• whether the customer has any alternative

• whether the cost of serving each new customer falls or rises over time

These questions matter more than the entry price.

He would apply this logic, with devastating clarity, for the next seventy years.

1955. The Year That Reframes Everything.

In 1955, Munger’s son Teddy died of leukaemia. He was nine years old.

Munger used to walk to the hospital because he didn’t want to spend money on cabs he didn’t have. He sat with his son through the illness knowing the outcome was likely irreversible, knowing that no amount of intelligence or willpower would change what was happening.

I include this not for sentiment but because it is the context for everything that follows.

The man who rebuilt his finances in his mid-30s had already survived something that breaks most people. He had lost a marriage, lost his savings, started over in a single room, and then watched his firstborn son die. By any conventional measure of adversity, Munger had experienced more by 31 than most people accumulate in a lifetime.

What he didn’t do is almost as important as what he did do.

He didn’t become reckless, betting everything on a single big play to recover lost ground fast. He didn’t become paralyzed, retreating into the safety of a lawyer’s salary and stopping there. He didn’t become bitter, and there is no recorded evidence of self-pity in anything Munger ever said or wrote about those years.

He remarried. He kept practicing law. He kept studying businesses and markets. He kept building relationships with interesting people. He kept going.

“I had a child die. I had a divorce. I had a lot of adversity. And I just kept going.” — Charlie Munger

Three sentences. The entirety of what he had to say on the subject, in most interviews. Not because the grief wasn’t real; it clearly was (and he spoke about Teddy unprompted even in his 90s), but because Munger had internalized something the Stoics had been writing about since Marcus Aurelius: that the only rational response to the things you cannot control is to accept them fully and direct all your energy toward the things you can.

If you are in your 30s reading this, I want you to sit with that for a moment. Whatever difficulty you are carrying — financial, personal, professional — Munger’s 30s is the answer to the question “what do I do when it gets really hard?”

You keep going. Methodically, rationally, one decision at a time.

Subscribe now

Late 1950s. The Relationship That Changed Everything.

Through his law practice in the late 1950s, Munger got to know a man named Otis Booth.

Booth was a real estate developer and investor. He and Munger became friends. The kind of friendship that forms between two intelligent people who recognize something in each other. Booth was practical, experienced in how physical assets worked, how to develop land, what made a project viable. Munger brought the analytical mind, the legal clarity, and an increasingly sharp sense of business economics.

In 1961, Booth came to Munger with a specific problem. He needed help handling a probate settlement ; a piece of property that had come to him through a deceased estate.

Munger looked at the property. His advice was immediate and clear: don’t sell it. Develop it.

Booth agreed. Then he said something that changed both their financial trajectories: “Only if you join me.”

This is the moment worth studying most carefully, because it contains several layers of wisdom that are easy to miss.

First: Munger had earned this opportunity through relationship, not transaction. He and Booth were friends. Booth trusted his judgement.

The deal came because Munger had spent years building genuine relationships with interesting people, actually engaging with clients, understanding their problems, doing U-turns in the street to stay involved. The quality of your relationships, particularly with people who are doing interesting things, is a long-term asset that most people dramatically underinvest in.

Second: Munger said yes despite the risk. He was not a wealthy man in 1961. Putting $100,000 into a single real estate development — alongside his existing practice and a family of several children — was not a trivially comfortable decision. But he had done the analysis, he trusted his partner, and he committed.

Third: He brought his legal skills directly to the investment. The probate settlement required exactly the kind of expertise Munger had spent over a decade building. He wasn’t starting from scratch; he was finding the intersection of what he already knew and where capital could be deployed intelligently.

The Caltech Deal: $100,000 In, $500,000 Out

The property they developed was a set of apartments adjacent to Caltech in Pasadena — the same institution where Munger had studied meteorology during the war, the city that had become his home.

Each man put in $100,000. They owned 50% each.

The project took six years. It was completed in 1967 and sold at a 400% profit. Each man walked away with $500,000.

From a standing start of $100,000, Munger had turned one deal into half a million dollars. In 1967. That is roughly $4.5 million in today’s money.

But the more interesting part is what he learned during those six years, because the lessons shaped the four deals that followed.

The first thing he noticed was which units sold fastest. It was the ground-floor apartments. Interestingly, not the upper floors or the ones that felt more exclusive, that had better views.

No, the ground floor. Why? Because buyers in that market wanted ease. Access. The absence of stairs. This was not an obvious insight. It required actually paying attention to what was happening on the ground rather than what seemed theoretically preferable.

From that observation, Munger and Booth made a decision that sounds almost too simple: they would make the next project entirely single-story. No upper floors. Lower building costs, faster sales, higher margins per unit.

“Lush landscaping. That is what sells,” Munger declared. “You spend money on trees, and you get it back triple. Stinting on landscaping is building malpractice.”

This is the observation of someone who is actually watching what drives buyer decisions, not what should drive them in theory.

The lush landscaping insight is quintessential Munger. It is specific, counterintuitive, based on direct observation, and completely ignored by competitors who are cutting costs rather than watching what sells.

They did it again. The single-story condos sold even faster, at higher prices. So they did it a third time. Then a fourth. Then a fifth.

When it was over, Munger had $1.4 million from real estate alone.

“When it was over, I had $1.4 million as the result of my real estate involvement. That was a lot of money at that time. I did a total of five projects, then stopped.” — Charlie Munger

Five projects. Five iterations of the same thesis, refined each time based on what the market was actually telling him. Not fifty projects. Not a sprawling property empire. Five disciplined executions of a well-understood edge, then a clean exit to focus on something with even more potential.

This is perhaps the most underrated part of the story. Munger knew when to stop. He didn’t mistake a successful edge for a permanent one, or confuse the accumulation of assets with the building of wealth. When the real estate had served its purpose, which was to generate the capital base he needed to go full-time into investing, he stopped.

The ability to close a chapter cleanly, without nostalgia, is rarer than it sounds.

Share

Running Multiple Things Simultaneously

What makes Munger’s mid-30s genuinely remarkable is that he was not doing one thing. He was doing three.

He was practicing law. He was developing real estate with Otis Booth. And from 1962 onwards, he was running an investment partnership called Wheeler, Munger & Company — a fund he co-founded with Jack Wheeler, with a seat on the Pacific Coast Stock Exchange.

From 1962 to 1975, that fund generated compound annual returns of 19.8%. The Dow, over the same period, returned 5.0% per year.

He was doing this while developing apartments. While running a law firm he had co-founded, Munger, Tolles & Olson.

While raising eight children from two marriages.

The point is not to make this sound superhuman. It wasn’t. The point is that Munger understood something about the early stages of wealth building that most people never grasp: you do not get to choose between your day job and your investment activity until your investment activity can replace your day job.

Until that moment, you run both.

Most people wait until they feel “ready” to invest seriously. They want to finish one thing before starting another. Munger’s answer to this instinct was essentially: you don’t have that luxury. The compounding on the investment side needs to start as early as possible, because time is the one input you cannot manufacture.

He kept the law practice alive, he was generating income, building relationships, providing deal flow. And he did this until the investment side was clearly the superior use of his time. Then, and only then, did he walk away from the law.

By the time he did, he was already wealthy. Not rich in the Berkshire sense; that would come later. But free.

The independence he had wanted since his single room in 1953 was now his.

What Munger Was At 40, And How He Got There

By the time Munger met Buffett in 1959, he was 35. By the time he wound down his legal career, he was in his early 40s.

Here is what he had built by then:

• A network of relationships, with clients, partners, and counterparties, that provided constant deal flow and intellectual stimulation.

• An investment partnership running at nearly 20% annual returns.

• A real estate portfolio that had converted $100,000 into $1.4 million across five disciplined projects.

• A law firm bearing his name that was already becoming one of California’s most respected.

And a mind that had been sharpened by failure (Transformer Engineers), grief (Teddy), forced rebuilding (the divorce), and the daily practice of thinking carefully about how businesses actually work.

He succeed through the relentless accumulation of learning, relationship, and capital across a decade of parallel effort.

The law fed the real estate, which fed the investment partnership, which eventually made the law unnecessary. Each activity generated returns — financial, intellectual, or relational — that compounded into the next.

Subscribe now

The Actionable Framework: What Munger’s 30s Actually Tell You

If you are in your 30s, building something — a business, a newsletter, a research platform, an investment framework — here is what Munger’s decade actually tells you to do.

1. Don’t wait until you’re ready. Run two (or more) things. Munger ran law and investing simultaneously for years. He didn’t wait until the investing was proven before starting it. He started it while the law was covering his costs, and let time do the compounding work.

Whatever your day income source is right now, the investment or ownership activity needs to start today, and not when you feel financially comfortable enough to focus on it.

2. Your professional relationships are a deal pipeline. Every significant opportunity Munger had in his 30s came through a relationship he had built while doing his day job. Hoskins through his legal practice. Booth through his legal practice. Buffett through a mutual friend connected to his legal and investment circles.

He was genuinely engaging with interesting people and staying in their orbit. The best deals of your career will come from the people who already trust your judgement.

3. Iterate on what the market actually tells you, not what you expect. Munger learned that ground floors sold faster not by theorising about buyer psychology but by watching what actually happened.

Then he rebuilt the entire project model around that observation. Whatever you are building — products, content, research — the market’s response to what you have already done is more valuable than any plan you can write about what you haven’t done yet. Watch what sells. Double down on it.

4. Know when to stop. Five real estate projects. Not fifteen. Munger stopped when the thesis had run its course and a better use of his capital and time was available. Most people stay in the thing that worked in the past because it is comfortable and familiar. Munger’s discipline was knowing when the edge had been extracted and it was time to move.

5. The independence goal is more powerful than the wealth goal. Munger wanted the freedom to think and act without financial constraint.

That goal — not a number, not a lifestyle — shaped every decision he made about what to work on and when to stop. If your goal is a number, you will either stop short of it (afraid) or overshoot it (addicted). If your goal is independence, every decision becomes clearer: does this move me closer to owning my time, or further away?

The Last Thing Worth Saying

In 1959, when Munger met Buffett over dinner in Omaha, he was 35 years old. He was a divorced lawyer, recently remarried, running a small practice, just starting to invest seriously.

Thirty-nine years later, Berkshire Hathaway was one of the most valuable companies on earth.

None of that was obvious in 1959. None of it was guaranteed. What was present in 1959 was a man who had already survived the worst, rebuilt from zero, and developed the judgement that comes only from having done both.

That judgement — not the brilliance, not the quips, not the famous partnerships — is what made everything else possible.

You build it the same way he did. One careful decision at a time, across a decade of parallel effort, without waiting until you feel ready.

He wasn’t ready either.

He just started anyway.

“The best thing a human being can do is to help another human being know more.” — Charlie Munger

You’ll notice something different about this post.

It says Thesis Brief at the top, not Deep Dive. That’s not an accident. It’s the start of something I’ve been thinking about for a while.

From now on, every company I cover gets two pieces.

The Thesis Brief is Part 1; the story, the business model, the moat. Why this company exists, why it might matter, and whether it deserves a place on your watchlist. It’s designed to stand completely on its own. You’ll finish it knowing exactly what you’re looking at.

The Deep Dive is Part 2 ; where I go all the way. The numbers, the valuation, the financial model, my conviction score, and whether I’d actually own it. At some point, the Deep Dives will move behind a paid tier. But until then, they’re yours. Completely free, just like everything else here. You can expect the deep dive in your inbox next Sunday.

For now; let’s get into it.

Subscribe now

I want to start by telling you a story.

In 1973, Warren Buffett bought a controlling stake in The Washington Post Company. The market valued the whole business at around $80m. Buffett thought it was worth $400m. He was not being clever. He was just reading the business correctly while everyone else was reading the stock price.

What made Washington Post worth $400m was not the journalism. It was the classifieds: Job listings. Apartment listings. Car listings. Every employer, landlord, and car dealer in the Washington metropolitan area had one place to reach buyers, and that place was the Post.

They had no real alternative, and they knew it. The Post raised its rates every year. So they kept paying. The economics were, as Buffett later put it, like owning an unregulated toll bridge.

Buffett held that position for decades. It became one of the most celebrated investments in history.

Here is what I find interesting: The same flywheel that made Washington Post’s classifieds extraordinary now runs on the internet, in markets where one digital platform has won so completely that competition has effectively stopped trying.

Baltic Classifieds Group is not The Washington Post. I want to be clear about that. Buffett bought Washington Post at roughly twenty cents on the dollar during a full market panic. BCG today is a fair price for a good business, not an absurd discount to obvious value.

Subscribe now

The degree of cheapness is completely different.

But the structure of the moat is the same. Same type of business. Same type of professional dependency. Same type of pricing power. Same type of local dominance that looks boring from the outside until you understand why nobody can compete with it.

Buffett understood something in 1973 about classifieds franchises that most investors still miss today. BCG is the same insight, fifty years later, in digital form. The question worth asking is whether the market currently understands what it owns.

I think it does not. Here is why.

Baltic Classifieds Group is a small company in Northern Europe that most investors have never heard of, charging brokers, car dealers, and job recruiters a modest monthly fee to exist professionally online.

The brokers pay. The dealers pay. The recruiters pay.

And because everyone pays, everyone lists their properties, cars, and jobs on BCG’s websites. And because everything is listed there, anyone in Lithuania, Estonia, or Latvia who needs to buy or sell something significant goes there too.

Fourteen websites. Six million people. A 78% EBITDA margin.

Yup, 78%.

Sit with that for a second. Apple, one of the most profitable companies in the history of capitalism, runs at around 33%. BCG runs at 78% on a portfolio of classifieds websites in a corner of Europe most investors could not find on a map.

First, understand what this business actually is

A classifieds business is a middleman that connects buyers and sellers. Bah! That description makes it sound… ordinary.

It is not.

The thing that makes classifieds businesses extraordinary is what happens once they get big enough.

Think about it from a seller’s perspective. If you are a Lithuanian trying to sell your apartment, you want to list it where the most buyers are looking. And if you are a buyer looking for an apartment in Vilnius, you go to whichever website has the most listings. The seller follows the buyers. The buyers follow the listings. The listings attract more buyers. The buyers attract more listings.

This is a flywheel, and once it gets spinning it is almost impossible to stop. The market leader gets more listings because it has more buyers. It gets more buyers because it has more listings. Everyone else gets the scraps.

BCG has been spinning this flywheel since 1999. Its real estate portal in Lithuania now leads the nearest competitor by 48 times on time spent on site. Its auto portal in Estonia leads by 31 times. These numbers are not the result of clever marketing. They are the mathematical consequence of a flywheel that has been running for twenty-five years.

Share

Peter Lynch used to say the best businesses are the ones you can explain in a sentence.

Here is BCG in one:

It owns the only relevant classifieds platforms in three small countries, and because it owns the only relevant platforms, nobody can afford not to use it.

Now understand why the margins are what they are

BCG is not profitable because it is efficient. It is profitable because of what kind of business it is.

In the six months ended October 2025, BCG collected €44.8m in revenue. It spent €9.7m running the operation: salaries for 153 people, some third-party IT, modest marketing, a small amount of data costs. The remaining €35.2m was EBITDA.

Here is why it stays there: When BCG wants to grow, it does not build a factory. It does not hire a thousand new salespeople. It raises prices and ships product features.

The cost of serving one more broker, one more dealer, one more private seller is close to zero. There are no physical goods to produce, no delivery infrastructure, no inventory to finance. The platform exists. Adding more users to it costs almost nothing.

Capital investment for the half-year was €0.4m. Not €4m. Not €40m.

€0.4m.

Buffett has a word for businesses like this. He calls them toll roads. You want to cross the bridge, you pay the toll. BCG is the only bridge, so everyone pays.

And unlike a real toll road, BCG never needs to repave the asphalt.

Okay, so why is the stock down 50% from its peak?

Well, the short and sweet answer is: Estonia taxed car ownership.

In December 2024 the Estonian government introduced a vehicle transaction and ownership tax. Car transactions in Estonia promptly collapsed, falling between 45% and 66% every single month through 2025 compared to the year before.

Fewer car sales meant fewer private sellers listing cars on BCG’s Auto24.ee platform. Auto listing volumes fell 29%. The market looked at the numbers, saw a business where the largest segment appeared to be in freefall, and sold.

Here is what it missed. Auto segment revenue for the six months ended October 2025 was €16.0m. Exactly flat with the prior year. Not down. Flat.

How? Professional car dealers pay BCG a monthly subscription regardless of whether anyone is buying cars that month. And the private sellers who still needed to sell had nowhere else to go, so they kept listing, paying BCG’s higher per-listing prices as the company continued its annual yield increases. The volume collapse and the pricing increase cancelled each other out almost perfectly.

Share

I find this genuinely fascinating. A government policy that halved the car transaction market in an entire country, and BCG’s Auto revenue did not move. That is what a real moat looks like. Not in a PowerPoint. In the actual numbers.

There is also a comparison problem making everything look worse than it is. H1 2025 was peak inventory across BCG’s platforms, the best comparable the company has ever produced. A 29% decline in listings against a record comparable looks catastrophic.

Against the actual number of listings on the platform today, it is a policy-specific correction in one country. Management has confirmed year-on-year Auto growth is expected to resume from January 2026. Not because Estonians suddenly start buying cars again in volume, but because you are now comparing against the already-collapsed numbers from a year ago.

The tax stays. The comparison distortion does not.

The bear case deserves a fair hearing

BCG serves six million people. That is pretty much the ceiling, and it is not going up a lot more. The growth of recent years has come almost entirely from raising prices on existing users and converting free users to paid tiers.

Both are finite. At some point the broker paying €238 a month says no. At some point the private seller decides €9 to list a used sofa is not worth it.

Facebook Marketplace is the name that comes up most often in the competitive risk discussion. If Meta decided to offer free listings across Lithuania, Estonia, and Latvia, BCG’s inventory advantage could erode faster than the financials suggest. It has happened in other small markets.

And regulation is a genuine concern. BCG is a functional monopolist in several verticals. The Estonian Competition Authority has active enquiries open. Raising prices every year on customers who have no real alternative is exactly the profile that attracts antitrust attention.

These risks are real. Anyone who tells you otherwise is not being straight with you.

But here is where the bear case runs into a problem

A real estate broker in Vilnius does not use Aruodas.lt because it has the most listings. She uses it because her entire professional life runs through it: her active listings, her client inquiries, her pricing data, the tools she uses to advise sellers.

Two years ago BCG introduced Property Price Compass, which pulls actual transaction data from the national land registry, connects it to listing history, and produces a professional pricing report she can hand to a vendor with her own name on it.

Her clients now expect that report at the first meeting.

Try to compete with that. You are not competing with a website. You are competing with a workflow embedded in thousands of professional relationships built over years.

Subscribe now

Car dealers use Autopulsas to track real-time market dynamics for specific models. Recruitment companies use CVbankas to access a salary estimator trained on a decade of job offers and CVs that no new entrant could replicate.

BCG has spent years quietly converting listing services into professional tools, and professional tools are a completely different proposition to a website with listings on it.

Facebook Marketplace can offer free listings to private sellers. It cannot replace the morning routine of a car dealer checking Autopulsas before he prices his inventory. The segment most exposed to free-listing competition, generalist C2C, is 15% of BCG’s revenue. The professional segments are protected by something that compounds with every year BCG operates.

Lynch called it a moat. Munger called it the nature of the business. Buffett called it pricing power. They were all describing the same thing:

A business that gets harder to displace over time, not easier.

The financials, laid out plainly

Strip out stock compensation as the real cost it is, net out the minimal capital requirements, and owner earnings come to roughly €52m annualised. Against an enterprise value (EV) of approximately €1.05bn, that is a 4.9% yield on a business moving to zero debt with 99% cash conversion.

At 4.9% you are paying what I would say is a fair price for a good business. The argument for owning BCG is not that it is mispriced in a screaming obvious way, even after a nearly 50% drop.

No, the argument is that a genuinely dominant franchise has been de-rated by a policy shock that is already reversing, that B2C price increases from October 2025 have not yet fully landed in the reported numbers.

And that a well-run, debt-free company with €60m of annual cash flow and an £880m market cap is about to have a very interesting capital return conversation with its shareholders.

Management outlook · H1 2026 half-year report

Management has said the company could be debt-free by April 2026. When that happens, the capital allocation question becomes very simple.

The base case, Estonian comparables normalising through H2 2026 and the pricing tailwinds feeding through, gets you to around 220p. Roughly 15% from here. The bull case, where product deepening drives yield growth above what management has guided, reaches closer to 280p. Neither requires heroics.

The question I keep coming back to is what would have to be true for the pessimists to be right. BCG’s pricing power would need to be more fragile than three consecutive years of evidence suggests, or a competitor would need to successfully attack the professional workflow layer rather than just the listing layer, or a regulator would need to act.

None of that is in the data right now. But this is exactly the kind of thesis where monitoring matters more than the initial call.

The two things I watch are simple:

1. First, Auto and Real Estate C2C active ad volumes: if they start declining for multiple consecutive quarters without a named policy cause, that is the early signal that something structural is happening to inventory depth.

2. Second, any formal announcement from the Baltic competition authorities specifically targeting BCG’s B2C pricing practices.

I am currently working on a platform for investors who think in businesses, not tickers. It’s the place to write your thesis, track what actually matters about the companies you own, and build a research trail that compounds alongside your portfolio. More on this very soon.

What is in the data is a business that absorbed a 50% collapse in car transactions in its second-largest market, held Auto revenue flat, grew Real Estate by 20%, and maintained a 78% EBITDA margin throughout. It ended the period in net cash for the first time.

Fifty percent de-rating. Seventy-eight percent margin. Two very different numbers telling two very different stories about this company.

I know which one I trust.

Disclaimer

This is not financial advice. Nothing in this post constitutes a recommendation to buy, sell, or hold any security. I am not a financial advisor, and Atomic Moat is not an investment advisory service.

Everything here reflects my own research, analysis, and opinions at the time of writing. I can be wrong — and when I am, I’ll say so.

I may hold a position in companies I write about. Where that is the case, I will disclose it. At the time of publishing this piece, I do not hold a position in Baltic Classifieds Group (BCG.L).

Do your own research. Use this as a starting point, not a conclusion. The goal of Atomic Moat has always been to help you build your own process; not to replace it.

First off, let me tell you how this week’s Deep Dive actually came to be.

I just finished reading Christopher Mayer’s fantastic book, 100 Baggers, for the fourth time. Yup, the fourth. When you find a legitimate blueprint for building generational wealth, you study the architecture until you memorize the floor plan.

After putting the book down this last time, I decided to put theory into practice. I sat down and built a custom stock screener specifically designed to hunt for the traits Mayer talks about: insanely high returns on capital, long runways for reinvestment, and management teams with real skin in the game. I wanted to find the compounding machines of tomorrow before everyone else caught on.

But here is where the story gets really interesting.

As the ticker symbols started spitting out of my screener, I noticed a massive, undeniable coincidence. A huge chunk of the companies lighting up my list were exactly the same businesses sitting right inside legendary British investor Terry Smith’s current portfolio.

If you’ve been reading Atomic Moat for a while, you know I hugely admire Terry Smith. His entire investing philosophy is beautifully, brutally simple: buy good companies, don’t overpay, then do nothing.

And this philosophy aligns perfectly with holding on to potential 100-baggers.

When my 100 Baggers screener started rhyming perfectly with the Fundsmith playbook, I knew immediately that I was digging in the right spot.

And sitting right there, gleaming near the top of that meticulously filtered list, was a clinical research organization called Medpace.

On the initial screen, the numbers looked almost too good to be true. The return on capital was nuclear, the cash generation was pristine, the buybacks were massive, and the founder was still steering the ship. It looked incredibly interesting, despite being a tad on the larger side, market-cap-wise.

So, I did what we always do here: I rolled up my sleeves, ignored the Wall Street noise, and ripped into the actual SEC filings to see if the engine matches the paint job.

Here is what I found.

Subscribe now

If You’re In a Rush

• What they do: They are the outsourced operational engine for clinical trials. When a biotech company invents a new drug, Medpace steps in to recruit the human subjects, run the specialized lab tests, manage the massive datasets, and navigate the regulatory red tape.

• Why it’s ‘hated’: CROs sit straight downstream of biotech funding cycles. If biotech catches a cold, CROs get pneumonia. On top of that, Medpace carries a persistent “founder control + related-party optics” fog that can keep institutional money managers incredibly twitchy, even when the actual P&L results are squeaky clean.

• What fixes it: To shake off the bears, their awards need to stay visibly ahead of their revenue (meaning a book-to-bill > 1). The backlog needs to actually grow (not just convert into cash), and FY2026 needs to land safely inside their guidance without relying on any “working-capital magic” to make the math work.

What is Medpace?

If you are new to Medpace, your first thought may be if they are biotech company. And people are easy to dismiss biotech companies due to their riskier, binary nature.

Medpace invents exactly zero drugs.

They own zero drug patents.

If one of the trials they run cures a major disease, Medpace does not get a single dime of the royalty checks.

They are a pure service business.

Think of them like a general contractor building a custom home. The biotech company is the wealthy architect who drew the blueprints and owns the land. Medpace is the construction crew. They show up with the hard hats, pour the concrete, run the plumbing, and make sure the house passes the strict city inspections (the FDA).

Here is why investors love this specific setup: the biotech company takes 100% of the scientific risk. If a drug completely fails in Phase III testing and turns out to be useless, the biotech company’s stock might collapse to zero.

Medpace generally gets paid for work performed, but it does not get paid for future work if projects are cancelled or delayed.

I like to think of them like they sell the picks and shovels to the gold miners. Whether the miner strikes gold or finds dirt, Medpace gets paid for the shovel. And this is a business model I like.

Imagine you’re a biotech CEO with a molecule that looks brilliant on paper. Now imagine the nightmare of turning that molecule into an FDA-approved drug. You have to coordinate investigators, patients, specialized labs, data, and regulators across the globe, without blowing your budget or ruining the dataset.

That exact mess is the problem Medpace sells relief from.

In their own words, Medpace is a global provider of clinical research-based drug and medical device development services.

They handle full-service Phase I–IV clinical development, plus central lab coordination, project management, regulatory affairs, clinical monitoring, data management/analysis, pharmacovigilance, and post-marketing support. They also run the heavy science: bio-analytical lab services, clinical pharmacology, imaging, and ECG reading support.

The “product” here is not a software license. It’s execution under constraints.

How do they get paid?

They earn fees through customer contracts that are typically fixed-fee or unit-of-service. Most contracts are structured beautifully: they collect an upfront fee at signing, with the balance collected over the contract duration (via a billing schedule or milestones). Revenue is recognized over time as services are performed (they note progression is measured primarily using an input method, cost-to-cost).

August J. Troendle is the Chief Executive Officer and founder. He controls approximately 19.0% of the outstanding shares through direct and beneficial ownership (including shares held by Medpace Investors LLC).

In other words: this is a true owner-operator structure, not a “CEO-for-hire” passing through.

Share

So where’s the moat and the switching cost?

Medpace pitches a disciplined, integrated full-service operating model, complete with coordinated labs, Phase I clinic capabilities, and internal technology.

Their contracts can range from a few months to several years. But customers can terminate, typically with ~30 days’ notice terms, and cancellations happen in the ordinary course of business.

The switching costs here are less about “contractual lock-in” and much more about “operational pain.” Once a trial is underway, swapping out the team managing your sensitive data, monitoring, labs, and regulatory rhythm is like changing pilots mid-flight: it’s technically possible, but it’s expensive, risky, and slow.

Atomic Take: Medpace sells “complexity insurance” (not software) and the moat is integrated execution plus practical switching friction, even if the contracts aren’t ironclad.

Falsifier: Evidence of weakening practical stickiness (a sustained drop in awards/book-to-bill alongside rising cancellations or backlog pressure disclosed over time).

The Setup

Here’s the scoreboard we actually have right now, and the common-sense questions it forces us to ask.

FY2025 revenue was $2,530.2m and net income was a very healthy $451.1m. Net new business awards were $2,646.8m and ending backlog sat at $3,027.2m. Net book-to-bill for FY2025 was 1.05x.

So, what exactly is the market’s underlying argument hiding inside those numbers?

The market worry is incredibly simple, like worrying about your pantry during a snowstorm: FY2025 revenue grew fast, but backlog growth was modest.

If revenue is being fed by backlog conversion rather than fresh backlog replenishment, that growth can keep going… right up until the pantry is empty.

Subscribe now

The bull case is equally simple and grounded: backlog conversion rose because Medpace’s execution is fantastic, not because customer demand is weak.

If awards stay healthy and that conversion rhythm remains steady, Medpace can just keep compounding per-share economics.

The bear case is the classic, old-school CRO bear case: demand in this industry is notoriously cyclical, trial sponsors can terminate projects, and the financial pain usually shows up with a frustrating lag.

Add in that founder control and the related-party headlines I mentioned earlier, and the stock’s multiple can compress even if the actual P&L doesn’t implode.

Atomic Take: This is fundamentally a “duration vs price” debate. The underlying business looks exceptionally high-quality, but that $12.82B market cap is underwriting continued excellence and clean optics from here to eternity. Owner yields look more forgiving, but only if buybacks stay funded.

Falsifier: A full-year net book-to-bill falling below 1.00x (company KPI) would be the clearest, cleanest sign that underlying demand is slipping, even if the accounting on the surface still looks totally fine.

Founder & Control-Room

Dr. August Troendle, MD founded Medpace back in July 1992 and has been the CEO and Chairman ever since. Before he built Medpace, he actually worked at the FDA as a Medical Review Officer, and later as a manager at Sandoz (which is now Novartis) focusing on clinical development.

The man knows the bureaucratic maze from the inside out. He also holds an MD from the University of Maryland and an MBA from Boston University.

From a shareholder’s perspective, the point of bringing this up isn’t just to recite biography trivia. It’s all about incentives and control. The company’s 10-K explicitly flags his heavy influence via ownership and control as a core governance factor.

They also separately disclose related-party items, things like the company using CEO-owned lodging and leases, and certain travel services structures.

A recent SEC Form 4 from November 2025 shows Dr. Troendle reported direct sales of shares on 11/24/2025 and 11/25/2025.

Now, he is still reporting substantial direct and indirect beneficial ownership (including massive holdings through Medpace Investors, LLC), so he hasn’t abandoned ship. But when the founder sells, Wall Street notices.

How the Business Actually Makes Money

Medpace sells execution. Specifically: they sell the ability to run incredibly complex clinical trials with fewer nasty surprises, fewer regulatory delays, and fewer “why is this data missing?” moments that make drug developers age in dog years.

Subscribe now

Mechanically, CRO economics all come down to three linked plumbing pipes.

• Pipe 1: awards. When a trial sponsor officially signs on for work, Medpace records “net new business awards” (a company KPI). That’s the very top of the funnel. The water entering the house.

• Pipe 2: backlog. Those awards then become backlog (company KPI), which is simply the reservoir of contracted work that hasn’t yet been recognized as official revenue.

• Pipe 3: conversion. Finally, that backlog converts into revenue as the actual work is performed, recognized under their specific revenue recognition model.

That chain matters deeply because Medpace is not selling a simple one-time widget off a store shelf. They are selling complex, multi-period project execution where timing shifts, scope changes, and sudden sponsor decisions can dramatically change the shape of their reported growth.

The customer mix tells you exactly what kind of economic cycle you’re exposed to. By 2024 revenue mix (company classification), they were 79% small biopharma, 17% mid-sized biopharma, and just 4% large pharma.

That is a wonderful, highly profitable place to be when biotech funding budgets are healthy and flowing.

And it’s a completely jittery, nerve-wracking place to be when the funding taps dry up.

Now, here is the “don’t get fooled by the top line” part of the story.

In FY2025, Medpace had $1,037.5m of reimbursed out-of-pocket expenses.

Now, that is very real revenue under GAAP accounting, but economically, it behaves a lot more like pass-through spend (like reimbursing an employee for a flight) than it behaves like “we raised our prices and got rich.”

If pass-through spending rises, total revenue rises. That does not automatically mean the underlying service economics of the business improved one bit.

The Audit: Reimbursed out-of-pocket revenue can turn standard growth charts into a highly flattering funhouse mirror. It’s not fake money, but it’s certainly not proof of a widening moat, either. If you want to truly understand whether Medpace is getting better at its job, watch the operating income and the cash conversion, not just the total revenue fireworks.

Finally, there’s a subtle balance-sheet tell that’s incredibly easy to ignore if you’re skimming: advanced billings.

Medpace often receives customer cash well in advance (recorded as contract liabilities/“advanced billings”), which helps brilliantly to reduce credit risk and support their working capital. That’s a fundamentally good, sound operational design, but it also means their cash position can look “extra strong” in periods where advanced billings happen to rise.

Atomic Take: The true moat here is their operational integration and execution reliability, but you have to judge that moat through awards/backlog conversion, operating profit, and cash generation, not through flashy top-line growth.

Falsifier: Ending backlog falling year-over-year (as of Dec 31) while revenue still manages to grow would heavily imply that the cash flywheel is being fed by drawing down the backlog pantry, not by replenishing it.

Share

What Went Wrong

Let’s be clear: nothing “went wrong” in the sense of a broken business. The wheels didn’t fall off.

What went wrong is the strict setup for future expectations: FY2025 delivered a very strong year on paper, but some of the underlying KPIs raise the legitimate question of how much of that success was “conversion intensity” (working faster) versus actual “demand acceleration” (getting more work).

FY2025 revenue was $2,530.2m, up sharply year-over-year. Ending backlog, however, was $3,027.2m, which was only up modestly.

And importantly, the backlog conversion rate rose to 21.8%, up from 18.2%.

The other part of the puzzle is capital allocation.

They aggressively repurchased $912.9m of shares in FY2025, with another $821.7m still authorized for buybacks.

Cash and cash equivalents ended the year at $497.0m.

Big buybacks can be a phenomenal use of capital, but when the stock screens expensive on headline multiples, they can also read as ‘we’re paying up just to retire shares,’ which makes the market hypersensitive to any hint of a cycle wobble.

Then you’ve got the governance cloud. It’s the kind of thing that doesn’t just disappear just because the income statement behaves itself for a few quarters.

The CEO/founder controls about 19.0% of outstanding shares.

Rebound Catalysts

Alright, this isn’t some distressed turnaround checklist where we’re praying for a miracle. Medpace isn’t broken.

This is a proof checklist. We just need them to prove to Wall Street that the engine is still humming normally.

Catalyst 1: book-to-bill climbs. Think of book-to-bill like a bathtub. Awards are the water from the faucet; revenue is the water going down the drain. FY2025 net book-to-bill was 1.05x (company KPI), meaning the water is still rising, but barely.

A sustained improvement here would be the cleanest, simplest signal that new awards are outpacing revenue in a durable way. I want to see that tub filling up.

Catalyst 2: backlog growth re-accelerates. Ending backlog was $3,027.2m (as of Dec 31, 2025). That’s our reservoir of future earnings.

If this backlog starts growing faster than the low-single-digit pace implied by FY2025, the whole “we have a massive future runway” narrative improves overnight. Wall Street loves a long runway.

Catalyst 3: 2026 conversion visibility holds. The company laid their cards on the table: they disclosed an expectation that $1,890.0m–$1,910.0m of backlog would convert to revenue in 2026.

That is a beautiful chunk of locked-in visibility. If that conversion stays steady while new awards remain strong, the dreaded “biotech cycle risk” starts looking incredibly manageable.

Catalyst 4: guidance lands inside the box. FY2026 guidance calls for revenue $2,755.0m–$2,855.0m and net income $487.0m–$511.0m.

Here is a secret about high-expectation stocks: the market doesn’t always need a massive, hero-level beat. It just needs boring, predictable reliability. Hit the numbers. Don’t cause a fuss.

Subscribe now

Catalyst 5: cash stays boring too. FY2025 operating cash flow was a massive $713.2m. If cash generation remains this strong without relying on unusually favorable working-capital magic (which we’ll discuss below), that’s an absolute credibility amplifier. Cash in the bank is a fact; everything else is an accounting opinion.

Atomic Take: The so-called “rebound” here is simply awards and backlog proving to the market that FY2025 wasn’t just a one-year backlog conversion party.

Falsifier: Two consecutive quarters of net book-to-bill falling below 1.00x (company KPI) would be an early-warning air raid siren that the next shoe is dropping. If the tub is draining faster than it fills, you eventually run out of water.

Financial Quality Rubric

Profitability (4/5)

FY2025 income from operations was $534.9m on revenue $2,530.2m. Run the math, and that implies an operating margin around 21%. Let me be clear: that is premium services economics.

You don’t get a 21% operating margin in a highly competitive industry unless you are exceptionally good at what you do.

Growth quality (4/5)

FY2025 delivered very strong growth. But remember, the key quality question in the CRO business is not simply “did it grow?” — it’s “was that growth actively replenished by new awards, or was it just pulled forward by burning through the backlog?” Right now, it’s a mix, which is why we deduct a point.

Cash conversion (4/5)

FY2025 operating cash flow was $713.2m versus a net income of $451.1m. That is spectacularly strong conversion. However, some of that boost is tied to working-capital timing. We’ll separate the genuine fuel from the temporary turbo down below.

Balance sheet resilience (4/5)

There is absolutely no long-term debt outstanding (as of Dec 31, 2025) and they carry meaningful cash. The liabilities they do have skew toward operational obligations rather than dangerous financial leverage. This is the kind of balance sheet that lets you sleep soundly at night during a recession.

Governance & alignment (3/5)

Founder ownership is usually a massive positive for alignment. I want the captain heavily invested in the ship. But control combined with related-party disclosures can, and often will, keep a persistent valuation discount on the equity. It just makes institutions nervous.

Capital allocation discipline (3/5)

Share buybacks were huge in FY2025. Buying back your own stock can be incredibly shareholder-friendly, but it also violently increases the importance of not overpaying for it. If you buy high, you’re destroying value, not creating it.

Atomic Take: These financial statements read exactly like a premium operator should read. The only deductions are the durability uncertainty (the biotech cycle) and the optics (the governance cloud).

Falsifier: Operating margin compressing materially away from that ~21% zone (derived) while book-to-bill hovers near a stagnant 1.0x would strongly suggest real competitive or cost pressure is building, not just harmless cycle noise.

Share

The Statements

Balance Sheet (The Geiger Test)

As of Dec 31, 2025, cash and cash equivalents were $497.0m, total assets were $1,975.5m, and total liabilities were $1,516.4m.

A major, vital part of their current liabilities is advanced billings (also called contract liabilities) of $854.4m (as of Dec 31, 2025). That’s customer cash received before the work is recognized as revenue. In plain English: their biotech sponsors are pre-funding a meaningful slice of the Medpace engine. Warren Buffett loves insurance float; I love operational float. It’s free money to run the business.

Accrued expenses were $408.4m (as of Dec 31, 2025). On the asset side, goodwill sat at $662.4m. I don’t mind goodwill as long as the underlying earnings power of those past acquisitions stays durable and real.

The clean, common-sense takeaway: this is absolutely not a balance sheet built on dangerous financial leverage. It’s built on operational float. That is incredibly valuable, but it’s also directly linked to the health of client demand and project cadence.

Atomic Take: This balance sheet is operationally pre-funded rather than financially levered. It’s a massive strength that only becomes a risk if biotech sponsor behavior suddenly shifts and they stop paying up front.

Falsifier: Advanced billings falling sharply while accounts receivable/unbilled rises (both as of Dec 31) would be a huge red flag indicating weakening prepayment dynamics and potentially much higher collection risk.

Cash Flow (The Turbine)

Start with the adult reconciliation.

FY2025 net income was $451.1m. FY2025 operating cash flow was $713.2m. That is a massive spread. Why did cash flow dwarf net income so heavily?

A key contributor was simply working capital shifting in their favor: advanced billings increased by $143.8m, and accrued expenses increased by $97.1m. This was partially offset by an increase in accounts receivable and unbilled of $106.2m. When you collect cash before you pay bills, your cash flow looks like a superhero.

Now, let’s look at “capex-like” spending. Property and equipment expenditures were just $31.1m. This is a wonderfully asset-light business. Using a conservative proxy, a sustainable free cash estimate can be Operating Cash Flow minus those PPE purchases: roughly $681.9m.

They also present a non-GAAP free cash flow figure of exactly $681.9m, which lines up beautifully with our simple proxy.

And then, we have the big cash outflow: share repurchases of $917.4m. That’s the entire turbine output (and then some) getting shoveled straight into per-share math.

Atomic Take: The cash turbine is undeniably strong, but part of the extra torque this year comes from working-capital timing — and buybacks are aggressively consuming most of the cash generated.

Falsifier: A year where operating cash flow suddenly falls below net income without a clear, logical timing explanation would signal either a nasty working-capital reversal or structurally weaker cash economics.

Income Statement (The Reactor)

FY2025 revenue was $2,530.2m. Income from operations was $534.9m. Net income was $451.1m. Diluted EPS came in at a beefy $15.28.

But the revenue composition is what prevents lazy investors from making bad conclusions.

Direct service costs (excluding D&A) and reimbursed out-of-pocket expenses are the large line items here. Crucially, those reimbursed out-of-pocket expenses were a massive $1,037.5m.

If you want to think clearly about this business, you absolutely must separate their actual “service margin engine” from the “pass-through volume” of reimbursements.

Therapeutic mix shows a heavy concentration in areas where biotech spending tends to be highly meaningful. FY2025 oncology revenue was $747.6m and metabolic was $745.0m, with other therapeutic areas contributing the remainder. They are fishing in the ponds where the biggest fish live.

Atomic Take: The reactor runs incredibly hot on operating profit and cash — but that top-line growth needs careful interpretation because massive pass-through revenue can severely inflate the optics of growth.

Falsifier: EPS declining year-over-year while revenue somehow still rises would point directly to mix deterioration or hidden cost creep hiding behind the smokescreen of pass-through growth.

Valuation (The Terry Smith Lens)

Let’s get down to brass tacks. You can love a business to the moon and back, but if you pay the wrong price, it will still break your heart.

At the time of writing, the share price is $451.75. They generated FY2025 diluted EPS of $15.28.

I am using the exact shares outstanding of 28,381,283 (as of Feb 6, 2026, shares).

Multiply the shares by the price, and that implies a total equity value of about $12.82B (derived: price × shares).

That is the sticker price for the entire farm today. Now we have to figure out if the soil is rich enough to justify it.

Quality Gate

Before we even talk about whether the stock is expensive, we have to ask if the business is actually any good. Investors like Terry Smith don’t buy junk, and neither do we.

FY2025 income from operations (EBIT) was a massive $534.9m on total revenue of $2,530.2m.

If you run the math, that gives you an ~21.1% EBIT margin.

FY2025 operating cash flow was $713.2m. Meanwhile, the money they actually had to spend to keep the lights on and the labs running—property & equipment expenditures—was a tiny $31.1m.

Atomic Take: Quality absolutely clears the gate here. This is a high-margin operator with serious, undeniable cash generation. They aren’t just making accounting profits; they are making cold, hard cash.

Falsifier: A full-year period where operating cash flow drops below net income without a very clear, temporary timing explanation (like a weird working capital or tax shift).

Owner Yields (The “what do owners get?” question)

Earnings yield:

If we look at standard earnings, the FY2025 earnings yield = EPS $15.28 / $451.75 = 3.38%.

Flip that upside down, and that’s a ~29.56x trailing P/E (derived). If you only look at that one number, you might choke on your coffee and call it too expensive.

FCF yield:

But earnings are an opinion; cash is a fact.

FCF ≈ operating cash flow of $713.2m minus PPE purchases of $31.1m = $682.1m.

If we take that FCF yield ≈ $682.1m / market cap $12.82B, we get 5.32%.

So, if you’re looking strictly at the “earnings multiple,” you’ll instantly call it expensive.

But if you’re looking at the actual “cash yield” they generate, it already starts to look significantly less premium and a lot more reasonable.

Atomic Take: On a pure owner-earnings basis, the stock looks meaningfully more attractive than the P/E headline suggests, entirely because their cash conversion is incredibly strong.

Falsifier: That cash proxy yield falling materially while the earnings multiple stays stubbornly elevated.

Capital Return Yield

This is where the story gets aggressive.

FY2025 share repurchases were a staggering $912.9m (USD) for 2,961,924 shares, with $821.7m still authorized for future buybacks (as of Dec 31, 2025, USD).

If you map that out, the buyback yield ≈ $912.9m / $12.82B = 7.12%.

But here’s the crucial reality check, the thing most investors miss: those buybacks actually exceeded the FCF proxy by about $230.8m. That “extra” return wasn’t magic. It was funded by actively reducing their cash on hand and shifting other balance sheet movements.

This matters deeply for how we frame the valuation:

• If buybacks continue anywhere near this FY2025 intensity, the per-share claim on earnings and cash can rise incredibly quickly (the share count retired is ~10% of year-end shares, proxy-derived). That is a monster tailwind.

• However, if buybacks are forced to revert to “FCF-funded only” because the savings account runs low, the buyback yield could be lower. But even then, it would still be potentially very meaningful given that strong ~5.3% FCF yield.

Atomic Take: If you treat your “owner return” as FCF yield plus sustainable net buybacks, the whole setup can look fairly decent in terms of value, even with a high level P/E on the surface. But only if the buyback machine remains credibly funded by recurring cash flow, not by simply drawing down the balance sheet until it hurts.

Falsifier: Repurchases slow down materially while the book-to-bill/backlog weakens (a nasty two-hit combo: less per-share support from buybacks, and less operating momentum from the business).

Insider Incentives

Wall Street loves to talk about “alignment,” but usually, it’s just a CEO with a few stock options. Not here.

The CEO/founder’s ownership is, as I stated earlier, officially disclosed at approximately 19.0% of outstanding shares (as of Dec 31, 2025).

When you own nearly a fifth of the company, it creates an unusually direct, burning incentive to heavily favor per-share compounding (aggressive buybacks, ruthless spending discipline, and fierce margin defense).

Yes, it also increases the control and optics risk we talked about earlier — but strictly on the topic of incentives: this is absolutely not a “hired-gun CEO paid in vibes” situation. He eats his own cooking.

Atomic Take: The entire incentive stack is brutally aligned with per-share outcomes, which makes this massive buyback program much more than just a corporate PR stunt.

Falsifier: Any SEC disclosure indicating a meaningful change or reduction in founder ownership/control, or a sudden, unexplained shift away from buybacks as the primary capital return mechanism.

Why Now?

At $451.75, here is exactly what you’re getting:

• A 3.38% GAAP earnings yield.

• A healthy 5.32% FCF yield.

• A massive 7.12% buyback yield

So the verdict is this: If Medpace is expensive or not entirely depends on which of those yields you believe is actually durable, and how safely you can underwrite the sustainability of those buybacks.

Atomic Take: If your core base case assumes that (a) their cash generation stays right near those strong FY2025 levels and (b) buybacks remain meaningfully funded without blowing up the balance sheet, it’s entirely reasonable to call this stock not expensive on an owner-return basis, even if standard stock screeners scream “expensive”.

Falsifier: Net book-to-bill drops < 1.00x for a full year (company KPI) and buybacks suddenly grind to a halt due to cash constraints — that lethal combination would permanently break the “attractive owner return” argument.

Risks (The Meltdown List)

Let’s be brutally honest. If our entire valuation case is built on the three-legged stool of “owner yield + aggressive buybacks + founder alignment,” then our risk checklist needs to attack that exact chain.

We aren’t going to waste our time with generic CRO industry hand-wringing. We need to know what breaks our specific machine.

Biotech funding cycle (demand shows up first in awards)

• FACT: FY2025 net new business awards were $2,646.8m and FY2025 net book-to-bill was 1.05x.

• HYPOTHESIS: If the biotech sponsor funding environment suddenly gets tight, it’s going to show up in the awards first. The backlog and the actual revenue will follow, but with a frustrating lag.

• MONITOR: Keep a hawk’s eye on the net book-to-bill and net new business awards each quarter (company KPI).

Cancellations and the “backlog isn’t money” reality

• FACT: The 10-K is refreshingly explicit here: awards and backlog can be impacted by scope, timing, and cancellations, and “the majority of our customers can terminate our contracts without cause upon 30 days’ notice.”

• HYPOTHESIS: A sudden cancellation wave makes our beautiful owner-yield stack look terrifyingly temporary because the revenue runway shrinks overnight.

• MONITOR: Watch the ending backlog and their specifically disclosed 12-month conversion expectation ($1,890.0m–$1,910.0m expected to convert to net revenue in 2026, as of Dec 31, 2025, USD).

Working-capital “turbo” reverses (cash can be timing theater)

• FACT: FY2025 operating cash flow was a massive $713.2m. But that was helped significantly by working-capital movements including advanced billings adding +$143.8m and accrued expenses adding +$97.1m, partly offset by accounts receivable/unbilled dropping by -$106.2m.

• HYPOTHESIS: If the growth in advanced billings slows down or reverses, their operating cash flow (CFO) can step down violently, even if the operating profit (EBIT) still looks perfectly fine.

• MONITOR: Track advanced billings, which sat at $854.4m, and accounts receivable/unbilled at $402.1m, and see where they move directionally year-over-year.

Human capital / culture risk (owner-yield sustainability)

• FACT 1: The company says success depends on attracting/retaining qualified staff and highlights internal promotion pipelines.

• FACT 2: External employee-review data shows low overall ratings and low CEO approval.

• HYPOTHESIS: If the culture drives persistent churn, Medpace may need to “buy” retention via higher comp/benefits or accept quality slippage — either way, margins and execution durability become less certain.

• MONITOR: Glassdoor rating/CEO approval trend, hiring, any evidence in filings that retention is becoming harder than management describes.
  Falsifier: A sustained deterioration in execution KPIs (book-to-bill/backlog quality) alongside evidence of talent strain (harder hiring/retention language in filings).

Atomic take: (note: I am 100% anecdotical here). From a strict investment standpoint, I believe an unpopular CEO isn’t always a deal-breaker. In fact, some of the best 100-baggers were run by “difficult” founders. And I think these are the reasons why:

• The “Shared Misery” Effect: Management at Medpace is as hard on themselves as they are on staff. They are not living high on the hog while the workers suffer; they are obsessed with winning.

• The Training Ground: Despite the hate, Medpace is known as the best place to learn the industry. It’s like the “Goldman Sachs” of clinical research. It’s miserable while you’re there, but your resume is golden afterward.

• Capital Allocation vs. Popularity: August Troendle probably doesn’t care about being liked. But it is obvious that he cares about ROE (Return on Equity) and share buybacks. He treats the company like a private partnership where the goal is maximum efficiency.

Falsifier: If employee sentiment stays poor yet the company continues to show consistent KPI performance with no retention stress appearing in filings, the “culture will break the machine” concern weakens materially.

Buyback sustainability (the valuation case lives or dies here)

• FACT: FY2025 repurchases were a staggering $912.9m (USD) for 2,961,924 shares, with $821.7m still remaining authorized (as of Dec 31, 2025, USD).

• FACT: In that same year, operating cash flow was $713.2m and property & equipment expenditures were $31.356m (FY2025, USD, US GAAP) — meaning those repurchases exceeded a conservative cash proxy (CFO − PPE) by roughly ~$231m (derived).

• HYPOTHESIS: If repurchases slow down materially (or swing from being a massive “accelerator” to completely “off”), our entire “not premium on owner return” framing weakens incredibly fast.

• MONITOR: Compare the repurchase pace versus CFO and the actual cash balance ($497.0m cash & cash equivalents as of Dec 31, 2025, USD).

Founder control

• FACT: August controls approximately 19.0% of outstanding shares via direct and beneficial ownership and this can exert significant influence over corporate actions requiring shareholder approval.

• FACT: Related-party transactions exist (e.g., a CEO-owned hotel is used for lodging; the HQ lease is with an entity owned by the CEO; and there are disclosed relationships with entities where executives have board roles/equity).

• HYPOTHESIS: Even if the actual business operations stay pristine, bad optics can act like a ceiling, capping the multiple you’re “allowed” to have in the market. Which matters deeply when Wall Street is debating whether it is expensive or not.

• MONITOR: Watch for any changes in the risk-factor disclosure language and any expansion in the scale or frequency of these related-party items.

Sneaky risk: “owner yield” depends on definitions

• FACT: Management actively defines Free Cash Flow as operating cash flow less capex and the principal portion of payments related to campus leases classified as deemed landlord liabilities (a non-GAAP definition).

• HYPOTHESIS: If those internal definitions start to shift (or if that lease component suddenly becomes much more material), our “FCF yield” comparisons get incredibly noisy, and the entire story gets much easier to misread.

• MONITOR: The consistency of the Free Cash Flow definition across future presentations and SEC filings.

Atomic Take: The biggest risks here aren’t “a bad quarter” — they’re strictly (1) awards/backlog weakening, and (2) buybacks losing sustainability, because that’s what actually makes the owner-yield stack look attractive.

Falsifier: A full-year net book-to-bill dropping below 1.00x (company KPI) combined with a visible deceleration in repurchases versus FY2025’s $912.9m (USD) pace.

The Atomic Verdict

Status: High Conviction ★★★★☆

(IMPORTANT: Star system is not a buy recommendation, only a judgement for the quality of the business based on my parameters. DYOR)

Here’s exactly why the “expensive” label gets significantly shakier once you stop blindly worshiping the P/E ratio and start doing the Terry Smith-style math:

The Owner-Yield Stack (FY2025 basis):

• Earnings yield: 3.38%

• FCF proxy yield: 5.32%

• Buyback “yield”: 7.12%

Watch that last number closely. In FY2025, Medpace spent roughly ~$231m more on share buybacks than the actual free cash the business generated (CFO minus PPE). They funded the difference simply by drawing down their existing bank account.

If you are buying this stock because you love that massive buyback yield, you have to decide exactly how long they can keep outspending their own cash flow before the corporate ATM runs dry.

Founder incentives matter immensely here because the capital allocation lever is so huge.

The CEO/founder controls ~19.0% of outstanding shares and can heavily influence corporate actions. You can dislike that control structure if you want — but the incentive to care deeply about per-share outcomes is absolutely not ambiguous.

Upgrade triggers (measurable)

• Net book-to-bill trends up from 1.05x (FY2025, company KPI) and backlog growth re-accelerates (ending backlog, as of year-end).

• Repurchases remain substantial but become definitively “cash-covered” (meaning CFO − PPE consistently covers the buybacks without a persistent cash drawdown).

• Evidence that trial cancellations remain strictly “normal course” (no visible hit to awards/backlog in their disclosures).

Downgrade triggers (measurable)

• Net book-to-bill drops below 1.00x for a sustained period (company KPI).

• Ending backlog declines year-over-year (as of Dec 31), or the 12-month conversion expectation steps down materially.

• Repurchase pace slows sharply despite the remaining authorization of $821.7m (as of Dec 31, 2025), suggesting either a real cash constraint or a management valuation/regret pivot.

Medpace sits right at the fascinating intersection of a Terry Smith quality engine and a Chris Mayer 100-bagger. It is a beautiful, highly profitable compounding machine hiding in the unglamorous plumbing of the biotech industry.

If Dr. Troendle can keep funding those massive buybacks with real cash flow, this execution engine has plenty of runway to justify the premium price tag.

Now, I want to hear your take:

Are you willing to pay up for this level of execution, or does the biotech funding cycle keep you safely on the sidelines?

Drop your verdict in the comments below. Let’s debate.

References

• Medpace Holdings, Inc. — 2025 Investor Presentation (PDF: “Medpace 2025 Investor Presentation.pdf”).

• Medpace Holdings, Inc. — Q4/FY2025 Earnings Presentation (PDF: “MEDP_4Q25_Earnings_Presentation.pdf”).

• Medpace Holdings, Inc. — Form 10-K (FY ended December 31, 2025) (PDF: “0001668397-26-000006.pdf”).

• Financials / model workbook (XLSX: “MEDP-Medpace Holdings Inc (1).xlsx”).

Company / regulator sources referenced for narrative context (founder / insider activity)

• Medpace corporate website — Leadership bio page for Dr. August J. Troendle (founder/CEO background).

• SEC EDGAR — Form 4 insider transaction filing(s) from November 2025 referenced in the founder/insider activity discussion.

Disclaimer
This Deep Dive is an educational breakdown of a public company based on information available in the materials provided (e.g., annual/quarterly reports, investor presentations, earnings transcripts) and my interpretation of that information. It is designed to be a “bolt-on” intelligence layer to your own due diligence — not a replacement for it.

Independence: I do not accept compensation of any kind from the companies discussed. My research is driven solely by my personal search for high-quality compounders.

Skin in the Game: Unless otherwise stated, assume the author may hold a long position in securities mentioned. Any position creates bias — treat this as commentary, not gospel.

Not Financial Advice: Nothing here is investment advice, a recommendation, or a solicitation. I am not a financial advisor. You are responsible for your own decisions. The stars rating is not a buy recommendation, but meant as a guide to understand the quality of the financial statement of the respective companies.

Error & Update Risk: Financial statements change, companies restate, guidance evolves, and I can be wrong. Verify key figures in the primary filings and consider reading the footnotes before deploying capital.

1. The “Impossible” Stat

If you had to calculate the odds of a mutual fund manager beating the S&P 500 for 15 consecutive years, the math is brutal: it is roughly a 1 in 2.3 million probability.

In the hyper-competitive arena of Wall Street, where the brightest minds routinely underperform basic index funds, Bill Miller achieved the impossible. Managing the Legg Mason Value Trust from 1991 to 2005, Miller didn’t just beat the market; he shattered the conventional boundaries of how to value a business.

He didn’t build his unparalleled streak by clinging to safe, predictable assets. He did it by making massive, highly concentrated bets on companies the old-guard “value investors” were terrified of—most notably, turning an early stake in a profitless online bookstore called Amazon into a 24x return.

But Miller’s strategy isn’t magic. It is a highly specific, probability-driven operating system designed to exploit the market’s inability to price the distant future.

Subscribe now

2. The Origin Story

Bill Miller’s edge didn’t come from a finance textbook, but from the philosophy department.

Before he ever managed a dollar on Wall Street, Miller served as an intelligence officer in the U.S. Army and pursued a PhD in philosophy at Johns Hopkins University. It was there that he became obsessed with “pragmatism,” a school of thought that fundamentally rewired his brain.

While traditional value investors were rigidly backward-looking—obsessing over past earnings, tangible book value, and historical P/E ratios—pragmatism taught Miller to look beyond the obvious and calculate future possibilities.

This philosophical lens gave Miller his ultimate unfair advantage. He realized that the stock market was obsessed with certainty, demanding immediate GAAP (Generally Accepted Accounting Principles) profitability.

By breaking his reliance on backward-looking analytics, Miller became perfectly positioned to spot value where others only saw risk: the chaotic, fast-paced frontier of the early internet.

3. The Superpower (The Mechanic)

Share

To traditionalists like Benjamin Graham, Miller was a heretic. But Miller’s superpower was recognizing a fatal flaw in Wall Street’s tribalism:

Miller famously declared, “Growth is an input into the calculation of value.” He realized that any stock could be a value stock if it traded at a discount to its intrinsic value. Instead of looking for companies trading at low multiples of today’s earnings, Miller built his strategy on probabilistic valuation.

The mechanic works like this:

• Ignore the GAAP, Follow the Cash: Miller discarded traditional accounting profits. He defined intrinsic value purely as the present value of future free cash flows, discounted back to today.

• The Cost of Capital Hurdle: He hunted for businesses whose economic models allowed them to earn returns on capital above their cost of capital over an entire economic cycle.

• Scenario Weighting: He didn’t try to predict one exact future. He envisioned multiple scenarios for a business, assigned a probability to each, and summed them up to find the “central tendency of value.”

This is how he bought Amazon in 1999. While Wall Street panicked over Amazon’s negative accounting profits, Miller recognized the economies of scale Jeff Bezos was building. He calculated that the massive future free cash flows justified the price, leading him to snatch up a 15% stake in the company.

To Miller, Amazon wasn’t an expensive growth stock; it was a deeply undervalued cash machine hiding in plain sight.

4. The Graveyard (The Risk)

If you play the odds aggressively enough, eventually, you draw a catastrophic hand. For Miller, that hand was dealt in 2008.

Miller’s operating system relied on a specific mechanic: “Lowest Average Cost Wins.” When a high-conviction stock dropped, he didn’t panic; he averaged down and bought more.

This strategy had saved him during the dot-com bust and the Savings and Loan crisis in 1990, where his 40% portfolio concentration in beaten-down financial stocks eventually propelled him to massive gains.

But in 2008, the global financial system wasn’t just cyclical; it was structural. As the housing market cracked, Miller used his old playbook. He loaded up on plummeting shares of Bear Stearns, Citigroup, AIG, and Freddie Mac. He caught a falling knife, and it severed his portfolio.

He bought Bear Stearns at $30 just days before it collapsed. He stubbornly held Freddie Mac even as colleagues begged him to sell, only to watch it get wiped out by government nationalization in September.

Because of these bets, his value fund lost over $12 billion in AUM, underperforming the S&P 500 by 20 percentage points. The losses were permanent, proving the brutal reality of his leverage-like concentration: when the rules of the game change entirely, the historical playbook becomes a death sentence.

Share

5. Steal Their Brain (The Toolkit)

You don’t need a PhD from Johns Hopkins to invest like Bill Miller. You just need to steal his mental models. Here is the toolkit:

• The “Probability Matrix” * The Concept: Stop asking “What will happen?” and start asking “What are the odds?”

  • The Actionable Rule: Never value a company based on a single outcome. Map out three scenarios (Worst, Base, Best), assign a percentage likelihood to each, and blend them. If the current stock price is vastly lower than your blended value, buy.

• The “Lowest Average Cost” Mandate

  • The Concept: If you are right about the intrinsic value, a dropping stock price is a gift, not a warning.

  • The Actionable Rule: When you buy a stock, mentally prepare for it to drop 20%. If nothing fundamentally changes about the business’s long-term cash flow, you must be willing to buy more.

• The “Silver Bullet of Simplification”

  • The Concept: Complex models create false confidence.

  • The Actionable Rule: Throw out the 50-tab Excel spreadsheets. Identify the 3 or 4 critical variables that actually drive the business. If you can’t map the future value on those few variables, it’s just noise.

6. The Human Factor (The Quirk)

The 2008 crisis didn’t just break Miller’s portfolio; it broke him physically. The stress of the financial collapse was visceral. Miller reportedly gained 40 pounds during this era.

He spent his nights waking up in a cold sweat, constantly checking his beaten-down stocks as his reputation was shredded in the pages of The Wall Street Journal, and he was unceremoniously fired from a $2.2 billion pension board.

But Miller’s ultimate human quirk is an unyielding, almost stubborn resilience.

He views losses as “tuition payments.”

Later in his career, he ruthlessly purged the complexity from his life. He stopped building financial models, calling them “stupid,” and retreated from the corporate spotlight of Legg Mason to run a smaller, highly concentrated fund under his own name.

He adopted a minimalist approach to data, tuning out the macroeconomic panic of the day to focus entirely on deep, intellectual curiosity—an evolution that eventually led him to place massive, highly lucrative bets on Bitcoin when the rest of Wall Street laughed at it.

7. The Verdict

Bill Miller is the patron saint of the “Contrarian Optimist.” He proved that you can generate monumental wealth by ignoring labels, trusting probabilities, and stepping into the fire when everyone else is running for the exits.

Copy this style if:

• You possess a stomach of absolute steel and do not panic when your portfolio drops 30%.

• You view stocks as fractional ownership of future cash flows, not squiggles on a chart.

• You are comfortable looking like a fool in the short term to be proven a genius in the long term.

Run away if:

• You rely heavily on standard metrics like P/E ratios and GAAP earnings to feel “safe.”

• You cannot mentally separate a company’s stock price from its underlying business fundamentals.

• The idea of averaging down on a plummeting stock keeps you awake at night.

I recently started reading Chris Mayer’s excellent book (which I have already read 3 times before), 100-Baggers. It is a fascinating deep dive into the math and psychology of finding stocks that return 100-to-1.

It’s a great read, but one specific chapter stopped me in my tracks. Mayer briefly highlighted the importance of extreme long-termism by pointing to an obscure mutual fund that achieved incredible success by doing, well, absolutely nothing.

I was hooked. I went down a rabbit hole, digging through financial archives and old news clippings, including a fascinating 2015 Reuters piece detailing the fund’s history. What I found wasn’t just a quirky financial anomaly; it was a masterclass in alpha generation, the power of corporate evolution, and the staggering edge you gain by simply leaving your investments alone.

Here is the story of the Voya Corporate Leaders Trust Fund, why its radically lazy approach beat the smartest guys in the room, and exactly how we can apply its playbook today.

Subscribe now

The Time Capsule from 1935

The story starts in 1935. The United States was grinding its way through the Great Depression. Franklin D. Roosevelt was in the White House, and the economic mood was grim.

Amidst this, the fund’s original sponsors, Corporate Leaders of America, launched a deceptively simple experiment.

They didn’t try to time the market, and they didn’t look for hidden, undervalued gems. Instead, they identified the undeniable pillars of the American economy; the industrial giants that kept the lights on, the trains moving, and the factories humming.

They bought equal amounts of stock in 30 major U.S. corporations. The blue-chips of the era like General Electric, Union Pacific, Procter & Gamble, and DuPont.

The fund’s charter essentially forbade the managers from ever buying a new stock. They were a trust, meant to hold these specific companies forever.

For the next 80-plus years—through World War II, the Cold War, the 1987 crash, the dot-com bubble, and the 2008 financial crisis—the fund made zero active investment decisions.

The results? Astonishing.

By doing zero work, this “do-nothing” approach crushed professional active managers, beating 98% of its large-value peers over 5- and 10-year stretches. Assets that were practically “dead in the water” at $60 million in the late 1980s swelled to over $1.7 billion as the strategy’s brilliance proved itself.

The Magic of “Corporate Darwinism”

If you bought 30 stocks today and didn’t touch them for 80 years, common sense says half of them could go bankrupt and leave you destitute.

And you know what? A bunch of them did. Companies like the Pennsylvania Railroad Co. and American Can eventually went bust or faded into irrelevance. Today, only about 21 “bloodlines” of the original 30 remain.

So how did the fund survive, let alone crush the market? Because while the portfolio managers were completely passive, the underlying companies were fiercely active.

Share

The portfolio benefited from what I like to call “Corporate Darwinism.” Over eight decades, the portfolio evolved organically through the natural lifecycle of business.

• Beneficial Mutations (Spin-offs): When a massive conglomerate in the portfolio decided to spin off a division into a new, separate company, the fund simply accepted the new shares and held them. For example, the original portfolio held Standard Oil. Over decades, through antitrust breakups and mergers, that single holding automatically mutated into massive stakes in both ExxonMobil and Chevron.

• Strategic Absorption (Mergers): When one of the portfolio companies was acquired by another giant, the fund received and held the stock of the new acquirer. An original holding in the Atchison, Topeka and Santa Fe Railway eventually, through a series of corporate deals, morphed into shares of Warren Buffett’s Berkshire Hathaway—which became the fund’s second-largest holding. F.W. Woolworth, the retail pioneer, eventually evolved into Foot Locker.

The lesson here is profound:

If you own the highest-quality businesses, they will find ways to survive, adapt, and acquire their way into the future. The losers in the portfolio went to zero, but the math of long-term investing is brilliantly asymmetrical.

A stock can only lose 100%, but it can grow 10,000% or more. The massive winners—the 100-baggers—more than compensated for the bankruptcies.

The Edge of Lethargy

Why did this lazy strategy work so incredibly well?

First, it eliminated human error. The greatest enemy of the investor is their own brain. We sell in a panic at the bottom and buy in a frenzy at the top. The Voya charter removed the ability for managers to make stupid emotional decisions.

Second, it created extreme tax efficiency. In taxable accounts, high turnover is a wealth killer. Every time you sell for a profit, the government takes a cut, leaving you less capital to compound. Because the fund never voluntarily sold, it generated virtually no capital gains taxes for decades, allowing nearly 100% of the capital to compound uninterrupted.

Finally, it let the winners run. Standard Wall Street advice is to “rebalance”—selling your winners to buy more of your losers. The 1935 trust did the exact opposite. It let its winners grow into massive, dominant positions that carried the entire portfolio.

The Modern Playbook: Building a 2100 Portfolio Today

Subscribe now

I am perfectly aware that you cannot buy the Voya fund today hoping for the same century-defining returns; its portfolio is frozen in 1935 and is heavily overweight in yesterday’s economy (like oil and old industrials).

But we can emulate their exact methodology today.

To be clear: I am not enthusiastic about this strategy if it is used recklessly. If you buy 30 speculative, profitless tech companies today and lock them in a drawer for 50 years, you probably won’t get a 100-bagger—you’ll just get a tax write-off.

This extreme “do-nothing” approach only works if you are buying companies with true, atomic moats. You need businesses so deeply entrenched that they act as the raw infrastructure of the economy.

Here are the rules of engagement for building your own 80-year portfolio today:

1. The Rules of the Trust

• Select 25 to 30 Stocks: This is the sweet spot. It provides enough diversification to absorb the inevitable bankruptcies of a few companies over a century, while remaining concentrated enough to let the mega-winners drive the total return.

• Start with Equal Weights: Put the same dollar amount into each company.

• The Blood Oath—Never Sell: This is the hardest rule. You must be mentally prepared to hold through 50% drawdowns without flinching. If a stock drops 80%, you hold. If it goes up 2,000%, you hold.

• Embrace the Mutations: When your companies spin off new divisions, keep the new shares. When they merge, keep the new company. This is how your portfolio stays automatically relevant.

• Reinvest Dividends: Use the dividends to buy more shares of the exact same original companies. Never add a 31st stock.

2. The Candidates: Finding Today’s “Pillars”

If you look at the original 1935 portfolio, the managers bought the obvious mega-caps of their day—heavy railroads, giant oil producers, and steel monopolies. But if our goal is to engineer a portfolio capable of returning multibaggers, and especially 100-to-1 over the coming decades, we cannot buy today’s $3 trillion tech giants. The math simply doesn’t allow a $3 trillion company to become a $300 trillion company.

When the Voya managers bought the giants of their era—companies like General Electric, DuPont, and Standard Oil—they were indeed buying the absolute largest, most dominant monopolies on earth.

But the scale of the economy was fundamentally different.

In 1935, the entire nominal GDP of the United States was roughly $74 billion. The absolute largest corporations in the country at the time had market caps hovering between $1 billion and $3 billion.

This meant that even the undisputed kingpins of American industry represented just 1% to 3% of total US economic output. They were massive, yes, but they still had a virtually infinite runway to grow alongside the industrial explosion of the 20th century.

Fast forward to today. The US GDP is pushing $28 trillion, and our modern titans—Microsoft, Apple, Nvidia—boast market caps around $3 trillion.

That means a single mega-cap tech company today represents roughly 10% of the entire US economic output. The structural ceiling has been hit. For a $3 trillion company to become a 100-bagger, it would have to grow to $300 trillion—which is more than double the GDP of the entire planet.

Therefore, to truly level the playing field and match the geometric growth runway that the Voya managers enjoyed in 1935, I don’t think we could buy today’s top 10 household names. We have to look for companies that represent the same relative economic footprint today that GE did in the 1930s.

This brings us down to the $10 billion to $50 billion market cap range (and if you want 100-baggers, preferably even less than $10 billion).

In this range, we find the “Hidden Champions”—businesses with the exact same monopolistic dominance and atomic moats as the original 1935 blue chips, but with the mathematical breathing room required to actually multiply your wealth, similar to what Voya did, over the next few decades.

Share

Here are the modern pillars for an 80-year portfolio:

• The Financial Gatekeepers: These are the businesses that act as the invisible referees of the economy. They require virtually zero physical capital to grow and operate as pure tollbooths on commerce.

  • Examples: Fair Isaac Corporation (FICO), MSCI Inc. (MSCI). FICO is the ultimate example; 90% of top lenders use their credit scores. It is so deeply embedded into the underwriting process of global finance that replacing it is functionally impossible.

• The Civic Operating Systems: Government agencies, courts, and municipalities are notoriously slow-moving and risk-averse. Companies that digitize these institutions benefit from punishingly high switching costs; once a city adopts a system, the revenue is practically guaranteed for life.

  • Examples: Tyler Technologies (TYL), Motorola Solutions (MSI).

• The “Dirt” Monopolies: In the digital age, physical land constraints create incredible advantages. Look for companies whose business models rely on owning physical infrastructure that nobody else wants in their backyard.

  • Examples: Copart (CPRT), Waste Management (WM). Copart dominates the online auction market for totaled vehicles because they own massive tracts of land near major cities to store the wrecks. No municipality is going to zone new land for a massive junkyard today, meaning Copart’s moat is made of literal dirt.

• The Essential Aftermarkets: Businesses that provide the crucial maintenance, parts, and distribution for massive industries. They don’t take the massive R&D risk of manufacturing the core product; they just tax the ongoing usage and repair of it.

  • Examples: HEICO Corporation (HEI), Pool Corporation (POOL), TransDigm Group (TDG).

• The Route-Density Masters: Service companies where unit economics drastically improve as they gain local market share. When one technician services 15 houses in the exact same neighborhood, fuel and labor costs plummet, making it impossible for a new startup to compete on price.

  • Examples: Rollins, Inc. (ROL), Cintas (CTAS).The Ultimate Test of Patience

The Voya Corporate Leaders Trust is a profound lesson in humility. It proves that over a long enough timeframe, the combined ingenuity of the world’s best businesses—left entirely alone by anxious humans—is an unparalleled wealth-creation machine.

To replicate this kind of success, you don’t need to trade faster or guess the next macro trend. You just need to buy exceptional quality, and then have the supreme discipline to do absolutely nothing.

Today, I’m finally launching The Multibagger Index (MBI) — a live, transparent project with a single goal:

This is not a list of “hot stocks” or momentum trades.

It is also not a mechanical list of microcaps that just happen to have great-looking historical financials. Relying purely on a spreadsheet to pick small companies is a reckless strategy.

A beautiful income statement tells you what happened yesterday, but it doesn’t measure the depth of a company’s moat, the vision of its management, or its runway for the next decade. To make the cut, these companies must clear a massive qualitative bar.

The MBI is an attempt to filter out the noise and isolate the true compounding machines.

My dream scenario is to build an index of companies that make you look at their quarterly reports and say, “Yup, they delivered again, like clockwork. Now let’s relax for another three months.”

The MBI Ecosystem

To make this process completely transparent, I have broken the project down into three core resources.

The first two are live right now:

1. The Index (Live Dashboard)

This is the scoreboard. Here, you can see the 10 inaugural companies, their portfolio weightings, entry prices, and real-time performance. No hiding, no cherry-picking.

👉 View The Multibagger Index Here

As a subscriber, you also get exclusive access to the mechanics behind the index:

2. The MBI Rulebook (The Framework)

How does a company earn a spot? Candidates must pass specific “hard gates” regarding business model quality, moat trajectory, and TAM runway. This document explains the rules of the game, and exactly what gets a company kicked out.

Subscribe now to get it (look for link in welcome email)!

Subscribe now

3. The Constituent Thesis (The “Why”)

An index is useless without rationale. I have compiled a breakdown of all 10 current holdings (including Kneat, Global-e, Duolingo, etc.). This document covers my “one-line thesis” for each, the source of their moat, and the specific “thesis-breakers” I am monitoring. (Keep an eye on your inbox—this will be sent to you very soon!)

What to expect next

The MBI isn’t static, but it is designed to be viewed from an owner’s perspective. Markets change, and theses can break. Moving forward:

• When a company is added or removed, I will publish exactly why.

• We will focus relentlessly on business performance and fundamentals, not short-term price action.

• The goal is to uncover real alpha, learn the mechanics of extreme winners together, and hopefully have some fun along the way.

Take a look at the dashboard and let me know what you think.

(P.S. I am also working on a new tool designed to help you track earnings reports for your companies while stripping away all the noise. I just need to figure out how to keep the costs down on it before rolling it out to you. More on that soon!)

Best, Rob

I write 20-page deep dives because I love digging into the numbers.

But I create these ‘Simple Truths’ summaries because I know not everyone have time read my ultra-long content.

My goal is simple: I do the hours of heavy lifting (stripping away the corporate jargon and complex tables) to hand you the pure signal.

Here is my full research on Salesforce, distilled into a 3-minute read that respects your time.

Share

1. The Napkin Pitch (The Hook)

The One-Liner: Wall Street is panicking that AI will kill software, putting Salesforce—an incredibly sticky, cash-minting machine—on what could be a sale for nearly half off its recent highs.

The “Back of the Napkin” Thesis:

• Salesforce generates a massive ~$12.1 billion in annualized Free Cash Flow (FCF), which is actual cash hitting the bank account.

• The stock price has plummeted from $358 down to roughly $189.72 because the market fears AI will make their software obsolete.

• Despite this fear, customers aren’t leaving; the company is sitting on a massive $29.4 billion in short-term contracted backlog (money customers are legally on the hook to pay).

• Instead of hoarding their cash, management is aggressively buying back their own stock and paying dividends, returning over $4.1 billion to shareholders in just one quarter.

2. The Lemonade Stand (Business Model)

If you run a giant corporation, you need a central nervous system to track your salespeople, customer complaints, and data. Salesforce provides the digital filing cabinets and workflows—often called “systems of record”—to do exactly that.

What they sell: They sell cloud-based software subscriptions that manage customer relationships. Rather than selling a CD-ROM once, they charge a recurring fee.

The Customer: Massive enterprises pay them billions every single quarter to keep their business running. This software becomes so deeply hardwired into a company’s daily operations that ripping it out is the enterprise equivalent of “open-heart surgery performed by a committee”. Nobody wants to do it.

3. The Moat (Why They Win)

Salesforce’s ultimate advantage is switching costs. Once a business builds all its rules, employee permissions, and customer history into Salesforce, leaving for a competitor is an incredibly painful, expensive nightmare.

The “Toothbrush Test”: Yes, corporate employees use this software every single day. The market currently believes that new, smart AI chatbots will allow companies to build their own cheap software and bypass Salesforce (the “Do-It-Yourself” threat).

However, building AI in a lab is easy; deploying it securely across 10,000 employees is a nightmare. Salesforce is capitalizing on this pain with a new product called “Agentforce,” charging customers to run secure, reliable AI agents directly on top of their existing data. This AI add-on is already generating nearly $1.4 billion in annual recurring revenue alongside their Data 360 platform.

Subscribe now

4. The Price Tag (Valuation)

Wall Street is currently pricing this stock like a melting ice cube, but the cash tells a different story. Based on a market cap proxy of ~$180.6 billion and an annualized FCF proxy of ~$12.1 billion, this stock is quietly offering incredible value.

What You Get For Your Money

• FCF Yield: 6.7% — The “Interest Rate” this company pays. If they paid out all their spare cash to you today, this is the return you would get.

• P/FCF: ~14.9x — The “Cash Payback” period. If the company never grew again, it would take about 15 years of cash flow to pay back your purchase price.

• P/E Ratio: ~21.6x — The “Accounting” Price. How much you pay for $1 of reported profit.

The “Cash Verdict”: This stock pays you a theoretical 6.7% cash yield. Five years ago, Wall Street would have trampled people to get a dominant enterprise software company at this price. Today, they are leaving it on the sidewalk because they are terrified of AI. You are getting an elite cash generator at a massive discount because the narrative is temporarily broken.

5. The Money (Financial Health)

Profitability: Salesforce is a cash-printing machine. They boast an elite 78% gross margin (the profit left over after the direct costs of delivering the software) and a solid 21.3% GAAP operating margin. Thick margins like these act as the ultimate financial shock absorber.

The Balance Sheet: They are built like a fortress. They hold roughly $11.3 billion in total liquidity (cash and marketable securities). This easily balances out their $8.4 billion in long-term debt. Even better, they have $14.9 billion in “unearned revenue” sitting on their books—which is simply cash sitting in their pocket from customers for software services they haven’t even officially provided yet.

Subscribe now

6. Skin in the Game (Management)

The Driver: The company is led by CEO Marc Benioff. Management is highly focused on proving the AI “doomsday” narrative wrong, putting a hard 12-to-18-month deadline on reaccelerating their revenue growth.

The Alignment: The biggest proof of management’s confidence is their capital return program. They aren’t just talking; they are acting. In a single quarter, they spent a massive $3.8 billion repurchasing their own shares and another $395 million paying dividends. The tempo of these buybacks shows they are happily eating their own cooking while the stock is on sale.

7. The Bear Case (Risks)

The Kill Switch: The “SaaS Scare.” If enterprise customers actually stop buying Salesforce applications and successfully use AI agents to “Do-It-Yourself,” Salesforce’s software could become an easily replaceable wrapper, and their growth will permanently stall.

The “Worry List”:

• Heavy Goodwill: They carry a massive $52.4 billion in “goodwill” (an accounting premium paid for past acquisitions) on their balance sheet. If growth stops, this turns into a massive accounting impairment risk.

• Acquisition Indigestion: They have a history of buying huge companies and recently closed their acquisition of Informatica. Digesting these massive purchases could distract management during a critical AI shift.

• Culture & Brand Risk: There is reported internal friction and employee backlash regarding political/social comments made by CEO Marc Benioff. Internal politics can quickly become a drag on execution.

8. The Summary

I like this stock because it is a highly durable, cash-minting business that is aggressively buying back its own shares while the broader market panics over an unproven AI threat.

But there is more under the hood. The difference between their “GAAP” (strict accounting) margins and “Non-GAAP” (adjusted) margins is massive—jumping from 21.3% up to 35.5% —and hides some interesting secrets about how management presents their expenses.

This was just the appetizer. For the full deep dive into how these adjusted margins might be masking the company’s true expense profile, read the full Salesforce Deep Dive here.

Disclaimer:

• I Am Not Your Financial Advisor: I am a researcher sharing my homework, not a wealth manager giving you a plan. This is for education, not a recommendation to buy or sell.

• The Golden Rule: It is your money. Do your own due diligence, read the actual filings, and never invest money you cannot afford to lose.

New to The Atomic Moat? This analysis of Salesforce ($CRM) is a prime example of how we dissect high-quality compounders. If you want these deep dives sent to your inbox, join 1,000+ other investors below.

Join for Free

Folks, the market loves to panic first and do the math later. Right now, Wall Street is having a full-blown existential crisis over enterprise software.

The reigning narrative? AI is going to eat the SaaS application layer alive. The fear is that autonomous AI agents will simply “DIY” complex workflows. Why pay for expensive per-seat licenses when a smart chatbot can do the job for free?

Right now, the market is throwing the baby out with the bathwater. We’re watching highly durable, cash-minting businesses get priced like melting ice cubes simply because they happen to sell software.

But indiscriminate panic is exactly where the best opportunities hide. And that led me straight to the granddaddy of the industry: Salesforce.

I wanted to look under the hood and strip away the noise. Is the Salesforce fortress actually cracking under the weight of AI disruption, or is Wall Street just hallucinating a structural decline for a company that is still printing billions in cash?

Let’s dig in and find out.

Subscribe now

If You’re In a Rush

Let’s break this down to the studs before we get into the weeds:

• What they do: Salesforce sells enterprise “systems of record” for customer work—sales, service, data, and automation. They make their money mostly as subscription & support revenue.

• Why it’s hated: The market is currently flirting with the terrifying idea that AI agents will simply “DIY” the application layer. Wall Street thinks SaaS is going to get commoditized, which means multiples compress even if the underlying fundamentals actually improve.

• What fixes it: Proving that “agentic” demand is additive—not cannibalizing. We need to see that bookings, backlog, and cash conversion stay rock-solid while the AI stack shifts.

• Atomic Position: No position, but on my watchlist.

The Setup

The stock is sitting at $189.72 per share today (Feb 14th 2026). That is a long, painful drop from the $358 top it hit back in December 2024.

On the inside, the scoreboard looks a heck of a lot sturdier than the price action suggests. In Q3 FY26, Salesforce reported $10.259B revenue and a 21.3% GAAP operating margin, alongside a very healthy 35.5% non-GAAP operating margin.

On the outside, however, sentiment is being governed by a very specific, very loud fear. The fear is that generative AI is “injurious to the SaaS-based application layer,” and that enterprise customers will simply DIY their way around legacy vendors.

Variant Perception

Let’s look at the three sides of this narrative coin:

• Market: “AI agents kill app-layer value capture; incumbents become expensive UI wrappers.”

• Bull: “Agents make systems-of-record more valuable; Salesforce monetizes trust + data + workflow + governance.” (By the way, this is the company’s “agentic enterprise” framing).

• Bear: “AI attach is theater; growth stays single digits; buybacks become the only growth story left.”

This deep dive is about whether Salesforce can convert the AI narrative from a radioactive leak (driving multiple compression) into a controlled reactor (driving forward demand + monetization + cash).

Atomic Take: Salesforce looks operationally healthier than its stock chart implies. But I’ll be blunt: it’s still trading under the massive “SaaS gets disintermediated” cloud until forward indicators force Wall Street to re-rate it.

Falsifier: Q4 FY26 cRPO growth misses the company’s ~15% Y/Y guide (Q4 FY26, %, company guide) — if they miss that, it would validate the bear thesis that “demand isn’t inflecting.”

How the Business Actually Makes Money

Salesforce is, at its core, a massive subscription engine with a services sidecar bolted onto it. Subscription and support revenue is $9.726B, versus professional services and other bringing in just $0.533B.

Mechanically, their compounding loop is beautifully straightforward. I love businesses like this:

1. Land a workflow that becomes the default answer to “how the company does customer work.”

2. Expand across products (and across departments) until the customer has hardwired their processes and permissions deep into your platform. It’s like pouring roots into concrete.

3. Renew, because ripping out the system-of-record is the enterprise equivalent of open-heart surgery performed by a committee. Nobody wants to do it.

Quick note: Salesforce uses a fiscal year, so ‘Q3 FY26’ is the quarter ended Oct 31, 2025. Think of it like the Premier League: the 2025–26 season includes matches played in both 2025 and 2026. Same idea here, where ‘FY26’ includes quarters played in 2025. Companies do this because a fiscal year that lines up with their business cycle makes budgeting and performance comparisons cleaner. And for Salesforce, it keeps the big end-of-year sales/renewal season from being split awkwardly across two reporting years.

In Q3 FY26, Salesforce’s revenue disaggregation is presented under the new “Agentforce” naming umbrella (and the company explicitly states the rename did not change revenue allocation).

That’s incredibly useful.

It tells you this is, at least partly, packaging and positioning. And make no mistake, packaging matters deeply when the market is busy repricing narratives.

Let’s look at the major subscription buckets (Q3 FY26, USD, GAAP):

• Agentforce Service: $2.495B

• Agentforce Sales: $2.297B

• Agentforce 360 Platform, Slack and Other: $2.180B

• Agentforce Integration and Agentforce Analytics: $1.393B

• Agentforce Marketing and Agentforce Commerce: $1.361B

Now, let’s talk about the “AI option.” Management isn’t pitching “hey look, we added a chatbot.” They’re pitching “we are the control plane for deployed agents inside the enterprise.”

The measurable proof points they’ve chosen to emphasize are adoption and ARR-style monetization, including Agentforce and Data 360 ARR reaching nearly $1.4B, and Agentforce ARR surpassing half a billion.

Atomic Take: Salesforce doesn’t need to “invent a new category”; it just needs to remain the system-of-record and become the system-of-agents that runs on top of it.

Falsifier: Agentforce paid deals stop growing quarter-over-quarter (paid deals were >9,500 and up 50% QoQ in Q3 FY26, company KPI) — if that stalls, it would imply the AI attach motion isn’t sticking.

Share

What Went Wrong

First, growth slowed. Multiples got severely compressed. Then, the market found a convenient story that rationalizes paying less for the stock forever.

What it shows is a shifting growth regime: subscription & support constant-currency growth steps down and sits at 9% through Q3 FY26.

That’s the basic setup for a re-rate. Once growth moves from being a “teen compounder” to “high-single-digit durability,” the market stops paying for endless possibility and starts demanding cold, hard proof.

Then comes the “Narrative Scare”: the belief that AI agents make the application layer less valuable, and that customers will DIY around vendors. Again, this isn’t speculative panic from the cheap seats. It is literally presented on the call as the investor expectation.

So what does Marc Benioff (and management) think of it?

Their stance is basically this: investors are pricing a world where AI agents DIY the application layer and shrink the value of SaaS, but management says customer reality is moving the other way.

They describe a “mismatch” between what the market expects (DIY replacement) and what they’re seeing in the field: companies tried building their own models/toolkits, then ran into the messy reality that enterprise deployment is the hard part.

In Benioff’s framing, the value isn’t in tinkering. It’s in shipping deployed “customer agents” that live inside real workflows.

That matters because it implies a likely path forward; not “magic growth next quarter,” but a migration from experimentation to production:

• Customers move from pilots to deployed agents in live workflows.

• Deployment forces governance: permissions, auditability, workflow integration, and real data context.

• The system-of-record becomes the control plane (because that’s where the workflows + context already live).

• Monetization shifts toward attach and expansion (agents/data/products layered onto the core), not just seat growth.

Atomic Take: Salesforce’s bet is that AI doesn’t delete the system-of-record, but it increases its importance, because enterprises will pay for agents that are governed, contextual, and reliably executable.

Subscribe now

Rebound Catalysts

Wall Street doesn’t need Salesforce to be a flawless diamond right now. It just needs the boogeyman story (the “SaaS gets disintermediated by AI” campfire tale) to stop being believable.

I’ve always said, you don’t need a perfect company to make money; you just need a mispriced one that proves the loudest skeptics wrong.

Here are the testable catalysts we need to watch. The beauty is, these are tied to the exact KPIs Salesforce is already disclosing. No guesswork required:

1. Backlog credibility stays strong

Think of the backlog like a farmer’s silo. If the silo is full of grain, you don’t worry about starving next winter.

Right now, Salesforce’s cRPO (current Remaining Performance Obligation) is sitting at a massive $29.4B, and total RPO is an even bigger $59.5B.

Even better, management is guiding Q4 FY26 cRPO growth at ~15% Y/Y. As long as that contracted backlog keeps swelling, the “DIY AI” threat remains a ghost story.

2. Agentforce monetization keeps moving line of sight

It’s one thing to have a slick AI presentation; it’s another to get enterprises to open their wallets for it. But the numbers are moving. Agentforce and Data 360 ARR reached nearly $1.4B, up an impressive 114% Y/Y.

Drill down further: pure Agentforce ARR surpassed half a billion, up a staggering 330% Y/Y. We are also seeing paid deals up 50% QoQ.

That is the sound of the cash register ringing, folks.

3. The DIY fear flips into “deployment pain” demand

Management describes a secular shift toward the “agentic enterprise.” Here is the plain English translation: building AI models in a lab is fun, but deploying them securely across 10,000 employees is a nightmare.

The “last mile” is where enterprise IT projects go to die. Ultimately, big companies prefer buying from vendors who can actually ship functional, secure products. When DIY pain sets in, they will call Salesforce.

4. The reacceleration clock stays intact

During the call, Robin Washington reiterated they’re on track to reaccelerate revenue in 12 to 18 months. I love this. That’s a claim with a hard deadline. Deadlines are fantastic for investors because they keep management honest and their feet held to the fire.

Atomic Take: The “way forward” for this stock isn’t about riding AI vibes — it’s about watching the backlog + paid adoption + reacceleration-by-deadline, with heavy cash returns acting as the stabilizer while the narrative fight plays out in the market.

Falsifier: Agentforce/Data 360 ARR is high but cRPO growth actually decelerates — that would be a red flag, implying they are generating temporary excitement without securing durable, long-term contracts.

Share

Financial Quality Rubric (1–5)

I like to look at the underlying plumbing of a business before I buy the house. Let’s grade the structural integrity here:

• Revenue durability: 4/5

  Make no mistake, this is still a highly sticky subscription business, not a low-margin services business.

• Margin discipline: 4/5

  They posted a 21.3% GAAP operating margin and an eye-popping 35.5% non-GAAP operating margin. The discipline is holding.

• Cash conversion: 4/5

  This is a cash-minting machine. Operating cash flow is incredibly robust versus the net income of $2.086B.

• Balance sheet resilience: 4/5

  Cash & cash equivalents were $8.978B balanced against noncurrent debt of $8.438B. They have the fortress they need.

• Capital allocation: 4/5

  The repurchases and dividends here are not symbolic, tiny gestures meant to appease activists; they are large and ongoing (we will get to the cash flow below).

• Narrative risk (AI + culture/politics): 2.5/5

  The AI disintermediation fear is loud enough that it literally had to be discussed on the earnings call.

  
  Separately, Wired reports employee backlash tied to Marc Benioff’s ICE comments.

  Never ignore culture. Internal politics can quickly become an execution drag during major platform transitions.

Now, let me remind you that non-GAAP margins can sometimes look like a superhero cape masking a dad bod.

GAAP is where the actual laws of financial physics live, and it includes items (like restructuring costs) that can linger a lot longer than management’s sunny PowerPoint deck suggests.

Atomic Take: Financially, Salesforce looks exactly like a mature compounder with a highly measurable AI call option attached to it. The entire debate is whether this AI option translates into durable, long-term economics or if it’s just a beautifully produced demo loop.

Falsifier: GAAP operating margin drops while revenue growth stays stuck in the high-single digits — that would suggest their newfound “discipline” was just a temporary phase, not a structural foundation.

Alright, let’s have a look at the financial statements.

The Balance Sheet (The Geiger Test)

Let’s look under the hood. As of Oct 31 2025, Salesforce held a massive $8.978B in cash & cash equivalents. Add to that marketable securities of $2.345B. They have plenty of dry powder.

But the “enterprise software reality” is also here: they are carrying goodwill of $52.4B. Now, this is perfectly normal for a company with a long, aggressive acquisition history (MuleSoft, Slack, Tableau, etc.). But it is exactly why forward demand signals matter so much. When growth stops, that mountain of goodwill stops looking like a history of smart buys and starts looking like a massive future impairment question.

On the liability side, the recurring-revenue engine shows its absolute beauty in unearned revenue: $14.996B. That is money sitting in their pocket for services yet to be rendered.

Atomic Take: The balance sheet is highly liquid and not debt-stressed. The key sensitivity here isn’t bankruptcy; it’s growth durability. Why? Because goodwill-heavy balance sheets absolutely hate stagnation.

Falsifier: A sustained decline in total RPO (as of quarter-end, USD, company metric) — that would be the canary in the coal mine, turning “normal goodwill” into “headline impairment risk.”

Subscribe now

Cash Flow (The Turbine)

Cash is the lifeblood of any business, and here’s the plain-language bridge of how the Salesforce turbine is spinning.

GAAP net income was $2.086B. But the actual cash coming in the door—Operating cash flow—was $2.316B.

You have to maintain the machine, so capital expenditures were $0.139B.

If we take OCF and back out those capex costs, the simple cash proxy (or free cash flow) is ~$2.177B.

Now, let’s look at the capital return reality check. Share repurchases were an astonishing $3.801B and dividends were $395M.

Did you catch that?

The money they are sending back to shareholders exceeds the simple cash proxy for the quarter. That means these returns are not being funded purely by that quarter’s operating cash after capex.

It tells you the tempo of their capital return program is incredibly aggressive.

Atomic Take: Cash generation is undeniably strong — but the capital return pace is even stronger. As an investor, you need to watch the turbine (the operating cash flow), and not just get distracted by the fireworks (the massive buybacks).

Falsifier: Operating cash flow growth misses the company’s ~13–14% Y/Y guide (FY26, %, company guide) — if that engine sputters, it would eventually force management to rethink their aggressive capital return tempo.

Income Statement (The Reactor)

Let’s look at the core reactor for Q3 FY26 (GAAP):

Revenue was $10.259B (USD). The gross margin is shown at an elite 78%. Operating income pumped out $2.188B, and the bottom line net income was $2.086B.

When you strip out the noise, non-GAAP operating margin was 35.5%, driven largely by the company’s adjustments.

Atomic Take: The core reactor of this business is highly stable. The entire debate on Wall Street right now is whether the new fuel (AI agents) actually increases the reactor’s output, or if it just adds a glossy new control-room label to the exact same machine.

Falsifier: Non-GAAP remains perfectly smooth while GAAP profitability silently deteriorates — that’s the moment when “adjustments” start doing too much heavy lifting and narrative work.

Valuation and Quality

Before I even look at a stock chart, a company has to earn the right to be in my portfolio by passing a basic quality check. Salesforce clears the “quality business” bar with room to spare.

Look at the profitability and cash conversion: they are sitting on a massive 78% gross margin and a 21.3% GAAP operating margin. When you have margins that thick, you have the ultimate shock absorber for whatever the economy throws at you.

Owner Yield

Alright, let’s talk about what we are actually paying for this machine.

• Share price: $189.72.

• Shares used in computing diluted EPS: 952M (Q3 FY26, shares).

Do the simple math, and that implies a rough market cap proxy of ~$180.6B (USD, derived from price × diluted shares).

Now, let’s look at the cash proxy anchored in the actual reported lines, not the adjusted fantasies. For the first nine months of the year (9M FY26), operating cash flow was $9.532B and capex was a measly $0.453B.

Subtract the capex from the operating cash, and your 9M FCF proxy is ~$9.079B (USD, derived).

If we annualize that 9-month figure as a straight run-rate (and I’ll be the first to tell you, this is a blunt tool, so treat it as such), you get ~$12.1B/year.

Put that against our market cap proxy, and it implies a run-rate FCF yield of ~6.7%.

Now, a run-rate math is not the gospel truth. It’s a Geiger counter. It tells you the “implied burden” the current stock price puts on the business; it doesn’t tell you the exact temperature of the reactor.

The reason is that the market is currently pricing the “SaaS scare” as a permanent, structural decline.

Management, on the other hand, is screaming from the rooftops that this is just a temporary mismatch, and they are putting a hard timeline on reacceleration: 12 to 18 months.

Because of the steep drop to today’s price of $189.72, the burden of proof has entirely shifted. You no longer have to believe in “hypergrowth to the moon” to make money here. You just have to believe in “durability + credible reacceleration.”

Atomic Take: At this level, the debate isn’t “is Salesforce cheap?” — it’s “is the market over-penalizing a highly durable cash generator just because the AI narrative temporarily spooked the multiple?”

Falsifier: If the 12–18 month reacceleration timeline slips meaningfully, and there is no forward-demand strength (like cRPO) to compensate, then you are stuck in a value trap: a cash machine with a permanently discounted story.

Subscribe now

Risks (The Meltdown List)

I never buy a stock without looking for the trap doors. Here are the very real risks we are monitoring:

1. AI disintermediation risk (the core “SaaS scare”)

• FACT: The fear that AI is “injurious to the SaaS application layer” is explicitly and officially an issue.

• HYPOTHESIS: Value capture shifts upward to the AI models and orchestration layers, leaving legacy apps as thin, easily replaceable wrappers.

• MONITOR: We watch Agentforce paid-deal momentum vs guidance. If they can’t sell the AI, they become the wrapper.

2. Backlog conversion risk

• FACT: RPO includes unbilled amounts that are not yet recorded on the balance sheet. It’s contracted, but it’s not cash in the bank yet.

• HYPOTHESIS: The backlog stays high on paper, but it actually converts to cash much slower because enterprise AI deployments elongate and get bogged down.

• MONITOR: We need to watch the cRPO-to-revenue conversion trend and management’s commentary on deal cycles.

3. Capital return sustainability risk

• FACT: Repurchases were a massive $3.801B and dividends were $395M (Q3 FY26, USD, GAAP cash flow).

• HYPOTHESIS: If the core cash generation softens, the tempo of these massive returns will slow down—and investor sentiment will take a brutal second hit.

• MONITOR: Keep a hawk’s eye on FY26 operating cash flow growth vs guidance.

4. M&A / integration risk

• FACT: The Informatica acquisition is referenced as completed in the presentation deck.

• HYPOTHESIS: Digesting massive acquisitions is hard. Integration could distract management from execution right in the middle of a critical AI platform shift.

• MONITOR: Watch for any slippage in margin discipline and their forward guidance posture.

5. Culture / politics / brand risk (the sneaky risk)

• FACT: Wired reports employee backlash tied to Marc Benioff’s ICE-related comments, including calls for denouncement and restrictions on use.

• HYPOTHESIS: Talent bleeding and customer optics degrading at the exact worst possible moment (during a major platform transition) can cripple a software company.

• MONITOR: Watch for repeated internal friction becoming external customer friction (but only react when explicitly acknowledged in primary sources, not just rumor mills).

Atomic Take: The biggest risk here is not “Salesforce can’t do AI.” The biggest risk is “the market simply decides Salesforce can’t capture AI economics,” and keeps the multiple severely compressed until the KPIs force a reset.

Falsifier: Agentforce/Data 360 ARR stays strong on the surface, but cRPO stalls out — generating PR excitement without contracted demand is exactly how narratives die.

The Atomic Verdict

★★★★☆ (4/5)

(IMPORTANT: Star system is not a buy recommendation, only a judgement for the quality of the business based on my parameters. DYOR)

The cash engine is humming.

They posted $2.188B in operating income and $2.086B in net income (USD, GAAP), backed up by operating cash flow of $2.316B (USD, GAAP). Let me be clear: this is not a liquidity panic or a margin collapse story. The physics of the business are sound.

Why the stock can still act allergic anyway: The market is currently trading a thesis about the future of SaaS economics—and that fear is directly captured in the transcript.

Management’s rebuttal is essentially: DIY has peaked, real enterprise deployment is hard, and customers are moving from science-fair experimentation to production agents. Wall Street will only believe this when the backlog and monetization make it too expensive not to.

Upgrade Triggers (Measurable things that make me more bullish):

• cRPO growth stays around the guided ~15% Y/Y level while subscription & support constant-currency growth improves from its ~9% rut.

• Agentforce paid deals continue meaningful QoQ growth from the >9,500 paid baseline.

• Hard evidence that the “12–18 months” reacceleration clock is actually showing up in reported growth rates, not just in executive talking points.

Downgrade Triggers (Measurable things that make me run for the hills):

• cRPO growth misses guidance and trends down from the $29.4B base.

• Agentforce/Data 360 ARR growth decelerates sharply from that impressive 114% Y/Y level (Q3 FY26, company-defined).

• GAAP operating margin compresses meaningfully from the 21%+ level while growth stays stuck in the high-single digits.

Atomic Take: Salesforce is a highly disciplined cash engine fighting a brutal narrative war. And in the stock market, narrative wars end when the next two quarters’ KPIs make one side look completely unserious.

Falsifier: If forward demand (cRPO) fails to support the reacceleration timeline, this stock stays Overhang-Heavy regardless of how good the cash returns look.

Note from me:

On Wednesday, February 25, 2026, Salesforce reports Q4 and full-year FY2026 results after the close. Headlines will do what headlines do, so the “cheat sheet” is the underlying scoreboard: cRPO (forward demand), Agentforce paid deals (AI monetization traction), and whether subscription & support constant-currency growth and GAAP operating margin are holding up.

Reference List (Sources Used)

1. Salesforce, Inc. “Q3 FY26 Quarterly Investor Deck”. Used for: KPI tiles, subscription & support disaggregation, constant-currency growth tables, regional growth, capital return framing, and non-GAAP expense profile (slides 5, 8, 9, 15, 16, 17, 18, 19).

2. Salesforce, Inc. “Q3 FY26 Earnings Press Release”. Used for: GAAP income statement items, margins, cash flow figures (CFO, capex, FCF), balance sheet line items (cash, unearned revenue), and RPO/cRPO disclosures.

3. Salesforce, Inc. “Q3 FY26 Earnings Conference Call Transcript” (Salesforce Investor Relations / Q4 CDN-hosted transcript; accessed Feb 14, 2026). Used for: the “SaaS scare” framing (investor question), management’s rebuttal (DIY vs deployed agents), and the 12–18 month revenue reacceleration timeline language.

4. Salesforce Investor Relations site (investor.salesforce.com; accessed Feb 14, 2026). Used for: document hosting/verification context.

5. Wired (web article; accessed Feb 14, 2026). “Letter Salesforce Employees Sent After Marc Benioff’s ICE Comments.” Used for: culture/politics headline risk context.

6. Nasdaq (web page; accessed Feb 14, 2026). “CRM Insider Activity.”

Disclaimer
This Deep Dive is an educational breakdown of a public company based on information available in the materials provided (e.g., annual/quarterly reports, investor presentations, earnings transcripts) and my interpretation of that information. It is designed to be a “bolt-on” intelligence layer to your own due diligence — not a replacement for it.

Independence: I do not accept compensation of any kind from the companies discussed. My research is driven solely by my personal search for high-quality compounders.

Skin in the Game: Unless otherwise stated, assume the author may hold a long position in securities mentioned. Any position creates bias — treat this as commentary, not gospel.

Not Financial Advice: Nothing here is investment advice, a recommendation, or a solicitation. I am not a financial advisor. You are responsible for your own decisions. The stars rating is not a buy recommendation, but meant as a guide to understand the quality of the financial statement of the respective companies.

Error & Update Risk: Financial statements change, companies restate, guidance evolves, and I can be wrong. Verify key figures in the primary filings and consider reading the footnotes before deploying capital.

When Peter Lynch was managing the legendary Magellan Fund, he famously bought Dunkin’ Donuts.

He didn’t use a proprietary algorithmic model to find it. He didn’t read a 400-page academic white paper on the future of carbohydrates. He just noticed the long lines, loved the coffee, and bought the stock.

Wall Street laughed at him (see video below). Retail investors thought it was a joke. A coffee and donut shop didn’t sound smart enough to be a serious financial thesis.

We have a deep-seated psychological need for our investments to stroke our intellectual egos.

But here is the “A-ha” moment that everyone forgets about that story: Lynch didn’t buy Dunkin’ Donuts just because the coffee was good.

He bought it because, after noticing the lines, he looked at the books and saw a hyper-resilient, scalable business with exceptional unit economics.

Unfortunately, modern investors only remember the first half of the story. They weaponized Lynch’s famous “buy what you know” mantra to justify lazy investing.

This brings us to a strange, persistent psychological trap in the market, that I see is going on right now: The more accessible and easy-to-understand a product is, the lazier our financial analysis becomes.

Subscribe now

The “Sample Size of One” Trap

Whenever I discuss a consumer app like Duolingo, my feed instantly fills up with anecdotal analysis:

“I downloaded the free version, tried it for an evening, didn’t like the gamification, and deleted it. The moat is dead.”

Or my personal favorite:

“My father used it for 5 years and did not learn a single piece of Spanish.”

It is absolutely fascinating that this collective failure of logic only happens with consumer-facing products. Because everyone knows how to swipe a screen or tap a green owl, they subconsciously believe they understand the global addressable market.

They are confusing a user with a cohort.

Your father? He is a data point of one.

Duolingo has nearly 100 million monthly active users. If their engineering team tweaks the gamification algorithm and increases free-to-paid conversion by just 0.5%, your dad won’t notice, and your personal user experience won’t change. But that tiny shift generates tens of millions in high-margin recurring revenue.

When a product is simple, we substitute actual financial modeling for a Yelp review. We mistake our own reflection for the macroeconomic environment.

The Complexity Bias & The “Whisper Stock”

But here is where the hypocrisy gets truly entertaining.

This anecdotal arrogance completely vanishes the second things get complicated.

You rarely see this with complex, established tech. Nobody says:

“I tried an $AMD EPYC server processor for a week in my basement, didn’t like the architecture latency, so I’m shorting the stock.”

With AMD, people are forced to actually read the fundamentals. Nobody drives past an $IREN facility, decides the liquid cooling hum is “bad vibes,” and assumes the stock is doomed.

With IREN, investors actually build spreadsheets to model out power pipelines and cost-per-megawatt.

But what happens when the tech is so complex that there are no fundamentals to model yet?

We surrender to the hype train.

We suffer from “Complexity Bias”; the tendency to give undue credit to things we don’t understand. When faced with the complex AI, space tech, or ESG waves, people happily abandon logic. They assume that if they can’t understand the tech, the people building it must be geniuses, and therefore, it’s a guaranteed winner.

Peter Lynch used to call these “Whisper Stocks.” These are the companies with hypnotic, world-changing stories, complex sci-fi pitch decks, and absolutely zero revenue. You hear about them at a dinner party: “I hear they’re going to revolutionize liquid-cooled AI infrastructure...”

This strategy is catastrophic when used recklessly. Investors blindly buy into the peak of the hype cycle, mistaking incomprehensibility for inevitability. We overthink the simple, profitable apps because we understand them, and we blindly buy the unprofitable tech infrastructure because we don’t.

Share

Building an Atomic Moat Around Your Mind

So, how do we stop being anecdotal tourists and start investing with discipline? We have to invert our natural psychological defaults.

1. For the “Simple” Stuff: Track the Cohort, Not the Cousin.

You don’t have to love the Duolingo owl. You don’t have to enjoy gamified learning. But to find a true atomic moat, you must respect the aggregate data.

• Look at DAU/MAU Growth: Are people showing up globally?

• Look at Free-to-Paid Conversion: Is the engine actually working?

• Look at Churn: Are the paid users sticking around?

Right now, for companies like Duolingo, those fundamentals look incredibly strong, completely regardless of whether you enjoyed your 5-minute French lesson.

2. For the “Complex” Stuff: Demand the Receipt.

Stop letting a sci-fi story override a lack of fundamentals. Whisper stocks are great for cocktail parties and terrible for portfolios. Look for actual revenue, signed enterprise contracts, and a realistic path to profitability. Do not invest recklessly just because a slide deck uses the word “quantum” or “LLM.”

Your portfolio doesn’t care if you enjoyed your Spanish lesson, and it doesn’t care how cool a liquid-cooled GPU cluster sounds.

Stop treating your investments like a Yelp review. Follow the data.

Rob H.

Disclaimer: The content of Atomic Moat is for educational and entertainment purposes only and does not constitute financial, investment, or legal advice. I am not a financial advisor, and these are not recommendations to buy or sell any security.

Risk Warning: Investing in equities, especially in the technology sector, involves a high degree of risk. The market is irrational, and prices can fluctuate wildly. Please do your own due diligence (DYODD) and consult with a certified professional before making any investment decisions.

There is a seductive simplicity to the restaurant industry. You see a line of cars wrapping around a drive-thru at 11:00 PM, and your intuition whispers, “This business is printing money.” You buy a burger, you enjoy the burger, and you wonder if you should buy the stock.

This is the siren song that Peter Lynch, the legendary manager of the Fidelity Magellan Fund, famously encouraged us to listen to.

But Lynch also warned that observation is only the start of the process, not the end.

If you buy a stock solely because you like the curly fries, you aren’t investing; you are gambling with a condiment preference.

Today, we apply the rigorous, common-sense lens of Peter Lynch to Jack in the Box (JACK). The brand is ubiquitous, the tacos are legendary, but does the financial engine under the hood meet the standards of history’s greatest mutual fund manager?

Let us begin.

Subscribe now

The Titan: Peter Lynch

The Strategy: “Growth at a Reasonable Price” (GARP) & “Invest in What You Know.”

Before we dissect the stock, we must understand the man. Peter Lynch didn’t rely on complex algorithms or insider whispers. Between 1977 and 1990, he steered the Fidelity Magellan Fund to an average annual return of 29.2%, crushing the S&P 500’s ~15%. He turned $18 million into $14 billion, earning him a place on the Mount Rushmore of capital allocators.

Lynch’s philosophy was bifurcated into two steps:

1. Observation: Use your eyes. What is popular? What is trending?

2. The “2-Minute Drill”: Verify the story with hard math. Check the earnings, the debt, and the category.

He famously categorized companies into six “stories”:

1. Slow Growers

2. Stalwarts

3. Fast Growers

4. Cyclicals

5. Turnarounds

6. Asset Plays

He treated each differently. A “Fast Grower” (his favorite) required explosive expansion; a “Slow Grower” required a fat dividend.

So, where does Jack in the Box fit? And would the Sage of Magellan add it to his portfolio today?

Pillar I: The Categorization

To apply the Lynch Test, we must first answer his most fundamental question: What kind of stock is this?

Lynch would look at the historical data provided in our files and pause. A “Fast Grower”—the coveted “tenbagger”—is characterized by 20–25% annual expansion. Jack in the Box is decidedly not that.

According to the financial records:

• 2006 Net Sales: $2.38 Billion

• 2015 Net Sales: $1.54 Billion

• 2024 Net Sales: $1.46 Billion

A cursory glance suggests a company in decline.

However, Lynch was a master of nuance. He would recognize that this revenue drop isn’t necessarily a failure of popularity, but a shift in business model—likely a move toward heavy refranchising (selling company-owned stores to franchisees). This reduces top-line revenue but often improves margins.

However, Lynch preferred “Fast Growers” where the top line was expanding alongside the bottom line. Jack in the Box has the revenue profile of a Slow Grower or perhaps a Turnaround.

Lynch’s rule for Slow Growers is strict: “If you aren’t growing, you better be paying me.” He would demand a high, safe dividend yield to justify holding a company with shrinking sales volume. Without 20% growth, the “story” relies entirely on efficiency and capital return.

The Lynch Takeaway: He would strip away the “growth” label immediately. This is a mature, potentially saturated business. He would proceed with extreme caution, looking for a fortress balance sheet to protect the downside.

Pillar II: The Balance Sheet “Minefield”

This is where the thesis faces its stiffest challenge. Peter Lynch famously said, “It’s very hard to go bankrupt if you don’t have any debt.”

Lynch loved companies with “Net Cash”—meaning their cash on hand exceeded their long-term debt. He viewed debt as a math problem that works against the shareholder, especially in cyclical industries like dining.

Let us look at the data for JACK:

• Price-to-Tangible-Book Ratio (P/B-tang): The data shows consistent negatives.

  • 2021: -3.25x

  • 2022: -5.62x

  • 2023: -4.65x

  • Recent (R12): Negative values persist.

A negative Price-to-Tangible-Book ratio implies that the company’s liabilities exceed its tangible assets. In Lynch’s era, this was often a disqualifier.

While modern finance tolerates higher leverage for franchise models (since they require less capital to run), Lynch was “old school.” He wanted a margin of safety.

He would look at the Equity Ratio and the Net Debt. If he saw a company buying back stock (which boosts EPS) while the balance sheet deteriorated, he called it “diworsification” of capital strength.

While Jack in the Box has maintained profitability (Gross Income has remained relatively stable around $400M-$500M despite revenue drops), the quality of the balance sheet would likely offend Lynch’s sensibilities.

He avoided companies where the bankers owned more of the company than the shareholders did.

The Lynch Takeaway: The “Balance Sheet Check” fails. The negative tangible book value is a red flag that would likely cause Lynch to stop his “2-minute drill” right here.

Pillar III: The Valuation (The PEG Ratio)

Let us assume, for the sake of argument, that Lynch looked past the debt. He would then look at the price.

Lynch popularized the PEG Ratio (Price/Earnings to Growth).

• PEG < 1.0: Fair.

• PEG < 0.5: Undervalued.

• PEG > 2.0: Expensive.

With reported earnings per share (EPS) recently diving into negative territory (approx. -$4.24 TTM), a standard P/E ratio is mathematically undefined or meaningless. You cannot calculate a PEG ratio on negative earnings. Lynch would stop reading right here.

However, let’s play devil’s advocate and look at the Forward P/E—what analysts expect the company to earn next year.

• Stock Price: ~$22.77

• Forward P/E: ~5.8x

• Projected Earnings Growth: Analysts are forecasting a rebound in earnings (some estimates sit near 80-90% growth simply because they are bouncing back from near-zero or negative lows).

The “Mathematical Mirage”: On paper, a Forward P/E of 5.8x with high projected growth creates a PEG ratio well under 1.0.

But this is a classic “Value Trap” that Lynch warned about.

The low PEG isn’t driven by a booming business; it’s driven by a collapsed stock price and a statistical quirk of recovering from losses. Lynch preferred companies with consistent, durable growth (10-20% annually), not companies zigzagging between losses and profits.

Furthermore, revenue is forecast to decline by roughly 8% per year. Lynch hated shrinking sales. You can cut costs to boost earnings for a while (which lowers the P/E), but you cannot cut your way to prosperity forever.

The Lynch Takeaway: The “cheap” valuation is a mirage. A low P/E on a company with shrinking sales and negative momentum isn’t a bargain; it’s a “falling knife.” Lynch would see the negative historical earnings and the shrinking top line as immediate disqualifiers.

The Verdict: The Titan Speaks

If Peter Lynch were sitting at his desk at Fidelity today, reviewing the file on Jack in the Box, what would be the move?

He would likely appreciate the brand. He might even enjoy a Jumbo Jack. He would acknowledge that the company has successfully transitioned to a franchise model, insulating it somewhat from operational costs.

However, the Titan Test is binary.

The Verdict: Avoid

Why?

1. Identity Crisis: It is no longer a “Fast Grower,” yet it carries the risks of a cyclical business.

2. The Debt Load: Lynch despised negative equity. The negative Price-to-Tangible-Book ratio is the antithesis of the “fortress balance sheets” he sought in the 1980s.

3. No “Tenbagger” Potential: The math simply doesn’t support a 10x return from these levels without a fundamental change in the business economics.

Lynch often said, “There are 60,000 stocks listed on the exchanges. You only need to find a few good ones.”

For Lynch, Jack in the Box is a company to watch from the drive-thru window, not from the portfolio. It lacks the explosive growth of a start-up and the financial safety of a true Stalwart.

In the eyes of the master, there are easier games to play.

Closing Thought from me

It is often tempting to feel that research is “wasted” if it does not end with a buy order. We are wired to crave the action of the transaction. However, I want to leave you with a personal truth I have learned after years of dissecting balance sheets: The most profitable decision you make this year might be the stock you didn’t buy.

Capital preservation is the silent engine of long-term compounding, and the ability to say “no” is the investor’s most important muscle.

Think of this analysis not as a failed search for a treasure, but as a successful defense of your fortress. By applying the Lynch framework today, we stripped away the nostalgia of a familiar brand to reveal the mathematical reality beneath. Every hour spent disqualifying a weak company is an hour invested in protecting your future returns. The burger may be tasty, but the discipline to walk away when the numbers don’t add up? That is the true taste of “old money” wisdom.

Stay prudent, and happy hunting.

— Rob

Disclaimer

Not Financial Advice: The content provided in “The Atomic Moat” and “The Titan Test” is for informational and educational purposes only. It represents the opinions of the author and should not be construed as professional financial, legal, or tax advice. We are analyzing businesses, not providing personal investment recommendations.

Do Your Own Research: Financial markets are inherently risky. The strategies and frameworks discussed (including those of Peter Lynch) may not be suitable for your specific risk tolerance or time horizon. Always conduct your own due diligence or consult with a licensed financial advisor before making any investment decisions.

No Guarantees: Past performance is not indicative of future results. The numbers, figures, and “falsifiers” presented are based on current data and management guidance, which are subject to change without notice.

I write 20-page deep dives because I love digging into the numbers.

But I create these ‘Simple Truths’ summaries because I know not everyone have time read my ultra-long content.

My goal is simple: I do the hours of heavy lifting (stripping away the corporate jargon and complex tables) to hand you the pure signal.

Here is my full research on AVTECH, distilled into a 3-minute read that respects your time.

Subscribe now

The Napkin Pitch (The Hook)

The One-Liner: AVTECH is a boring, profitable, debt-free Swedish microcap that sells software to airlines to help them save fuel and arrive on time—and once an airline plugs it in, they rarely unplug it.

The “Back of the Napkin” Thesis:

• The “Invisible” Toll Booth: They embed software into the cockpit workflow that saves airlines millions in fuel; it’s mission-critical “sticky” revenue.

• Fortress Balance Sheet: They have zero long-term debt and a massive pile of cash relative to their size (91.8% equity ratio).

• The “Land and Expand” Play: They are already installed on 2,200 aircraft, but most aren’t using the full menu of tools yet—growth comes from simply upselling existing friends.

• Microcap paradox: It’s too small for Wall Street to care about yet (MSEK 408 market cap), which is exactly why the opportunity exists.

  

The Lemonade Stand (Business Model)

Imagine a lemonade stand, but instead of lemonade, you sell a specialized GPS calculator to truck drivers that tells them exactly how to drive to save 2% on gas.

What they sell: AVTECH builds digital tools that help airplanes “talk” to air traffic control and pilots. Specifically, their software analyzes weather and flight paths in real-time to optimize flight profiles. This solves the three things that keep airline CEOs awake at night: high fuel costs, environmental emissions, and being late.

The Customer: Commercial airlines (like Wizz Air). These customers are massive, slow to make decisions, but incredibly loyal once they sign a contract.

How the cash enters the building: It is shifting to a subscription model (the “Holy Grail” of business). They measure success in Annual Recurring Revenue (ARR). As of Q4 2025, they have an ARR of 51.2 MSEK. This means they are moving away from one-time sales and toward “renting” their genius to airlines every month.

The Moat (Why They Win)

Why can’t a competitor just write some code and steal their lunch?

1. The “Don’t Touch It” Factor Aviation is a high-stakes game. Once an airline like Wizz Air integrates AVTECH into their safety and efficiency workflow, the cost and headache of ripping it out are massive. It becomes “mission-critical.” If the software saves them a fortune on fuel, removing it is literally burning money.

2. The Toothbrush Test Is this used daily? Yes. Every time a plane takes off, the pilot needs data to fly efficiently. AVTECH positions itself as the “pick and shovel” play—they don’t build the risky plane; they just make every flight 10% more profitable by existing.

3. The Upsell Runway They don’t need to hunt for new customers to grow. They are already on 2,200 planes. The moat is their existing footprint. They can double their revenue simply by convincing their current friends to buy the “Dessert Menu” (new modules launching this spring)

Subscribe now

The Price Tag (Valuation)

Warning: This is a Microcap (tiny company). The stock price will swing wildly. Do not bet the farm.

We need to look at what you are paying for every dollar of cash this business generates. The market currently values the company at SEK 407.78m (approx. SEK 7.22 per share).

The “Cash is King” Discrepancy: On paper, they look reasonably priced (Earnings Yield of 4.17%). However, their actual cash flow is lower than their reported earnings because they are reinvesting heavily and some customers paid late.

What You Get For Your Money

1. The “Accounting” Price (P/E Ratio)

• The Number: 23.99x

• The Translation: You are paying roughly $24 for every $1 of reported profit. This is a “growth” multiple, not a bargain bin price. Investors are paying a premium because they expect the company to get significantly bigger in the next few years.

2. The “Theoretical” Interest Rate (Earnings Yield)

• The Number: 4.17%

• The Translation: If their accounting profits were paid out as cash today, this is the annual return you would get. It matches a decent high-yield savings account, but remember: you are taking stock market risk to get it.

3. The “Cash Payback” (Price-to-Operating-Cash-Flow)

• The Number: ~33.7x (Calculated: Market Cap 408m / Operating Cash Flow 12.1m)

• The Translation: Based on the SEK 12.1m operating cash flow, it would take roughly 33 years of current cash flow to pay back your purchase price. This looks expensive today, but if their cash flow grows as fast as their sales (38%), this number drops quickly.

The Cash Verdict: The stock is priced for growth. The market is paying a premium (24x earnings) because they see the sales growing 38% year-over-year. If that growth stops, this price tag is too high. If the growth continues and the cash flow catches up to the earnings, this could be cheap.

Share

The Money (Financial Health)

This is where AVTECH shines. They are built like a bunker.

Profitability: They are printing accounting profits. Net sales jumped from 34.3 MSEK to 47.4 MSEK in one year. Net earnings rose to 17.0 MSEK. They have a “Rule of 40” score of 67.6% (Growth + Profit Margin), which is “Valedictorian” status in the software world.

The Balance Sheet (Solvency): They have zero long-term debt and roughly 34 MSEK in cold hard cash sitting in the bank. Their equity ratio is 91.8%. This means they can survive a recession while their debt-heavy competitors go bust.

The “Lumpy” Cash Warning: While they reported 17 MSEK in profit, only 12.1 MSEK came in as Operating Cash Flow. Why? Two reasons:

1. Late Checks: Some customers haven’t paid their bills yet.

2. Investment: They are spending money on R&D and hiring people to fuel growth.

Subscribe now

The Bear Case (Risks)

What could blow this up?

1. The “Paper Asset” Risk (The Kill Switch) This is technical but important. They have 14.1 MSEK in “balanced development expenses” on their balance sheet. This is money they spent on salaries to build software, but they counted it as an “asset” instead of an “expense.” If that software turns out to be useless and doesn’t sell, that asset vanishes, and their profits were an illusion.

2. The Waiting Game Selling to airlines is painfully slow. Decisions take forever. If the sales cycle drags out, the growth slows down, and that 24x P/E ratio will look very expensive very quickly.

3. Currency Gremlins They are a Swedish company selling globally. Fluctuations between the US Dollar and the Swedish Krona (SEK) can eat their profits. A weak dollar hurts them.

The Summary

I like this stock because it passes the “sanity test.” It has no debt, high margins, and a product that customers are afraid to turn off. It is a classic “picks and shovels” play on the aviation industry without the risk of actually owning airplanes.

It is currently in a transition phase—spending cash now to hire sales staff and build products for a massive payoff later. If the “ARR Staircase” keeps climbing past 51 MSEK, the current price is a steal.

There is a hidden catalyst launching this spring: new “Time” and “Dispatch” modules. If these upsells work, the company could see a massive spike in profit margins without finding a single new customer.

You can read the full 3000+ word Deep Dive here.

Do you enjoy complex Deep Dives distilled into a simple 3-minute read? ⏳

Do a friend (and me) a huge favor: Forward this to a busy investor who values quality over quantity.

Share

Disclaimer:

• I Am Not Your Financial Advisor: I am a researcher sharing my homework, not a wealth manager giving you a plan. This is for education, not a recommendation to buy or sell.

• I Am Biased: I own AVTECH in my personal portfolio. I have skin in the game and I want this company to win. Read this with that in mind.

• The Golden Rule: It is your money. Do your own due diligence, read the actual filings, and never invest money you cannot afford to lose.

⚠️ MICROCAP ALERT: This is a MSEK 408 flyweight. Expect thin liquidity and wild swings. A single big trade can move the needle here, so don't bet the farm—size your position for the turbulence. This is not a buy recommendation; do your own research (DYOR).

New to The Atomic Moat? This analysis of AVTECH ($AVT B) is a prime example of how we dissect high-quality compounders. If you want these deep dives sent to your inbox, join 1,000+ other investors below.

Join for Free

Everyone seems to be looking for the latest flashy AI startup or the electric flying car or space company nowadays. But if you’ve followed my writing for a while, you know I have a soft spot for something a bit different.

I like the “picks and shovels”. The companies that don’t necessarily build the plane, but make the plane 10% more profitable just by existing.

That brings us to AVTECH.

I own this because it represents a specific kind of growth machine that is becoming increasingly rare in the microcap universe. Here’s why I’m holding this one for the long haul:

1. The “Invisible” Toll Booth

AVTECH has spent years embedding itself into the cockpit workflow. Once an airline like Wizz Air realizes they can save a fortune on fuel and hit their arrival times more consistently using this software, they don’t just “unplug” it.

It’s high-margin, mission-critical, and increasingly recurring. I love businesses where the customer would have a headache if they tried to leave.

2. A Fortress Built on Common Sense

A lot of small caps are “burning the furniture to keep the house warm”—they have massive debt and negative cash flow. AVTECH is the opposite.

They have a 91.8% equity ratio and zero long-term debt. This is a company that can survive a storm, which gives them the luxury of reinvesting when their competitors are just trying to keep the lights on.

3. The “Land and Expand” Runway

They are already on 2,200 aircraft, but here’s the kicker: most of those planes aren’t using the full suite of tools yet.

We aren’t just betting on them finding new customers (though they are); we’re betting on them selling more to the friends they already have. That’s the cheapest kind of growth there is.

4. Discipline That’s Actually Discernible

It’s easy for a CEO to talk about growth. It’s much harder to grow sales by 38% year-over-year while remaining profitable and paying out a dividend. That tells me management isn’t just chasing “growth at any cost”; they’re chasing profitable compounding.

The Bottom Line: AVTECH is still a “tiny” company in a massive global industry. They have the balance sheet of a conservative grandfather and the growth engine of a hungry startup. That’s a combination I’m willing to wait on.

Let’s dig in.

Subscribe now

If You’re In a Rush

• The Gig: AVTECH builds digital tools that help airplanes talk to air traffic control. They optimize for the stuff that keeps airline CEOs awake at night: fuel costs, emissions, punctuality, and safety.

• The “Ugh” Factor: It’s a microcap. That means low volume and price swings. Plus, selling to airlines takes forever, and currency swings (FX noise) can make a good quarter look messy on paper.

• The Fix: As long as that Annual Recurring Revenue (ARR) keeps climbing like a plane on takeoff, and they don’t spend like drunken sailors to get it, the story stays intact.

• Atomic Position: I hold shares in AVTECH at the time of writing. Please have this in mind when reading, as I can be biased.

The Setup: Numbers That Make You Grin

AVTECH’s year-end report is the kind of document that makes a spreadsheet geek smile and everyone else look for a calculator. It’s a microcap in a complicated industry, but the numbers are starting to look very good.

Let’s look at the hard evidence from the Q4 2025 print:

• Record Growth: Q4 2025 net sales hit MSEK 12.9. Management says that’s the highest quarterly revenue in their history. And get this: they did it even with a weak dollar working against them.

• The Annual Scorecard: For the full year 2025, sales climbed to MSEK 47.4 (up from MSEK 34.3 in 2024). Net earnings followed suit, jumping to MSEK 17.0 from MSEK 12.6.

Now, here is the “Microcap Paradox.” Wall Street usually thinks a company this size is either too small to matter or too small to trust. Both can be true on a Monday and totally wrong by Thursday. That’s why we ignore the “vibes” and stick to the facts.

The Fact Base:

• ARR: MSEK 51.2 (as of end of Q4 2025).

• Rule of 40: 67.6% (Growth + Margin). In the software world, anything over 40% is an “A.” 67.6%? That’s “Valedictorian” territory.

This isn’t a “turnaround” story. It’s a “scaling” story. They aren’t fixing a broken plane; they’re trying to see how high this one can fly without the engines overheating.

The Atomic Take: The debate isn’t whether planes will keep flying. The debate is whether AVTECH’s adoption flywheel stays intact while they start spending more on staff and development in 2026.

The “Show Me” Metric (Falsifier): If that MSEK 51.2 ARR drops for two quarters in a row, the thesis is grounded. Period.

How The Business Actually Make Money

AVTECH says they do “digital air traffic management.” That sounds like jargon designed to put you to sleep.

Let’s translate: they sell software that helps pilots and ground crews make smarter decisions in real-time.

Here is what we know for sure:

1. It’s a Subscription Model (The Holy Grail): They track ARR by taking the last month of the quarter and multiplying by 12. It’s a proxy, sure, but it shows they are moving away from one-off projects and toward “renting” their genius.

2. They Are Already On the Planes: Management says about 2,200 aircraft use their services. The beauty here isn’t just finding new airlines; it’s selling more “add-ons” to the planes they already have.

3. The “Wizz Air” Proof Point: You want to see how they scale? Look at Wizz Air. They went from testing products on 20 planes to rolling them out to the whole group of 200 planes this past year. That is how you win in this business; start small, prove it works, and then take over the whole fleet.

The Strategy: Management is getting ready to launch new “on-time” and “dispatch” tools this spring. If those land, the “upsell” story gets a massive boost.

The Atomic Take: This is a “land and expand” play. They’ve already landed. Now we watch the expansion.

The “Show Me” Metric (Falsifier): If FY2026 sales don’t beat MSEK 47.4 despite management talking about a “growing pipeline,” we’ll know the talk is cheap.

Share

What Went Wrong (The “No-Panic” Audit)

If you came here expecting a dramatic story of a company cratering into the earth, I’m going to have to disappoint you. This is the more irritating kind of story; a strong year where one quarter reminds you that microcaps don’t do “clean” narratives.

They’re messy, like a teenager’s bedroom.

Q4 2025 delivered record revenue, yet the bottom line didn’t do a victory lap. Why?

• The Currency Bug: Management flags an unfavorable USD/SEK impact. When the exchange rates wiggle, your paper gains can shrink.

• The Earnings Dip: Net earnings were MSEK 4.0 in Q4 2025, compared to MSEK 4.2 a year ago.

• The Investment Bill: They spent more on people (personnel costs) and ate a ~MSEK 1.1 one-off expense for an R&D tax repayment. They’re appealing it in 2026, but for now, the cash is out the door.

• Lumpy Cash: Q4 cash flow was positive but felt a bit thin because some customers were late with their checks.

This is a fork in the road. Management says they invested intentionally in sales and product development. In my book, spending money to make more money later isn’t a “miss”; it’s a strategy. But you have to make sure that “investment” doesn’t just become a permanent “expense.”

The Atomic Take: Nothing broke. But Q4 is a reminder that when a company is accelerating and reinvesting at the same time, the road is going to have some potholes.

The Rebound Catalysts: A Checklist for 2026

Management hasn’t just given us excuses; they’ve given us a checklist. Now we get to sit back and watch them try to tick the boxes.

1. New Blood in Sales: Philip Nordfeldt took over as Chief Commercial Officer (CCO) on January 19, 2026. His one job? Turn that tech into more ARR.

2. The Need for Speed: They’ve promised faster deployment. In aviation, “fast” is relative, but if they can get software onto planes quicker, the cash flows faster.

3. The “Full Meal” Strategy: Remember, many of those 2,200 aircraft are only using some of AVTECH’s tools. Selling a current customer a second or third product is way cheaper than finding a brand-new airline.

4. Spring Training: New functions for “on-time” and “dispatch” are hitting the market this spring. This is a near-term “put up or shut up” moment for the product team.

5. The Wizz Air Blueprint: Expanding from 20 to 200 planes with Wizz Air proved they can handle a fleet-wide rollout. Now, can they do it again with someone else?

The Atomic Take: These catalysts aren’t about the economy or the price of jet fuel. They are about execution. Either they do it, or they don’t. It’s that simple.

The Financial Quality Rubric

I like to grade companies on a scale of 1 to 5. Here’s how AVTECH stacks up:

• Growth Quality: 4/5 — Annual sales jumped from MSEK 34.3 to MSEK 47.4. That’s not a fluke; it’s momentum.

• Profitability Durability: 4/5 — They’re sporting a 34.7% operating margin for the year. That’s a massive cushion.

• Cash Conversion: 3/5 — Net earnings were MSEK 17.0, but operating cash flow was MSEK 12.1. It’s positive, but there’s a gap we need to watch.

• Balance Sheet: 5/5 — They have zero long-term debt and MSEK 33.9 in cash. This is a fortress. They aren’t going broke anytime soon.

• Reinvestment Discipline: 3/5 — They capitalize their R&D (turning expenses into “assets” on the balance sheet). It’s legal, but it can make profits look prettier than they are. We’ll keep an eye on it.

Share

Capital Efficiency: Getting More “Bang” for Your Buck

To me, AVTECH’s best hidden feature is that it doesn’t need a lot of “stuff” to make money. This isn’t just a feeling; it’s baked into the math. When you look at how little capital and how few people are required to keep this reactor humming, the efficiency is actually quite startling.

The “Per Head” Math:

• Sales Productivity: With MSEK 47.4 in sales and only 17 employees, they’re pulling in roughly ~MSEK 2.8 per person.

• Profit Productivity: Net earnings hit MSEK 17.0, which means each employee is essentially generating ~MSEK 1.0 in pure profit.

• The Cash Reality: Operating cash flow was MSEK 12.1, or roughly ~MSEK 0.7 per employee.

The Asset-Light Engine: Now, look at what they actually “own.” As of December 31, 2025, they had MSEK 63.7 in total assets. But here’s the kicker: MSEK 33.9 of that is just cold, hard cash sitting in the bank.

This means the business isn’t trapped in heavy machinery or expensive real estate. In Peter Lynch terms, it’s an “asset-light” dream. Their sales-to-assets ratio is roughly 0.74x. It tells us one thing loud and clear: this is not a hungry machine that needs constant infusions of cash to stay alive.

The Audit: The only place this efficiency can look a little “polished” is in the MSEK 14.1 of balanced development expenses. Because they capitalize some of their work (turning salary costs into an asset on the balance sheet), it can make the efficiency look slightly better than a pure cash-expense model.

The Atomic Take: The model is incredibly lean. The only catch? That capitalized development “asset” has to keep paying rent. If it doesn’t lead to more ARR and more cash, then the efficiency is just an accounting trick. So far, the gauges say it’s real.

The “Show Me” Metric (Falsifier): If operating cash flow starts to drop significantly below MSEK 12.1 while capitalized development stays high, we’ll know the efficiency is turning into “accounting-backed optimism” rather than real-world results.

Subscribe now

The Statements (The Geiger Counter Test)

The Balance Sheet: A Bunker

AVTECH is sitting on MSEK 63.7 in total assets and almost no liabilities. Their equity ratio is 91.8%. In plain English: they own almost everything outright.

The Risk: The only “isotope” to watch is the MSEK 14.1 in “balanced development expenses.” That’s money they’ve spent developing software that they expect to pay off later. If the software doesn’t sell, that “asset” vanishes.

The Cash Flow: The Turbine

Operating cash flow for the year was MSEK 12.1. What’s impressive? They’re paying a dividend of SEK 0.10 per share (~MSEK 5.6).

A microcap paying a dividend while growing sales at this rate is like finding a teenager who actually saves their allowance. It shows a level of discipline you don’t often see in the small-cap world.

The Income Statement: The Reactor

Sales are up, but personnel costs rose from MSEK 10.7 to MSEK 15.4 for the year.

The Audit: Management is betting on people. They are fueling the reactor. In 2026, we need to see that extra fuel turn into more “output” (sales), not just more “heat” (expenses).

The Atomic Take: The financials are rock solid, but the “truth serum” will be whether the cash flow keeps pace with the earnings report in the next six months.

The “Show Me” Metric (Falsifier): If operating cash flow (CFO) stays below MSEK 12.1 while they claim they are “thriving,” something is leaking in the pipes.

Share

Valuation: When the Market Starts Charging Rent

This is the part of the story where the market stops patting you on the back for a “nice year” and starts asking for the rent.

On February 6, 2026, the tape showed AVTECH at a share price of SEK 7.22, giving it a market cap of SEK 407.78m.

That gives:

• P/E Ratio: 23.99x.

• Earnings Yield: ~4.17%

At a ~24x P/E, the market isn’t treating this like a dying cigar butt. It’s pricing AVTECH like a real, recurring software business.

Based on my metrics, the price today is fair, but it’s not “dirt cheap.”

To justify this multiple, the cash reality eventually has to give the earnings reality a big, warm hug. If the earnings stay high but the cash stays “lumpy” for too long, the market will lose patience.

The Atomic Take: At a SEK 408m market cap, the durability test is simple: do the cash-based metrics improve, or are we just living on a pretty narrative?

Subscribe now

The Meltdown List (Risks to Watch)

We DO need to have the risks in mind when we analyze, because every investment has a “self-destruct” button.

Here’s where AVTECH’s is hidden:

1. The “One-Trick Pony” Risk: A huge chunk of revenue still comes from one core product. They’re diversifying, but for now, they are heavily dependent on that single engine.

2. The Waiting Room: Airlines take a long time to buy things. Management admits decision processes are getting longer. A “slow” sales cycle can kill a microcap’s momentum.

3. Currency Gremlins: They hit record revenue in Q4, but the USD/SEK exchange rate still took a bite out of them. If the dollar stays weak, the uphill climb gets steeper.

4. The “Check is in the Mail” Problem: Delayed customer payments dragged down Q4 cash flow. If “delayed” becomes “defaulted,” we have a problem.

5. The Paper Asset: They have MSEK 14.1 in “balanced development expenses.” That’s money spent that hasn’t been “expensed” yet. We need to see that turn into actual sales.

The Atomic Take: The biggest danger isn’t a spectacular crash, but a “slow leak” where the KPIs look great, but the bank account doesn’t grow.

The Atomic Verdict: Trust the Gauges, Not the Vibe

★★★★☆ (4/5)

(IMPORTANT: Star system is not a buy recommendation, only a judgement for the quality of the business based on my parameters. DYOR)

I own shares of AVETCH at the time of writing this. And I intend to hold them for a very long time, unless the fundamentals crack.

And to me, the fundamentals are not showing any cracks to fear as of now:

• Sales Momentum: MSEK 47.4 (FY2025) vs MSEK 34.3 (FY2024). That’s real growth.

• The Bottom Line: MSEK 17.0 in net earnings. The reactor is producing power.

• The War Chest: MSEK 33.9 in cash and a 91.8% equity ratio. This company is built like a tank.

• The Speedometer: MSEK 51.2 ARR. This is the number that dictates the share price.

What would make me buy more (The Upgrades):

• ARR keeps climbing above that MSEK 51.2 baseline through mid-2026.

• Operating cash flow stays healthy and consistent compared to the MSEK 12.1 full-year figure.

• Margins stay resilient (targeting that 34.7% FY average) even as they hire more people.

What makes me walk away (The Downgrades):

• ARR stalls or drops for two quarters in a row.

• Cash flow (CFO) falls way behind reported profits. If the profit is “real,” the cash should follow.

• Hiring keeps going up, but sales stay flat. That means the “investment” was actually just “bloat.”

The Atomic Take: This looks like a compounding machine in the making; as long as the ARR staircase keeps going up and the cash conversion doesn’t start to rot.

What do you think? Does AVTECH’s 91% equity ratio make you feel safe, or does the “capitalized development” make you nervous? Let’s talk about it in the comments.

References

1. Company disclosures and investor materials

2. AVTECH Sweden AB (publ). “Year-End Report January–December 2025.” (Full-year report / financial statements). Dated 2026.

3. AVTECH Sweden AB (publ). “Q4 2025” (Quarterly results presentation/report). Dated 2026.

4. AVTECH Sweden AB (publ). “AVT B – Avtech” (Financial model / compiled financials workbook). Excel file.

5. Market data and third-party screeners (7 Feb 2026)

6. StockAnalysis. “AVT.B (Avtech Sweden AB) — Market Cap / Valuation snapshot” (price, market cap, P/E).

7. TipRanks. “AVTECH Sweden — Statistics” (screen-level cash flow, capex, derived free cash flow).

8. TipRanks. “AVTECH Sweden — Financial Ratios” (screen-level FCF yield and ratio series).

9. Simply Wall St. “AVTECH Sweden — Valuation”.

10. Yahoo Finance. “AVT-B.ST — Quote”

Disclaimer

This Deep Dive is an educational breakdown of a public company based on information available in the materials provided (e.g., annual/quarterly reports, investor presentations, earnings transcripts) and my interpretation of that information. It is designed to be a “bolt-on” intelligence layer to your own due diligence — not a replacement for it.

Independence: I do not accept compensation of any kind from the companies discussed. My research is driven solely by my personal search for high-quality compounders.

Skin in the Game: Unless otherwise stated, assume the author may hold a long position in securities mentioned. Any position creates bias — treat this as commentary, not gospel.

Not Financial Advice: Nothing here is investment advice, a recommendation, or a solicitation. I am not a financial advisor. You are responsible for your own decisions. The stars rating is not a buy recommendation, but meant as a guide to understand the quality of the financial statement of the respective companies.

Error & Update Risk: Financial statements change, companies restate, guidance evolves, and I can be wrong. Verify key figures in the primary filings and consider reading the footnotes before deploying capital.

The Man Who Sold America

On the evening of October 29, 1929, the Livermore estate was in a state of funeral panic.

While the rest of New York City was reeling from “Black Tuesday”—with traders sleeping on office floors and fortunes vaporizing into thin air—Jesse Livermore walked through his front door. His wife, Dorothy, and her mother were weeping. They had heard the news of the market’s total collapse and assumed they were destitute.

Livermore looked at them, confused.

While the world was buying, he had sensed a shift. He had spent days living out of his office, aggressively shorting the market. He looked at his terrified wife and delivered the news:

In a single session, he had cleared $100 million. Adjusted for inflation, that is roughly $1.5 billion today.

He was the “Boy Plunger.” The man who J.P. Morgan once personally begged to stop trading. But his story isn’t just about the money he made—it’s about the demons that eventually came to collect it.

Subscribe now

The Origin Story: The Prodigy in Disguise

Jesse Livermore was not normal. He was a computational anomaly born into a family of farmers.

He learned to read and write by age three and a half. By age five, he was ignoring storybooks to devour the financial pages of the newspaper. His father, a pragmatist who saw no value in books, pulled him out of school at age 14 to work the farm. Jesse responded by packing a bag and escaping to Boston with nothing but a few dollars in his pocket.

He charmed his way into a job as a “board boy” at Paine Webber for $5 a week. His job was to update stock prices on a giant chalkboard as they came in over the wire.

This was his “10,000 Hours.” By staring at the numbers all day, he realized they weren’t random. They had a rhythm. At age 15, he made his first trade in a “bucket shop” (an off-exchange gambling hall). He risked $5 and made a profit of $3.12.

He became so lethal at predicting prices that the bucket shops started losing money. They banned him. But Livermore wasn’t done. He bought a fake beard, donned a disguise, and went right back in to fleece them again.

By age 20, he was banned permanently, but he walked away with his first small fortune: $10,000.

Share

The Superpower: The “Psychic Surge”

Livermore’s genius was his ability to fuse Tape Reading with Gut Instinct.

He didn’t care about the company’s “value.” He only cared about price action. His most famous trade wasn’t based on data, but on a “psychic surge.”

The Earthquake Short (1906)

In 1906, Livermore was on vacation in Palm Beach. Suddenly, he felt a visceral urge to short Union Pacific stock. He couldn’t explain it. The stock was in a bull run. His friends told him he was crazy.

He shorted it anyway.

Days later, the great San Francisco earthquake hit. The city was leveled. Union Pacific tracks were destroyed. The stock plummeted, and Livermore pocketed $250,000.

It wasn’t magic. It was his subconscious processing thousands of micro-data points from the ticker tape that his conscious mind couldn’t articulate. He learned to trust the “tape” over everything else.

The Graveyard: The “Tip” That Cost $5 Million

To understand Livermore, you must understand his specific weakness. He was invincible when he traded alone. He was vulnerable when he listened to others.

His “Kryptonite” was the Inside Tip.

In 1908, he was befriended by “Teddy” Price, a famous cotton trader. Livermore had built his fortune to $5 million. Price convinced Livermore that the cotton market was going up. Livermore respected Price, so he violated his own rules. He stopped reading the tape and started listening to the “expert”.

While Price was telling Livermore to buy, Price was secretly selling.

The market collapsed. Livermore lost everything. He went from a $5 million fortune to bankruptcy in a single year.

The Lesson: “No man can always have adequate reasons for buying or selling stocks daily - or sufficient knowledge to make his play an intelligent play.”. The moment you outsource your thinking, you outsource your survival.

Steal Their Brain: The Livermore Toolkit

Livermore’s life was volatile, but his rules were ironclad. Here is the operating system he used to turn bankruptcy into millions, repeatedly.

1. The “Probe” System

Livermore never went “all in” at the start. He used probing positions.

• The Concept: When he bought his first share at age 15, he risked a tiny amount ($5) to test his thesis.

• The Action: Buy a small amount. If the price moves in your favor, the market is confirming you are right. Then you add to the position. If it moves against you, cut it immediately.

2. Beware the Lag

Why did Livermore lose his first fortune in New York?

• The Concept: In the bucket shops, prices were instant. In New York, the ticker tape lagged 30 to 40 minutes behind reality.

• The Action: Understand your data latency. If you are trading on old information, you are the “sucker” at the table.

3. Desperation is an Edge

Livermore was a “Phoenix.” He went bankrupt three times, and each time he rose from the ashes richer than before. Why? Because he had to.

• The concept: When he married his third wife, Harriet Metz, she had a massive inherited fortune ($7 million).

• The Risk: The safety net killed him. His wife’s fortune “lulled him into a sense of comfort and killed the desperation to win”. Without the fear of poverty, he lost his edge.

Subscribe now

The Human Factor: The Curse of the “Boy Plunger”

Livermore lived a life of Gatsby-esque excess.

• The Highs: After his 1907 win, he bought a $200,000 yacht and a private rail car to mimic J.P. Morgan. He had a stream of mistresses, including dancers from the Ziegfeld Follies.

• The Lows: His family life was a horror story. His wife Dorothy became an alcoholic. In a drunken Thanksgiving argument, Dorothy actually shot their son, Jesse Jr. (He survived).

In the end, the market changed. The creation of the SEC in 1934 regulated the wild swings Livermore relied on. He felt he had lost his “touch.”

In 1940, sitting in the cloakroom of the Sherry Netherland Hotel, the man who had owned Wall Street took his own life. He left almost no money to his children.

He left a note to his wife:

“My life has been a failure. I am tired of fighting."

The Verdict

Jesse Livermore is the father of trend following. He proved that price is the only thing that matters.

Copy this style if:

• You are a trader, not an investor.

• You believe “the trend is your friend.”

• You have the discipline to cut a loser instantly without emotion.

Run away if:

• You are a “Value Investor” (Livermore didn’t care about value; he cared about price).

• You want to “buy low and sell high” (Livermore bought high and sold higher).

• You cannot handle volatility.

Livermore taught us that the stock market is the most dangerous place on earth because it acts as a mirror. It doesn’t just show you prices; it shows you your own greed, fear, and stupidity.

“The game of speculation is the most uniformly fascinating game in the world. But it is not a game for the stupid, the mentally lazy, the person of inferior emotional balance, or the get-rich-quick adventurer. They will die poor.” — Jesse Livermore

Last week, we looked at how the market is currently panicking over the “AI Apocalypse” in the software sector. The sentiment has shifted from “software is eating the world” to “AI is eating software”.

The TL;DR on the AI Reset:

• The Herd is Panicking: Investors are fleeing SaaS giants like Salesforce and Adobe, fearing that generic LLMs can replicate decades of specialized enterprise logic over a weekend.

• Systemic Value remains: Companies like ServiceNow and Salesforce are the “Operating Systems” of the enterprise. You don’t move a company’s entire sales history just because of a new bot; you plug the bot into the existing system.

• Verified Truth is a Premium: In a world of AI “hallucinations,” companies that own high-fidelity, verified data (like FactSet) or regulatory pathways (like Veeva) become more valuable, not less.

• Be the Fox: Outperformance comes from being a “historian of hysteria”. The market always over-corrects, and the strongest trees are often revealed only after the fire has cleared the brush.

Building the “Atomic Moat” Media House

First of all, thank you.

In just over 30 days, this community has grown to around 850 investors. We are closing in on the 1,000-subscriber mark much faster than anticipated.

But Atomic Moat was never meant to be just a newsletter. My vision is to build a modern Investment Media House. A centralized hub providing the data, the “alpha,” and the systems you need to navigate the markets.

To celebrate our first 1,000 subscribers, I am preparing the launch of our first proprietary Index Dashboard. These indices will systematize world-class strategies, giving you a clear edge in your research.

I need your vote

I want to launch the tool that helps your research process the most.

These are live model portfolios consisting of specific stocks that meet the strict criteria of each strategy. Think of them as your proprietary “Investment Universe” dashboards.

• The Multibagger Index: A dynamic portfolio of high-growth companies screening for asymmetric 10x potential.

• The Cannibal Index: A curated list of companies currently executing the most aggressive share buybacks.

• The Insider Index: A real-time tracker of stocks where management is deploying significant personal capital.

• The Spinoff Index: A portfolio of recent market divestitures positioned for post-separation outperformance.

• The Superinvestor Index: We apply the strict frameworks of legends like Peter Lynch, Nick Sleep, and Terry Smith to today’s market. These are not copies of their current holdings, but a collection of stocks that meet their specific criteria, such as identifying the next “Scale Economies Shared” case for the Nick Sleep index.

The winning index will be available to everyone during the launch week, before eventually moving into our Premium Tier.

Thank you for being part of this journey from the ground floor. Let’s hit 1,000.

Rob, Founder, Atomic Moat

PS: I want to hit the 1,000-subscriber milestone before we roll out the winning Index. If you find my content useful, please share this poll with one fellow investor. Your recommendation is the only way we grow.

Share

Disclaimer: I am not a financial advisor. Atomic Moat is an educational platform providing investment research and analysis tools. These model portfolios are for informational purposes only and do not constitute financial advice. Always perform your own due diligence before making any investment.

If you had invested £10,000 in the global stock market (MSCI World) when Fundsmith launched in 2010, you would have a respectable pile of cash today.

But if you had given that same £10,000 to Terry Smith, a combative history graduate who manages money from a tropical island, you wouldn’t just be rich; you would be nearly three times wealthier than the average investor.

Terry Smith has built a £23 billion+ empire not by trading faster than the machines, but by doing something radical:

Absolutely nothing.

He is the “English Warren Buffett,” a man who thinks most fund managers are “closet indexers” charging champagne fees for lemonade performance. His strategy is so simple it almost feels illegal: Buy the best companies in the world, and then go to the beach.

Subscribe now

The Origin Story: The Analyst Who Knew Too Much

Terry Smith didn’t start as a billionaire fund manager. He started as the guy “everyone” wanted to fire.

Born in London in 1953, Smith studied history, not economics. This is his secret weapon. While other analysts were drowning in Excel sheets, Smith was trained to spot “official narratives” and dismantle them.

In the 1980s and 90s, he became the most dangerous man in the City of London:

• The Barclays Betrayal: As a top banking analyst, he issued a “Sell” rating on Barclays (his own former employer) days before they announced a disaster. He was right.

• The Accounting Assassin: In 1992, he wrote Accounting for Growth. The book was a grenade thrown into the London Stock Exchange, exposing how companies used “creative accounting” to fake their profits. UBS, his employer, told him to withdraw the book or be fired. Smith published it anyway. He was fired, the book became a bestseller, and a legend was born.

The Superpower: The “Quality” Obsession

Smith’s philosophy is a rejection of the “Buy Low, Sell High” gambling addiction. He believes there are only two types of companies: those you want to own, and those you don’t. Price is secondary.

He operates on a brutal three-step algorithm:

1. Buy Good Companies: Ignore 98% of the market. Only look at companies that have already won.

2. Don’t Overpay: Use Free Cash Flow Yield, not P/E.

3. Do Nothing: This is the hard part. Fundsmith’s turnover is often <5% per year. He buys a stock and holds it for decades.

Share

How to Screen for Stocks Like Terry

You don’t need a Bloomberg terminal to find a “Smith Stock.” You have the exact tools right in front of you. Based on your screener setup, here are the four “Golden Metrics” to input:

1. The Engine: Return on Capital Employed > 20%

• Why: This measures efficiency. For every dollar the company invests in itself, how much profit does it generate? Smith demands a consistent ROCE of over 20%. If a company can’t generate high returns on its own money, why should it generate returns on yours?

2. The Shield: Gross Profit Margin > 60%

• Why: High margins mean pricing power. If inflation hits and ingredients get expensive, a company like L’Oréal (80% margins) can absorb the cost. A supermarket (3% margins) cannot. High margins are your shield against inflation.

3. The Lie Detector: FCF / Net Income > 90%

• Why: “Profit” is an opinion; Cash is a fact. This metric (often called Cash Conversion) tells you if the profits are real. Smith demands that for every $1 of reported Net Income, at least $0.90 actually hits the bank account as Free Cash Flow.

4. The Fortress: EBIT / Interest Expense > 10x

• Why: This is your Interest Coverage. Debt kills. Smith hates leverage. He wants companies that earn enough profit (EBIT) to pay their interest bill 10 times over without blinking.

Share

The Graveyard: The AI Miss

To invest like Smith, you must be willing to look “stupid” during a mania.

Smith’s rigorous focus on history and proven cash flows means he often misses the “Next Big Thing.”

• The Failure: Between 2021 and 2024, Fundsmith lagged the market. Why? Because he owned zero NVIDIA.

• The Reason: He viewed the AI hardware boom as a cyclical hype cycle, similar to the Dot-Com bubble. While the “Magnificent 7” soared, Smith stayed on the sidelines.

• The Lesson: This strategy protects you from total ruin, but it guarantees you will underperform when the market goes parabolic on speculation.

Steal Their Brain: The Toolkit

1. The “Mayonnaise” Test Smith famously attacked Unilever for obsessing over the “brand purpose” of Hellmann’s Mayonnaise.

• The Actionable Rule: Read a company’s Annual Report. If they talk more about “saving the planet” or “social purpose” than they do about operating margins or return on capital, sell the stock. They have lost focus.

2. The “Bookie” Mental Model Smith loves businesses that take a small cut of a huge volume of small transactions. Think Visa, Mastercard, or Amadeus.

• The Actionable Rule: Look for “Toll-Booth” stocks. You don’t want to bet on who wins the football game; you want to own the ticket gate.

3. The “Cocaine” Check Smith compares share buybacks to cocaine: “You get a cheap high for a while, but eventually it kills you.”

• The Actionable Rule: Check the valuation. Is the company buying back its own stock at an All-Time High P/E ratio? If yes, management is destroying value to boost their EPS bonuses. Avoid.

The Human Factor: The Combative Islander

Terry Smith is not a suit-wearing wallflower. He runs his empire from Mauritius, an island in the Indian Ocean, far away from the “noise” and groupthink of London and New York.

He is famously frugal with his fund’s operations but lavish with his opinions. His annual letters are legendary for their “acerbic wit,” often openly mocking the companies he owns if they misbehave. He is a man who would rather be right than be popular.

Subscribe now

The Secret Library

You might think a fund managing over £20 billion would be too busy to talk to the “little guy.” You’d be wrong.

I actually contacted Fundsmith myself a little while ago, simply asking for reading recommendations to better understand his philosophy. I expected an automated reply, or even silence. Instead, they personally responded with a curated list of books that shaped Terry’s worldview.

It wasn’t a list of “Get Rich Quick” manuals; it was a syllabus on history, skepticism, and accounting. It proved that Fundsmith isn’t just a fund; it’s an educational project disguised as an asset manager.

The Verdict

Terry Smith is the ultimate antidote to the “Get Rich Quick” crypto culture.

Copy this style if:

• You have a “coffee can” mentality (buy it and forget it for 10 years).

• You prefer boring winners (cosmetics, medical devices, software) over exciting gambles.

• You value Free Cash Flow above all else.

Run away if:

• You need to own the “hot stock” of the month (NVIDIA, Tesla).

• You get anxious when your portfolio doesn’t change for six months.

• You believe “Valuation” (P/E) is the most important metric. (Smith believes Quality > Valuation).

The Final Word: “Stop trying to be smart. It’s better to be right.”

I write 20-page deep dives because I love digging into the numbers.

But I create these ‘Simple Truths’ summaries because I know not everyone have time read my ultra-long content.

My goal is simple: I do the hours of heavy lifting (stripping away the corporate jargon and complex tables) to hand you the pure signal.

Here is my full research on Sezzle, distilled into a 3-minute read that respects your time.

Subscribe now

1. The Napkin Pitch (The Hook)

• The One-Liner: A “Buy Now Pay Later” lender that is successfully pivoting into a subscription business, but currently trades at a massive discount because the market is terrified of its credit risk.

• The “Back of the Napkin” Thesis:

  • They just hit their first $1 Billion sales quarter.

  • They are profitable (Net Income of $26.7M in Q3).

  • The stock has crashed ~60% from its highs ($182 to $69).

  • The Bet: If they can keep credit losses below 2.75% while growing subscriptions, the stock is a bargain. If they can’t, it’s a “value trap”.

2. The Lemonade Stand (Business Model)

Think of Sezzle like a digital layaway counter for online shopping. They pay the store for your shoes, and you pay Sezzle back in 4 interest-free chunks over 6 weeks.

• What they sell:

  1. Credit: The core BNPL service.

  2. Sezzle Premium: A “club membership” (subscription) that gives users perks.

• How cash enters the building: They take three distinct bites of the apple:

  1. Merchant Fees: Stores pay Sezzle a fee to process the sale.

  2. Subscription Fees: Users pay a monthly fee for Sezzle Premium ($24.3M revenue in Q3).

  3. Consumer Fees: Late fees and convenience fees ($33.5M revenue in Q3).

3. The Moat (Why They Win)

Sezzle doesn’t have a “fortress” moat; they have a Habit Moat. They are betting that if you subscribe to their service, you will check the Sezzle app before you decide where to shop.

• The “Toothbrush Test”:

  • Pass: They have ~600,000 Active Subscribers who pay monthly.

  • The Stickiness: Subscribers order 10x more often than non-subscribers. This creates a recurring revenue base that is much safer than one-off transaction fees.

4. The Price Tag (Valuation)

Current Price: ~$69.00 | Market Cap: ~$2.4B

The market is currently pricing Sezzle like a risky lender, not a tech company.

P/E Ratio~19.9x

You pay roughly $20 for every $1 of reported profit. This looks cheap for a growth company.

P/FCF~33.6x

It would take ~34 years of actual cash flow to pay back your purchase price. This is expensive because they are spending all their cash to fund new loans.FCF

Yield~3.0%

This is lower than a savings account. The cash yield is low right now because they are aggressively reinvesting to grow the loan book.

The Cash Verdict:

The massive gap between the P/E (19.9x) and P/FCF (33.6x) exists because their cash is tied up in “Notes Receivable” (loans to customers). If those customers pay back their loans, that cash comes flooding back in, and the stock is cheap. If they default, that cash is gone forever.

5. The Money (Financial Health)

• Profitability: They are printing accounting profits. Net Income was $90.4M for the first nine months of the year. Margins are fat, with an Adjusted EBITDA margin of 33.9%.

• The Balance Sheet: It’s simple but leveraged.

  • Assets: $134.7M in Cash vs. $184.1M in Loans (Receivables).

  • Debt: They have drawn $117.3M on their credit line.

  • The Warning: They only have $32M of “unused capacity” left on their credit line. If they grow too fast, they will need to find more money quickly.

6. Skin in the Game (Management)

• The Driver: Charlie Youakim (CEO). He is the co-founder and largely responsible for the company’s pivot to profitability.

• The Alignment: Youakim owns approximately 43% of the company. This is massive insider ownership. If the stock drops, he loses a fortune, so he is highly incentivized to avoid blowing up the company.

• Capital Allocation: Management bought back $34.6M of stock this year, proving they believe shares are undervalued.

7. The Bear Case (Risks)

• The Kill Switch (Credit Spiraling): Management admitted they “widened the net” (lowered standards) to get more customers. This caused credit loss provisions to jump to $32.2M in Q3. If they lowered standards too much right before a recession, profits will vanish.

• Regulatory Risk: A large chunk of revenue comes from “Consumer Fees” ($33.5M) and “Late Fees” ($21.0M). Regulators (like the CFPB) hate late fees. If these get banned, Sezzle loses a major profit engine.

• Seasonality: Q4 is typically the “danger zone” for credit losses as shoppers overspend for the holidays.

Share

8. The Summary

I like this stock because it is a rare “profitable growth” story trading at a beaten-down valuation. The pivot to a subscription model (Sezzle Premium) is brilliant because it reduces reliance on merchant fees.

However, the “Cash Price” (P/FCF) is high because they are stuffing every spare dollar into new loans.

The Bottom Line:

• Buy if: You trust their algorithm to pick customers who will actually pay them back.

• Avoid if: You believe the economy is heading for a hard landing where people stop paying their bills.

While the subscription business is the headline, Sezzle has a hidden “Merchant Payable” float of $43 million. This is essentially an interest-free loan from their own merchant partners that funds their operations.

You can read the full Sezzle deep dive here.

Do you enjoy complex Deep Dives distilled into a simple 3-minute read? ⏳

Do a friend (and me) a huge favor: Forward this to a busy investor who values quality over quantity.

Share

Disclaimer:

• I Am Not Your Financial Advisor: I am a researcher sharing my homework, not a wealth manager giving you a plan. This is for education, not a recommendation to buy or sell.

• I Am Biased: is one the largest positions in my personal portfolio. I have skin in the game and I want this company to win. Read this with that in mind.

• The Golden Rule: It is your money. Do your own due diligence, read the actual filings, and never invest money you cannot afford to lose.

I. The Architecture of Moats (Structural Advantage)

1. Economic Moat: A durable structural advantage that protects a company’s profits from competitors, allowing it to sustain high returns on capital over long periods.

2. Scale Economics Shared (SES): A business model where a company (like Costco or Amazon) shares the benefits of its scale with customers through lower prices, widening its competitive moat daily.

3. Network Effects: A dynamic where a service becomes more valuable as more people use it. (e.g., Meta, Visa, Duolingo).

4. Switching Costs: The pain—financial, procedural, or psychological—a customer experiences when changing providers. The “stickiest” moat (e.g., Adobe, Salesforce).

Also read: Pain & Profit: Why Switching Costs are the King of Moats

5. Intangible Assets: Non-physical barriers to entry such as patents, government licenses, or brand loyalty that legally or psychologically block competition.

Also read: The Money Mind: Dr. Herbie Wertheim

6. Low-Cost Producer: A company that can produce goods or services at a lower cost than anyone else, often due to scale, geography, or unique process efficiency.

7. Counter-Positioning: A strategy where a newcomer adopts a business model that incumbents cannot copy without destroying their existing business (e.g., Netflix vs. Blockbuster).

8. Pricing Power: The ability to raise prices without losing customers. Warren Buffett calls this the single most important decision in evaluating a business.

9. The Flywheel Effect: A self-reinforcing loop where each part of the business accelerates the others. (e.g., MercadoLibre’s logistics feeding its fintech, which feeds its e-commerce).

Also read: Deep Dive: MercadoLibre ($MELI)

10. Toll Bridge: A company with a monopoly on a specific niche where you must pay them to cross. (e.g., Verisign, Moody’s, or dLocal in emerging markets).

Also read: The Titan Test: Would Dev Kantesaria Buy dLocal ($DLO)?

Share

II. The Financial Scout (FINS Metrics)

11. ROIC (Return on Invested Capital): The “God Metric.” It measures how effective a company is at turning capital into profit. Calculation: (NOPAT / Invested Capital).

Also read: Deep Dive: Evolution AB

12. Free Cash Flow (FCF): The cash left over after a company pays for its operating expenses and capital expenditures. This is the “real” owner’s profit.

13. Operating Leverage: When revenue grows faster than costs. A company with high operating leverage adds profit directly to the bottom line as it scales.

14. Gross Margin: The percentage of revenue retained after direct costs of goods sold. High gross margins often indicate a premium product or pricing power.

15. Negative Working Capital: A situation where a company gets paid by customers before it has to pay suppliers. This acts as an interest-free loan from the market.

16. Cash Conversion Cycle: The number of days it takes to convert inventory into cash. A negative cycle (like Amazon’s) is a powerful compounding engine.

17. Owner Earnings: Net Income + Depreciation/Amortization - Maintenance CapEx. The figure Warren Buffett uses to determine true valuation.

18. Maintenance CapEx: The money a company must spend just to keep the lights on and maintain its current competitive position.

19. Growth CapEx: Money spent to expand the business. Rational investors distinguish between “maintenance” (bad) and “growth” (good) spending.

20. Rule of 40: A SaaS metric stating that a software company’s Growth Rate + Profit Margin should exceed 40%.

Also read: Deep Dive: Sea Ltd ($SE)

Share

III. Capital Allocation (The CEO’s Job)

21. Capital Allocation: The process of deciding how to deploy a company’s resources: Reinvestment, M&A, Dividends, Buybacks, or Debt Repayment.

22. The Outsider CEO: A leader who ignores peer pressure and conventional wisdom, focusing solely on per-share value creation (e.g., Henry Singleton, William Thorndike).

23. Share Cannibal: A company that aggressively buys back its own stock, reducing the share count and increasing the remaining shareholders’ ownership stake.

24. Return on Incremental Invested Capital (ROIIC): The return a company earns on the new dollar it invests today. This predicts future growth better than historical ROIC.

25. Skin in the Game: When management holds a significant amount of their own personal wealth in the company stock.

Also read: Simple Truth: Evolution AB ($EVO)

26. The Conglomerate Discount: The market’s tendency to undervalue complex multi-business companies. Smart capital allocators (like Fairfax Financial) exploit this.

27. Float: Money held by an insurance company (from premiums) that can be invested for profit before claims are paid. Free leverage.

Also read: The Money Mind: Shelby Cullom Davis

28. Dividend Aristocrat: A company that has consistently increased its dividend for 25+ years. Often a sign of stability, but sometimes a sign of low growth.

29. Value Trap: A stock that looks cheap by traditional metrics (low P/E) but is cheap because the business is structurally dying.

30. Accretive vs. Dilutive: Whether a financial action (like an acquisition or buyback) increases (accretive) or decreases (dilutive) Earnings Per Share.

IV. Market Philosophy & Psychology

31. Margin of Safety: Buying a stock at a significant discount to its intrinsic value to protect against errors in judgment or bad luck.

32. Mr. Market: Ben Graham’s allegory for the stock market—a manic-depressive partner who offers you prices every day. You are free to ignore him.

33. Circle of Competence: The specific area where an investor has an edge. Staying inside this circle is key to avoiding disaster.

34. The Ick Factor: High-quality businesses that are ignored because they are boring, ugly, or controversial (e.g., waste management, debt collection, funeral services).

Also read: Rumbu Holdings: The Ick Factor Compounder

35. Time Arbitrage: The edge gained by having a longer time horizon than the average market participant (who focuses on quarterly results).

36. Coffee Can Portfolio: The strategy of buying high-quality stocks and never selling them, letting them sit for decades like valuable papers in a coffee can.

37. Second-Level Thinking: Howard Marks’ concept of thinking deeper than the consensus. (Level 1: “Outlook is bad, sell.” Level 2: “Outlook is bad, but less bad than priced in, buy.”)

Also read: The Art of Going Against The Crowd

38. The Red Queen Effect: Running fast just to stay in the same place. Describes businesses with no moat that must constantly reinvest just to survive.

39. Lollapalooza Effect: Charlie Munger’s term for when multiple biases or factors act together to drive an extreme outcome.

40. Sit-On-Your-Ass Investing: The discipline of inactivity. Recognizing that the big money is made in the waiting, not the trading.

Also read: The Art of Doing Nothing

Subscribe now

V. The Atomic Framework (Advanced Concepts)

41. The Davis Double: The powerful compounding effect of Earnings Growth + P/E Multiple Expansion happening simultaneously.

42. Capital Cycle Theory: A framework by Marathon Asset Management. It posits that high returns attract capital (competition), lowering returns, while capital flight leads to future opportunity.

Also read: Why You Need To Know About The Capital Cycle Theory

43. The Sleep Index: Our collection of companies that share scale economies to dominate their industries (inspired by Nick Sleep).

44. The Lynch Index: Our collection of “Fast Growers” and “Stalwarts” that fit Peter Lynch’s 10-bagger criteria.

45. The Nomad Index: Our collection of companies run by “Outsider” capital allocators (inspired by the Nomad Partnership letters).

46. Spawner: A company with the DNA to constantly launch new, unrelated business lines from within (e.g., Sea Ltd spawning Shopee from Garena).

47. Hidden Champion: A small, obscure market leader (often in B2B) that dominates a niche global market.

Also read: FINS Analysis: Norbit ASA

48. Unit Economics: The direct revenues and costs associated with a single unit of business (e.g., one user, one subscriber). If this doesn’t work, scale won’t fix it.

49. Total Addressable Market (TAM): The total revenue opportunity available for a product or service. A “limitless” TAM is key for multibaggers.

50. The Atomic Moat: A competitive advantage so deep and structural that it can survive bad management, macro downturns, and technological shifts.

Also read: START HERE: The Atomic Moat Ecosystem

Share

New to The Atomic Moat? This analysis of Sezzle ($SEZL) is a prime example of how we dissect high-quality compounders. If you want these deep dives sent to your inbox, join 1,000+ other investors below.

Join for Free

Every once in a while, you stumble upon a situation that would make Peter Lynch sit up in his chair and reach for a yellow legal pad. Recently I did a FINS analysis of this company, and I got intrigued to say the least.

The business is growing like a weed, but it’s sitting in a sector the market currently treats like a skunk at a garden party. It’s fallen from the “glory days” highs, the “experts” have moved on to the next shiny object, and suddenly, you look at the price tag and realize you might be looking at a steak dinner for the price of a side of fries.

Sezzle it’s the rare fintech story that can look like a perfectly tuned, tidy little reactor one quarter... and a live-action demonstration of “risk appetite” the next.

I’ve seen this movie before. It’s the kind of business that makes you lean in closer to the screen, wondering if they’ve found the secret sauce or if they’re just playing with the dials.

Let’s find out which one it is.

If You’re In a Rush

• What they actually do: Sezzle is in the business of saying “yes” at the cash register. They offer Buy Now, Pay Later (BNPL) credit, plus subscription goodies like Sezzle Premium and Sezzle Anywhere. They make money when you buy, when you subscribe, and—here’s the rub—from “other sources” (like fees).

• Challenges: The profit recipe is a mix of credit, fees, and subscriptions. That’s a trio that usually gets regulators’ ears perking up. Plus, management just admitted they’re widening the net to find more customers. In plain English: they’re turning up the “growth” dial, and that means the “credit risk” dial is turning right along with it.

• The “Fix”: For this to be a long-term winner, they need to keep their take rate at 11.2% (Q3 2025) while making sure the money they lose on bad loans stays in the neighborhood of 2.5%–2.75% of total sales (2025 management target).

  Disclaimer: I have got high conviction here, and have initiated a large position, as you can see in my recent portfolio update. Have this in mind when you read, as I can be biased.

What is Sezzle, exactly?

Think of Sezzle as a “financial buffer” for your shopping.

You know when you find a great pair of shoes for $100, but you don’t want to drop the full hundred right now because you have other bills? Normally, you’d either have to wait until payday (and hope the shoes don’t sell out) or put them on a credit card and deal with high interest later.

Sezzle lets you take the shoes home today for just $25.

How it works in real life:

• Today: You pay $25 (25%) at the register.

• In 2 weeks: They automatically charge you $25.

• In 4 weeks: Another $25.

• In 6 weeks: The final $25, and you’re done!

The best part for you, the customer? As long as you pay on time, it’s totally interest-free.

Sezzle make their money by charging the store a fee for the privilege of having you as a customer, so you aren’t stuck paying extra just to wait a few weeks. It’s basically a modern way to “layaway” items, except you get the product immediately instead of waiting until the final payment.

Subscribe now

The Setup: Dials, Knobs, and Big Numbers

The “why now” for Sezzle is pretty straightforward. Their Q3 report looked like a clean, well-oiled machine. They showed us scale, they showed us margins, and they showed us cash.

But (and there’s always a “but”) they got there by cranking up two knobs that investors usually love to fear: marketing and underwriting.

It’s like a restaurant that starts seeing huge lines because they started spending a fortune on flyers and decided to let everyone start a tab. It works great for the crowds, but you’ve got to make sure they eventually pay the bill.

The baseline numbers aren’t exactly shy:

• Total Revenue: $116.8 million (Q3 2025).

• Total Sales (GMV): $1,047.3 million (Q3 2025).

That’s right, the company just had its first $1 billion sales quarter. That’s a milestone in anyone’s book.

The “Engagement” side of the house moved, too. As of September 30, 2025, they had 2,971,000 Active Consumers and 784,000 Monthly Online Deep-divers (MODS). Inside that group, they’ve got 0.6 million Active Subscribers and 0.2 million On-Demand users.

How the Business Actually Puts Bread on the Table

If I had to describe Sezzle over a cup of coffee, I’d say it’s a “money-making stack” built on people coming back again and again.

They don’t just take one bite of the apple. They take several small nibbles across three different buckets. Here’s how the $116.8 million in Q3 2025 revenue actually broke down:

1. The “Per-Usage” Bucket (Transaction Income): $59.5 million. This is the classic stuff—fees from merchants and the interchange fees when you swipe.

2. The “Membership” Bucket (Subscription Revenue): $24.3 million. This is the recurring “club” fee for Sezzle Premium. It’s steady and predictable—the kind of revenue I love.

3. The “Extras” Bucket (Income from Other Sources): $32.9 million. This is the spicy stuff: late fees and affiliate marketing.

Hey, wait a minute! Look at these two sub-lines very closely:

• Consumer Fees: $33.5 million.

• Late Payment Fees: $21.0 million.

This is why Sezzle doesn’t care as much if merchant fees get squeezed by competition. They aren’t just relying on the store to pay them; they’re layering on subscriptions and fees.

Management likes to point to their “Take Rate” of 11.2%. That’s basically how much they keep out of every dollar that flows through the system. After paying the direct costs of the transactions, they’re left with $63.3 million—or about 54.2% of their total revenue.

Share

Is There a Moat Here?

I don’t think Sezzle has a “fortress” around the merchants. Instead, they’re betting on habit. They’ve moved their marketing budget toward getting people to subscribe—reaching 568,000 subscribers by the end of the quarter.

The idea is simple: if Sezzle is the first thing you think of when you’re about to buy a pair of shoes, they win. They get to monetize you over and over without having to “buy” your attention again.

• The Fact: Sezzle makes money from everywhere; merchants, subscribers, and late fees.

• The Theory: As long as people keep coming back (high usage) and staying subscribed, the business stays healthy even if the BNPL market gets crowded.

• The Warning: Don’t confuse a “mix shift” with magic. If the revenue is growing because fees are going up rather than more people buying things, that’s a different story.

The “Atomic Take”: Sezzle’s engine is humming, and the diversification is impressive. But it’s only a “Moat” if this growth doesn’t lead to a massive credit hangover down the road. If those “Active Subscribers” keep going up but the revenue doesn’t follow, we’ll know the story has hit a snag.

The “What Went Wrong”

Now, this is the part where most fintech companies start pointing at the “macro economy” or “the Fed” like they’re reporting on the weather.

Not Sezzle. They did something much more refreshing—and a bit more nerve-wracking: they told us they changed their own behavior.

Look, two lines in the ledger tell the whole story here:

First, Marketing went through the roof: $8.775 million in Q3 2025, compared to just $2.726 million a year ago.

Second, their Provision for Credit Losses (the money they set aside for people who won’t pay them back) jumped to $32.177 million, up from $15.402 million last year.

Management is leaning into a classic growth playbook: pay more to get ‘em in the door and widen the funnel so more people qualify. They’re using Sezzle Premium as the main hook, and On-Demand as the backup for folks who aren’t ready for a subscription.

But there’s an uncomfortable truth here: levers work in both directions. If you turn up the heat right as you enter the “seasonal credit-heavy period” (Q4 is historically a bit of a mess for charge-offs), you’re running your reactor hot just as the cooling water starts to warm up.

The Atomic Take: The real risk isn’t some hidden line on the balance sheet; it’s the fact that they’ve got the Underwriting and Marketing dials cranked to “11” at the same time. If credit losses (as a % of sales) keep rising while their profit per sale stays flat, the story changes fast.

The Rebound Catalysts: No Magic, Just Math

We don’t need “AI buzzwords” to see the path forward here. Sezzle has given us a clear roadmap.

1. Credit Normalizes: This is the big one. Management says credit provisions hit 3.1% of GMV in Q3, but they expect that to trend down toward 2.5%–2.75% for the full year 2025. If they hit those numbers while sales stay strong, the profit machine gets a massive boost without needing a miracle.

2. The “Subscription-First” Pivot: They’ve got 0.6 million Active Subscribers now. If they can keep these folks around, it creates a “sticky” base that’s much cheaper to maintain than finding new customers every month.

3. Marketing Payback: Management claims they get their money back on marketing spend in six months or less. That’s a bold claim for an $8.775 million spend. We need to see if this is a “sugar rush” or real, durable growth.

4. Growth Room: They recently bumped their credit facility from $150 million to $225 million. As of Sept 30, they had $32.0 million in unused capacity. They have the “gas” in the tank to keep growing, provided the engine doesn’t knock.

5. Side Projects Stay Small: They spent about $1.3 million on “strategic projects” this quarter. The goal is to keep these from becoming a distraction or a money pit.

Subscribe now

The Financial Quality Rubric (Scorecard: 1-5)

• Profitability Quality (4/5): $26.7 million in Net Income (GAAP). This isn’t “funny money” or weird adjustments. This is real profit.

• Cash Conversion (4/5): They brought in $55.6 million in operating cash over nine months, compared to $90.4 million in net income. Don’t panic—the gap is mostly because they’re using cash to fund new loans ($85.2 million went into notes receivable).

• Reinvestment Intensity (5/5): This business is lean. They only spent $0.6 million on property and equipment. If the credit stays good, this thing is a cash-flow fountain.

• Balance Sheet Simplicity (4/5): It’s mostly cash ($134.7 million) and receivables ($184.1 million). It’s easy to see what’s under the hood.

• Risk Discipline (3/5): They intentionally lowered the bar to grow. That’s either a genius move to grab market share or the start of a slippery slope. We’re watching this closely.

• Capital Allocation (4/5): They bought back $34.6 million worth of shares this year. I love seeing a company return cash to owners, as long as they don’t leave themselves short on liquidity.

The Audit: The biggest trick here is the “weak” cash flow. It’s not weak; it’s just being used to grow the loan book. If you think the loans are good, the cash flow is fine. If you think the loans are shaky, the cash flow is a red flag.

The Atomic Take: Sezzle is a high-quality machine right now, but you have to treat credit and growth as “first-class” risks. If operating cash drops while profits look good, it means the quality of those profits is starting to rot.

The Statements: Reading the Geiger Counter

Folks, if you want to know if a nuclear reactor is safe, you don’t just look at how much power it’s putting out; you check the radiation levels.

In a lending business, the Balance Sheet is your Geiger counter.

As of Sept 30, 2025, the “Big Five” numbers look like this:

1. Cash (the oxygen): $134.7 million.

2. Notes Receivable (the loans): $184.1 million.

3. Allowance for Credit Losses (the safety net): $33.7 million.

4. Line of Credit (the debt): $117.3 million.

5. Equity (the owner’s stake): $155.3 million.

One sneaky thing to watch is something called DSIP (Delayed Settlement). It’s basically merchants saying, “Keep our money for a bit, pay us interest, and we’ll use it as a float.”

Sezzle has $43.0 million sitting in that bucket. It’s not “toxic,” but it’s not a normal payable either. It’s helpful funding, but in a crisis, merchant behavior can change fast.

The Atomic Take: The balance sheet is simple enough to stress-test on a napkin. But watch that unused borrowing capacity ($32.0 million). If that starts to shrink while loans grow, the car is running out of gas right as it’s trying to speed up.

Cash Flow: The Turbine

In most businesses, “Cash is King.” In Sezzle’s world, Cash is a Turbine. They made $90.4 million in Net Income over nine months, but “only” saw $55.6 million in Operating Cash.

Why the gap? Because they used $85.2 million to fund new loans.

The real “Free Cash” (Cash from Ops minus the tiny $2.1 million they spent on equipment and software) is about $53.5 million.

The Audit: The question isn’t “Where did the cash go?” It’s “Are these new loans high-quality?” If the loans are good, the cash flow is a coiled spring. If the loans are bad, the turbine is about to wobble.

The Income Statement: The Reactor Room

The reactor was humming in Q3:

• Revenue: $116.8 million.

• Operating Income: $35.6 million.

• Net Income: $26.7 million.

• Adjusted EBITDA Margin: A fat 33.9%.

But here’s the control rod: the Provision for Credit Losses was $32.177 million. Because they changed their underwriting to find more customers, they had to set aside more “just in case” money.

Unlike a software company that can just cut its travel budget to save money, Sezzle lives and dies by the “spread.” They have to make sure the 11.2% Take Rate stays comfortably above the cost of the loans going bad.

Share

Here is the “Capital Efficiency” section, rewritten to match the Simple Truths style and tone.

The Radiation Test (Capital Efficiency)

If you want to understand why Sezzle looks “cheap” on a screen but feels dangerous in your gut, you have to look at how hot the reactor is running. The business is generating a massive amount of profit relative to the tiny amount of capital actually sitting in the bank.

That is great... until it isn’t.

• The Metric: Return on Equity (ROE).

• The Number: ~74% (First 9 Months of 2025).

• The Translation: For every $1 of equity the owners have in the company, Sezzle generated $0.74 of profit in just nine months. If you annualized that, it’s nearly a 100% return.

• The Reality Check: Net Income was $90.4M while the average equity was only ~$121.6M.

The “Audit” (Why This is Scary): The returns are sky-high not just because the business is good, but because the equity base is small.

Think of it like a sports car that has been stripped of its roll cage and bumpers to save weight. It goes incredibly fast (high efficiency), but if it hits a single bump (a spike in bad loans), it doesn’t just dent; it shatters.

The Atomic Take: Don’t admire the glow without checking the containment vessel.

• The Good: They are printing money with very little capital required (ROCE is ~52%).

• The Bad: This only works if the “credit dial” stays disciplined.

• The Falsifier: Watch the Return on Capital (ROCE). If it drops below 30% in the next two quarters, the “capital-light profit machine” is broken, and the stock deserves to stay cheap.

Valuation

Alright, let’s address the elephant in the room. In July 2025, this stock hit $182. Today, as of writing this deep dive, it’s trading at $69.

That is a ~62.1% drawdown. Yikes.

That is not a “dip.” Not even the “dip of the dip”. That is a full-blown haircut. When a stock drops like that, you don’t just ask, “Is it cheap now?” You have to ask the harder question: “What did the market believe at $182 that it stopped believing at $69?”

The Math of the Fall

Let’s assume the share count hasn’t changed much (Sezzle told us they had 34,153,102 shares outstanding as of Nov 3, 2025). At $69, that gives us a market cap of roughly $2.4 billion.

Now, let’s translate that price drop into what actually changed: the valuation multiple.

Scenario A: The $69 Reality (Today)

If we look at the business right now, here is what you are paying for:

1. The Earnings Lens (GAAP):

• Net Income (9 months): $90.4 million.

• Run-Rate (Annualized): About $120.5 million (just taking the 9 months and adding a third).

• The Price Tag: At a $2.4 billion market cap, you’re paying a P/E of ~19.9x.

• The Yield: That’s an earnings yield of about 5.0%.

If you prefer per-share math:

• Run-Rate EPS: ~$3.53.

• P/E: Still ~19.6x.

2. The Cash Flow Lens (The “Truth Serum”): We can build a disciplined proxy for Free Cash Flow (FCF), not to take a victory lap, but to see how much cash actually hits the till.

• Cash from Operations: $55.6 million (9M 2025).

• Capex (Property + Intangibles): A tiny $2.1 million ($0.6m + $1.5m).

• FCF Proxy: $53.5 million.

• Run-Rate FCF: ~$71.3 million.

• The Price Tag: A P/FCF of ~33.6x.

• The Yield: An FCF yield of about 3.0%.

Scenario B: The Ghost of $182 (What Were We Thinking?)

Now, let’s hop in the time machine back to July. If the share count was roughly the same, that $182 price tag implied a market cap of about $6.33 billion.

Run those same earnings through that price, and here is what the market was paying:

• Implied P/E: ~52.5x.

• Implied Earnings Yield: ~1.9%.

• Implied P/FCF: ~88.7x.

• Implied FCF Yield: ~1.1%.

The Story in One Sentence: The market stopped treating Sezzle like a “Premium Tech Compounder” (where you pay 50x earnings for growth) and started treating it like a “Credit-Sensitive Cash Converter” (where you demand a discount because lending is risky).

So, Is It Cheap?

The market is basically saying: “I’ll buy it at 19x earnings, but I need you to prove you aren’t going to blow up.”

It all comes down to a simple spread trade:

1. The Take Rate: 11.2% (Q3 2025). This is the money coming in.

2. The Credit Losses: 3.1% (Q3 actual), trending toward 2.5%–2.75% (2025 target). This is the money leaking out.

If the Take Rate holds and the Credit Losses drop to that 2.5% range, then 19.9x earnings could be a bargain, in my view.

But if credit stays sticky or the take rate drops, the valuation compression wasn’t just a bad mood—it was math.

Atomic Take: The move from $182 to $69 was a massive “Multiple Reset.” We went from a ~2% earnings yield to a ~5% earnings yield. The market is now demanding proof that the profit margin is real and not just a temporary luck of the draw.

Falsifier: If the provision for credit losses doesn’t trend down to 2.5%–2.75% while the take rate stays at 11.2%, then the “Cheap P/E” narrative falls apart. The earnings aren’t durable, and the stock isn’t cheap—it’s just risky.

Subscribe now

The “Meltdown” List (Risks)

1. The Seasonal Spike: Q4 is “Danger Zone” time for credit. They’re widening the net right as the shark-infested waters get choppy.

2. The “Fee” Optics: They made $33.5 million from consumer fees and $21.0 million from late fees. Regulators love to look at those numbers. It’s a headline risk.

3. The “Optional” Parasites: They’re spending $1.3 million on “strategic projects” like exploring a bank charter (ILC) and dealing with Shopify legal matters. It’s small now, but distractions can grow.

The Atomic Verdict: High Conviction

★★★★☆ (4/5)

(Star system is not a buy recommendation, only a judgement for the quality of the business based on my parameters)

Sezzle has earned the “Real Business” label. They make actual GAAP profit, and the balance sheet isn’t a house of cards. But it’s “Overhang-Heavy.” The next act depends on discipline, not just momentum.

Watch for the Upgrade: If credit costs drop toward 2.5% and subscribers keep growing past 0.6 million, I’m pounding myself on the chest.

Watch for the Downgrade: If cash from operations starts to look puny compared to net income, or if the “borrowing gas tank” hits empty, we’ve got a problem.

If you are pure numbers guy, and dont want anything else but the data,you can read the FINS analysis of Sezzle here.

Are you a believer in the “Subscription BNPL” model, or do you think the reliance on consumer fees is a regulatory ticking time bomb? Let’s hash it out in the comments below!

Sources

• Sezzle Inc. — Form 10-Q (PDF): “10-Q_-Sezzle_INC-_11-06-2025.pdf”

• Sezzle Inc. — Q3 2025 Earnings Call Transcript (PDF): “Q3_2025_Earnings_Call_Transcript.pdf”

• Sezzle Inc. — Investor Presentation (3Q25) (PDF): “Sezzle_Investor_Presentation_3Q25.pdf”

• Sezzle Inc. — IR Factsheet (3Q25) (PDF): “3Q25_IR_Factsheet_vFINAL.pdf”

• Atomic Moat Research — FINS Financial Audit (PDF): “Sezzle ($SEZL) Stock Analysis_ FINS Financial Audit.pdf”

• Sezzle Inc. — Financial Model / Dataset (XLSX): “SEZL-Sezzle Inc.xlsx”

Disclaimer

This Deep Dive is an educational breakdown of a public company based on information available in the materials provided (e.g., annual/quarterly reports, investor presentations, earnings transcripts) and my interpretation of that information. It is designed to be a “bolt-on” intelligence layer to your own due diligence — not a replacement for it.

Independence: I do not accept compensation of any kind from the companies discussed. My research is driven solely by my personal search for high-quality compounders.

Skin in the Game: Unless otherwise stated, assume the author may hold a long position in securities mentioned. Any position creates bias — treat this as commentary, not gospel.

Not Financial Advice: Nothing here is investment advice, a recommendation, or a solicitation. I am not a financial advisor. You are responsible for your own decisions. The stars rating is not a buy recommendation, but meant as a guide to understand the quality of the financial statement of the respective companies.

Error & Update Risk: Financial statements change, companies restate, guidance evolves, and I can be wrong. Verify key figures in the primary filings and consider reading the footnotes before deploying capital.